,words,labels,sentence_id,full sentence
72,Moreover,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
73,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
74,selenium,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
75,content,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
76,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
77,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
78,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
79,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
80,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
81,gluten,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
82,-,I,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
83,free,I,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
84,cereals,I,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
85,like,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
86,corn,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
87,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
88,rice,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
89,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
90,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
91,buckwheat,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
92,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
93,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
94,relatively,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
95,new,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
96,or,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
97,less,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
98,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
99,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
100,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
101,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
102,oat,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
103,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
104,amaranth,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
105,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
106,teff,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
107,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
108,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
109,quinoa,B,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
110,was,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
111,compared,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
112,.,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
113,Selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
114,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
115,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
116,the,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
117,tested,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
118,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
119,ranged,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
120,from,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
121,0.9,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
122,to,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
123,24.5,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
124,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
125,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
126,The,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
127,average,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
128,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
129,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
130,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
131,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
132,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
133,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
134,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
135,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
136,gluten,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
137,-,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
138,free,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
139,cereals,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
140,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
141,2.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
142,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
143,g,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
144,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
145,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
146,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
147,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
148,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
149,oat,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
150,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
151,amaranth,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
152,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
153,teff,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
154,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
155,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
156,quinoa,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
157,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
158,10.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
159,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
160,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
161,It,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
162,indicates,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
163,that,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
164,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
165,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
166,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
167,less,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
168,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
169,grains,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
170,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
171,especially,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
172,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
173,oat,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
174,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
175,should,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
176,be,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
177,more,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
178,frequently,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
179,chosen,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
180,as,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
181,a,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
182,source,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
183,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
184,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
185,by,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
186,people,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
187,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
188,gluten,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
189,-,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
190,free,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
191,diet,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
192,than,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
193,traditionally,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
194,consumed,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
195,gluten,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
196,-,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
197,free,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
198,grains,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
199,.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
262,The,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
263,most,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
264,efficient,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
265,selection,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
266,scheme,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
267,for,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
268,local,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
269,dairy,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
270,sheep,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
271,breeds,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
272,is,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
273,based,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
274,on,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
275,pyramidal,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
276,management,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
277,of,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
278,the,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
279,population,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
280,with,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
281,the,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
282,breeders,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
283,of,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
284,nucleus,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
285,flocks,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
286,at,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
287,the,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
288,top,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
289,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
290,where,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
291,pedigree,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
292,and,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
293,official,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
294,milk,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
295,recording,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
296,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
297,artificial,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
298,insemination,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
299,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
300,controlled,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
301,natural,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
302,mating,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
303,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
304,and,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
305,breeding,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
306,value,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
307,estimation,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
308,are,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
309,carried,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
310,out,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
311,to,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
312,generate,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
313,genetic,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
314,progress,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
315,.,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
456,However,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
457,",",O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
458,the,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
459,possibility,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
460,of,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
461,including,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
462,other,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
463,traits,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
464,of,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
465,selective,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
466,interest,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
467,is,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
468,limited,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
469,by,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
470,high,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
471,recording,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
472,costs,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
473,.,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
499,In,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
500,this,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
501,context,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
502,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
503,the,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
504,application,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
505,of,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
506,selection,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
507,schemes,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
508,assisted,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
509,by,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
510,molecular,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
511,information,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
512,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
513,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
514,improve,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
515,either,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
516,traditional,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
517,dairy,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
518,traits,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
519,or,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
520,traits,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
521,costly,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
522,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
523,record,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
524,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
525,seems,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
526,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
527,be,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
528,attractive,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
529,in,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
530,dairy,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
531,sheep,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
532,.,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
1682,These,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1683,levels,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1684,are,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1685,much,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1686,higher,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1687,than,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1688,those,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1689,for,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1690,Americans,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1691,or,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1692,Western,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1693,Europeans,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1694,",",O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1695,whose,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1696,mortality,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1697,rates,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1698,for,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1699,breast,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1700,",",O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1701,colon,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1702,and,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1703,prostate,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1704,cancers,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1705,are,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1706,greater,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1707,than,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1708,the,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1709,Japanese,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1710,.,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1818,We,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1819,found,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1820,an,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1821,inverse,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1822,association,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1823,between,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1824,total,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1825,fruit,B,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1826,and,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1827,vegetable,B,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1828,intake,I,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1829,and,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1830,head,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1831,and,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1832,neck,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1833,cancer,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1834,risk,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1835,(,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1836,per,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1837,serving,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1838,/,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1839,"day/1,000",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1840,calories,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1841,",",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1842,Hazard,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1843,Ratio,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1844,",",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1845,95,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1846,%,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1847,Confidence,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1848,interval,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1849,:,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1850,0.94,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1851,",",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1852,0.89,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1853,-,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1854,0.99,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1855,),O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1856,.,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
2408,Additionally,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2409,",",O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2410,stimulation,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2411,of,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2412,the,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2413,browning,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2414,program,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2415,by,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2416,ginger,B,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2417,may,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2418,be,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2419,partly,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2420,regulated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2421,by,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2422,the,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2423,sirtuin-1,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2424,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2425,SIRT1)/AMP,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2426,-,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2427,activated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2428,protein,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2429,kinase,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2430,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2431,AMPK)/peroxisome,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2432,proliferator,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2433,-,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2434,activated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2435,receptor,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2436,γ,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2437,coactivator,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2438,1α,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2439,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2440,PGC-1α,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2441,),O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2442,pathway,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2443,.,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
3069,Forty,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3070,-,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3071,six,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3072,subjects,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3073,(,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3074,33F/13,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3075,M,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3076,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3077,body,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3078,mass,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3079,index,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3080,:,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3081,32.5,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3082,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3083,0.7,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3084,kg,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3085,/,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3086,m²,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3087,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3088,age,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3089,:,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3090,50,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3091,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3092,1,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3093,years,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3094,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3095,mean,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3096,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3097,SEMs,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3098,),O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3099,consumed,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3100,a,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3101,standard,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3102,sandwich,B,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3103,with,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3104,one,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3105,of,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3106,the,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3107,six,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3108,beverages,B,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3109,on,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3110,separate,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3111,mornings,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3112,in,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3113,randomized,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3114,order,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3115,.,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3116,The,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3117,test,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3118,beverages,B,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3119,(,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3120,except,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3121,water,B,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3122,),O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3123,each,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3124,contained,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3125,12,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3126,g,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3127,digestible,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3128,carbohydrate,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3129,.,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
4474,All,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4475,street,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4476,food,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4477,vending,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4478,sites,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4479,(,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4480,single,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4481,point,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4482,of,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4483,sale,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4484,),O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4485,located,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4486,in,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4487,a,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4488,1,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4489,-,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4490,km,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4491,buffer,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4492,centred,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4493,on,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4494,the,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4495,main,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4496,public,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4497,market,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4498,were,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4499,systematically,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4500,selected,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4501,(,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4502,n,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4503,439,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4504,;,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4505,n,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4506,328,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4507,participants,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4508,),O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4509,.,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4576,Fruits,B,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4577,",",O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4578,beverages,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4579,and,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4580,food,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4581,other,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4582,than,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4583,fruits,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4584,were,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4585,available,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4586,in,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4587,2·5,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4588,",",O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4589,74·3,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4590,and,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4591,80·8,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4592,%,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4593,of,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4594,the,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4595,vending,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4596,sites,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4597,",",O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4598,respectively,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
4599,.,O,145.0,"Fruits , beverages and food other than fruits were available in 2·5 , 74·3 and 80·8 % of the vending sites , respectively ."
5115,DMH,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5116,was,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5117,used,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5118,to,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5119,induce,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5120,colon,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5121,cancer,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5122,in,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5123,rats,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5124,;,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5125,while,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5126,olive,B,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5127,oil,I,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5128,was,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5129,given,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5130,to,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5131,separate,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5132,group,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5133,of,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5134,rats,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5135,along,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5136,with,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5137,DMH,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5138,treatment,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5139,.,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5443,Milk,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5444,peptides,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5445,may,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5446,also,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5447,have,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5448,other,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5449,additional,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5450,mechanisms,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5451,to,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5452,lower,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5453,blood,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5454,pressure,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5455,such,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5456,as,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5457,opioid,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5458,-,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5459,like,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5460,activities,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5461,and,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5462,mineral,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5463,-,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5464,binding,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5465,and,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5466,antithrombotic,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5467,properties,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5468,.,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5609,Daily,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5610,water,B,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5611,intake,I,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5612,was,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5613,associated,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5614,with,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5615,a,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5616,slight,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5617,decrease,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5618,in,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5619,bladder,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5620,cancer,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5621,risk,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5622,",",O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5623,with,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5624,the,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5625,protection,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5626,more,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5627,pronounced,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5628,among,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5629,women,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5630,(,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5631,p,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5632,for,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5633,trend,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5634,=,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5635,0.039,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5636,),O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5637,than,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5638,among,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5639,men,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5640,(,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5641,p,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5642,for,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5643,trend,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5644,=,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5645,0.62,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5646,),O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5647,.,O,183.0,"Daily water intake was associated with a slight decrease in bladder cancer risk , with the protection more pronounced among women ( p for trend = 0.039 ) than among men ( p for trend = 0.62 ) ."
5947,The,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5948,objective,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5949,of,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5950,the,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5951,study,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5952,was,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5953,to,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5954,conduct,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5955,a,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5956,screening,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5957,for,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5958,potential,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5959,anti,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5960,-,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5961,obesity,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5962,polyphenolic,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5963,plant,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5964,extracts,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5965,using,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5966,a,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5967,diet,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5968,-,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5969,induced,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5970,animal,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5971,model,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
5972,.,O,193.0,The objective of the study was to conduct a screening for potential anti - obesity polyphenolic plant extracts using a diet - induced animal model .
6225,Latest,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6226,research,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6227,highlights,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6228,the,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6229,relationship,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6230,between,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6231,consuming,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6232,tomato,B,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6233,and,I,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6234,its,I,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6235,products,I,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6236,with,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6237,reduced,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6238,risk,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6239,of,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6240,various,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6241,maladies,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6242,like,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6243,obesity,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6244,",",O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6245,hyperglycemic,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6246,and,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6247,hypercholesterolemic,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6248,attributes,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6249,",",O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6250,cardiovascular,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6251,disorders,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6252,",",O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6253,and,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6254,cancer,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6255,insurgences,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
6256,.,O,204.0,"Latest research highlights the relationship between consuming tomato and its products with reduced risk of various maladies like obesity , hyperglycemic and hypercholesterolemic attributes , cardiovascular disorders , and cancer insurgences ."
7373,Patient,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7374,history,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7375,of,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7376,food,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7377,intolerance,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7378,was,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7379,documented,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7380,by,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7381,a,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7382,standardized,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7383,questionnaire,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7384,.,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7399,Cross,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7400,-,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7401,reacting,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7402,IgE,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7403,antibodies,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7404,recognizing,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7405,latex,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7406,and,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7407,fruit,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7408,allergens,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7409,(,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7410,papaya,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7411,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7412,avocado,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7413,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7414,banana,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7415,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7416,chestnut,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7417,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7418,passion,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7419,fruit,I,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7420,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7421,fig,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7422,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7423,melon,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7424,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7425,mango,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7426,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7427,kiwi,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7428,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7429,pineapple,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7430,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7431,peach,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7432,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7433,and,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7434,tomato,B,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7435,),O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7436,were,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7437,demonstrated,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7438,by,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7439,RAST,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7440,-,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7441,inhibition,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7442,tests,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7443,.,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7468,However,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7469,",",O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7470,fruit,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7471,-,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7472,specific,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7473,IgE,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7474,antibodies,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7475,were,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7476,detected,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7477,only,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7478,in,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7479,serum,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7480,samples,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7481,from,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7482,32.1,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7483,%,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7484,of,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7485,the,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7486,patients,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7487,who,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7488,perceived,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7489,symptoms,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7490,due,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7491,to,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7492,these,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7493,fruits,B,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7494,.,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
8669,The,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8670,glycaemic,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8671,index,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8672,(,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8673,GI,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8674,),O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8675,ranks,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8676,foods,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8677,according,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8678,to,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8679,their,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8680,acute,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8681,glycaemic,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8682,impact,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8683,and,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8684,is,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8685,used,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8686,in,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8687,planning,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8688,meals,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8689,for,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8690,patients,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8691,invoking,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8692,glycaemic,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8693,control,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8694,through,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8695,diet,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8696,.,O,286.0,The glycaemic index ( GI ) ranks foods according to their acute glycaemic impact and is used in planning meals for patients invoking glycaemic control through diet .
8781,Kurakkan,B,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8782,flour,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8783,pittu,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8784,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8785,wheat,B,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8786,flour,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8787,roti,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8788,were,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8789,classified,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8790,as,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8791,medium,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8792,-,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8793,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8794,foods,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8795,with,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8796,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8797,values,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8798,of,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8799,85+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8800,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8801,72+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8802,.,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8803,Hoppers,B,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8804,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8805,rice,B,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8806,flour,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8807,pittu,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8808,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8809,wheat,B,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8810,flour,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8811,pittu,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8812,and,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8813,Olu,B,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8814,-,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8815,milk,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8816,rice,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8817,(,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8818,seeds,B,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8819,of,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8820,Nymphaea,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8821,lotus,I,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8822,),O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8823,were,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8824,categorized,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8825,as,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8826,high,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8827,-,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8828,GI,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8829,foods,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8830,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8831,and,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8832,the,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8833,corresponding,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8834,GI,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8835,(,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8836,+,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8837,/-,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8838,standard,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8839,error,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8840,of,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8841,the,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8842,mean,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8843,),O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8844,values,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8845,were,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8846,120+/-8,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8847,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8848,103+/-7,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8849,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8850,101+/-8,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8851,and,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8852,91+/-8,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8853,",",O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8854,respectively,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
8855,.,O,289.0,"Hoppers , rice flour pittu , wheat flour pittu and Olu - milk rice ( seeds of Nymphaea lotus ) were categorized as high - GI foods , and the corresponding GI ( + /- standard error of the mean ) values were 120+/-8 , 103+/-7 , 101+/-8 and 91+/-8 , respectively ."
9053,Whey,B,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9054,",",O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9055,lactalbumin,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9056,and,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9057,lactoferrin,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9058,improved,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9059,glucose,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9060,clearance,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9061,partly,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9062,through,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9063,differential,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9064,upregulation,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9065,of,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9066,glucoregulatory,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9067,transcripts,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9068,in,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9069,the,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9070,liver,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9071,and,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9072,skeletal,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9073,muscle,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9074,.,O,298.0,"Whey , lactalbumin and lactoferrin improved glucose clearance partly through differential upregulation of glucoregulatory transcripts in the liver and skeletal muscle ."
9075,Interestingly,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9076,",",O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9077,lactalbumin,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9078,and,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9079,lactoferrin,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9080,decreased,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9081,hepatic,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9082,lipidosis,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9083,partly,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9084,through,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9085,downregulation,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9086,of,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9087,lipogenic,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9088,and/or,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9089,upregulation,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9090,of,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9091,β,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9092,-,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9093,oxidation,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9094,transcripts,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9095,",",O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9096,and,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9097,differentially,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9098,modulated,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9099,cecal,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9100,bacterial,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9101,populations,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9102,.,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9661,Phenolic,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9662,compounds,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9663,are,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9664,a,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9665,large,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9666,class,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9667,of,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9668,phytochemicals,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9669,that,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9670,are,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9671,widespread,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9672,in,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9673,the,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9674,plant,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9675,kingdom,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9676,and,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9677,known,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9678,to,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9679,have,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9680,antioxidant,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9681,capacities,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9682,.,O,321.0,Phenolic compounds are a large class of phytochemicals that are widespread in the plant kingdom and known to have antioxidant capacities .
9754,Lingonberry,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9755,and,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9756,blueberry,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9757,plants,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9758,were,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9759,found,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9760,to,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9761,be,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9762,rich,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9763,sources,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9764,of,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9765,phenolic,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9766,compounds,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9767,.,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
10514,It,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10515,can,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10516,also,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10517,be,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10518,considered,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10519,as,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10520,a,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10521,substitute,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10522,for,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10523,animal,B,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10524,milk,I,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10525,due,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10526,to,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10527,various,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10528,allergy,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10529,concerns,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10530,associated,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10531,with,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10532,dairy,B,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10533,milk,I,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10534,.,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10636,In,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10637,addition,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10638,",",O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10639,it,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10640,also,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10641,provides,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10642,a,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10643,detailed,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10644,review,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10645,of,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10646,the,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10647,general,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10648,characteristics,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10649,and,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10650,functional,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10651,properties,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10652,of,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10653,these,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10654,plant,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10655,sources,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10656,.,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10889,A,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10890,higher,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10891,modern,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10892,score,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10893,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10894,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10895,1,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10896,SD,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10897,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10898,predicted,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10899,an,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10900,annual,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10901,decrease,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10902,in,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10903,2h,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10904,-,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10905,PG,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10906,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10907,0.015,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10908,mmol,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10909,/,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10910,L,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10911,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10912,P,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10913,<,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10914,0.01,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10915,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10916,regardless,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10917,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10918,glucose,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10919,tolerance,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10920,status,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10921,.,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
11624,Increased,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11625,IgE,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11626,serum,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11627,levels,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11628,were,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11629,found,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11630,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11631,36.8,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11632,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11633,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11634,exposed,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11635,and,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11636,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11637,9.7,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11638,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11639,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11640,the,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11641,control,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11642,workers,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11643,(,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11644,P,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11645,less,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11646,than,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11647,0.01,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11648,),O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11649,.,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11896,Pulses,B,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11897,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11898,including,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11899,peas,B,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11900,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11901,are,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11902,a,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11903,good,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11904,source,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11905,of,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11906,protein,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11907,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11908,dietary,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11909,fiber,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11910,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11911,folic,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11912,acid,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11913,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11914,and,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11915,iron,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11916,and,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11917,are,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11918,reported,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11919,to,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11920,reduce,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11921,the,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11922,risk,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11923,for,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11924,cardiovascular,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11925,disease,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11926,and,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11927,diabetes,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11928,.,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
12388,In,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12389,subsequent,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12390,tests,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12391,",",O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12392,panelists,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12393,(,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12394,n=50,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12395,),O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12396,evaluated,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12397,salty,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12398,intensity,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12399,of,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12400,these,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12401,food,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12402,products,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12403,in,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12404,separate,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12405,sessions,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12406,using,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12407,an,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12408,ascending,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12409,force,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12410,choice,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12411,method,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12412,to,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12413,determine,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12414,the,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12415,just,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12416,-,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12417,noticeable,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12418,difference,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12419,.,O,415.0,"In subsequent tests , panelists ( n=50 ) evaluated salty intensity of these food products in separate sessions using an ascending force choice method to determine the just - noticeable difference ."
12601,Appropriate,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12602,product,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12603,positioning,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12604,or,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12605,advertising,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12606,may,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12607,be,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12608,beneficial,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12609,to,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12610,consumer,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12611,acceptance,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12612,of,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12613,lower,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12614,sodium,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12615,types,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12616,of,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12617,products,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12618,.,O,421.0,Appropriate product positioning or advertising may be beneficial to consumer acceptance of lower sodium types of products .
12619,Our,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12620,aim,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12621,was,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12622,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12623,review,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12624,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12625,epidemiological,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12626,literature,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12627,on,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12628,possible,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12629,cancer,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12630,-,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12631,preventive,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12632,effects,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12633,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12634,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12635,consumption,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12636,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12637,fruits,B,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12638,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12639,vegetables,B,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12640,in,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12641,humans,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12642,",",O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12643,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12644,quantify,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12645,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12646,effect,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12647,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12648,high,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12649,versus,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12650,low,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12651,consumption,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12652,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12653,fruits,B,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12654,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12655,vegetables,B,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12656,",",O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12657,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12658,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12659,give,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12660,an,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12661,overall,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12662,assessment,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12663,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12664,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12665,existing,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12666,evidence,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12667,.,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
13172,A,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13173,total,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13174,of,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13175,twenty,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13176,-,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13177,five,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13178,obese,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13179,women,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13180,aged,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13181,38,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13182,-,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13183,68,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13184,years,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13185,consumed,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13186,isoenergetic,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13187,meals,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13188,rich,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13189,in,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13190,potato,B,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13191,(,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13192,POT,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13193,),O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13194,or,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13195,casein,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13196,(,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13197,CA,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13198,),O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13199,or,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13200,a,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13201,combination,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13202,of,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13203,both,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13204,these,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13205,meals,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13206,(,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13207,POT,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13208, ,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13209,+,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13210, ,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13211,CA,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13212,),O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13213,",",O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13214,in,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13215,random,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13216,order,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13217,in,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13218,a,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13219,cross,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13220,-,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13221,over,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13222,trial,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13223,.,O,438.0,"A total of twenty - five obese women aged 38 - 68 years consumed isoenergetic meals rich in potato ( POT ) or casein ( CA ) or a combination of both these meals ( POT   +   CA ) , in random order in a cross - over trial ."
13258,Plasma,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13259,IL-6,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13260,concentrations,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13261,increased,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13262,significantly,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13263,(,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13264,P,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13265, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13266,<,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13267, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13268,0·001,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13269,),O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13270,during,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13271,4,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13272, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13273,h,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13274,after,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13275,the,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13276,meals,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13277,.,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13440,We,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13441,determined,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13442,the,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13443,intake,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13444,of,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13445,gluten,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13446,from,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13447,wheat,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13448,",",O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13449,barley,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13450,",",O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13451,rye,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13452,and,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13453,oats,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13454,in,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13455,a,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13456,cross,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13457,-,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13458,sectional,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13459,National,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13460,Danish,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13461,Survey,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13462,of,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13463,Dietary,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13464,Habits,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13465,among,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13466,Infants,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13467,and,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13468,Young,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13469,Children,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13470,(,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13471,2006,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13472,-,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13473,2007,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13474,),O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13475,.,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13530,The,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13531,amounts,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13532,of,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13533,gluten,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13534,were,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13535,calculated,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13536,as,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13537,the,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13538,amount,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13539,of,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13540,cereal,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13541,protein,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13542, ,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13543,×,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13544, ,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13545,0·80,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13546,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13547,wheat,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13548,and,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13549,oats,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13550,",",O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13551,×0·65,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13552,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13553,rye,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13554,and,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13555,×0·50,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13556,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13557,barley,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13558,.,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
14323,Patients,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14324,who,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14325,developed,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14326,Apiaceae,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14327,sensitivity,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14328,showed,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14329,much,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14330,higher,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14331,birch,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14332,-,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14333,specific,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14334,IgE,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14335,levels,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14336,than,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14337,patients,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14338,who,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14339,developed,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14340,apple,B,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14341,/,B,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14342,hazelnut,B,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14343,allergy,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14344,only,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14345,(,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14346,median,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14347,15.5,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14348,vs,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14349,8.5,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14350,AU,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14351,/,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14352,ml,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14353,;,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14354,P,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14355,<,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14356,0.05,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14357,),O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14358,",",O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14359,whereas,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14360,those,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14361,who,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14362,remained,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14363,OAS,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14364,-,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14365,free,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14366,showed,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14367,the,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14368,lowest,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14369,specific,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14370,IgE,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14371,levels,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14372,(,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14373,median,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14374,5,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14375,AU,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14376,/,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14377,ml,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14378,),O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14379,.,O,478.0,"Patients who developed Apiaceae sensitivity showed much higher birch - specific IgE levels than patients who developed apple / hazelnut allergy only ( median 15.5 vs 8.5 AU / ml ; P < 0.05 ) , whereas those who remained OAS - free showed the lowest specific IgE levels ( median 5 AU / ml ) ."
14380,This,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14381,study,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14382,suggests,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14383,that,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14384,most,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14385,Apiaceae,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14386,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14387,cross,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14388,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14389,react,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14390,with,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14391,apple,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14392,or,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14393,hazelnut,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14394,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14395,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14396,whereas,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14397,only,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14398,some,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14399,apple,B,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14400,or,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14401,hazelnut,B,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14402,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14403,cross,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14404,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14405,react,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14406,with,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14407,Apiaceae,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14408,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14409,allergenic,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14410,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14411,;,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14412,moreover,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14413,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14414,it,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14415,shows,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14416,that,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14417,birch,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14418,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14419,specific,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14420,IgE,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14421,levels,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14422,heavily,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14423,influence,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14424,the,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14425,onset,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14426,of,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14427,OAS,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14428,as,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14429,a,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14430,whole,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14431,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14432,and,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14433,probably,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14434,play,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14435,a,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14436,critical,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14437,role,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14438,in,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14439,the,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14440,development,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14441,of,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14442,allergies,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14443,to,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14444,distinct,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14445,vegetable,B,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14446,foods,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14447,as,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14448,well,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14449,.,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14938,Importantly,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14939,",",O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14940,whereas,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14941,cell,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14942,-,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14943,autonomous,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14944,clocks,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14945,have,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14946,been,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14947,identified,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14948,in,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14949,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14950,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14951,",",O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14952,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14953,complete,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14954,circadian,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14955,programing,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14956,of,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14957,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14958,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14959,transcriptome,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14960,and,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14961,posttranslational,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14962,modifications,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14963,of,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14964,essential,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14965,metabolic,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14966,proteins,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14967,is,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14968,strongly,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14969,dependent,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14970,on,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14971,nutrient,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14972,flux,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14973,and,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14974,circadian,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14975,signals,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14976,from,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14977,outside,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14978,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14979,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14980,.,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
15012,To,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15013,study,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15014,the,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15015,postprandial,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15016,blood,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15017,glucose,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15018,and,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15019,insulin,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15020,responses,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15021,to,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15022,exchangeable,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15023,amounts,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15024,of,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15025,simple,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15026,and,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15027,complex,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15028,carbohydrates,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15029,",",O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15030,eight,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15031,non,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15032,-,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15033,insulin,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15034,-,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15035,dependent,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15036,diabetic,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15037,subjects,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15038,consumed,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15039,227,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15040,g,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15041,apple,B,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15042,",",O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15043,280,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15044,g,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15045,orange,B,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15046,or,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15047,50,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15048,g,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15049,white,B,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15050,bread,I,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15051,on,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15052,three,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15053,separate,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15054,days,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15055,.,O,500.0,"To study the postprandial blood glucose and insulin responses to exchangeable amounts of simple and complex carbohydrates , eight non - insulin - dependent diabetic subjects consumed 227 g apple , 280 g orange or 50 g white bread on three separate days ."
15444,The,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15445,administration,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15446,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15447,AMF,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15448,to,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15449,SHR,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15450,during,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15451,7,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15452,weeks,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15453,exerted,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15454,beneficial,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15455,effects,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15456,on,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15457,cardiovascular,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15458,risk,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15459,biomarkers,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15460,(,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15461,reduction,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15462,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15463,insulin,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15464,",",O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15465,blood,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15466,lipids,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15467,",",O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15468,increase,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15469,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15470,adiponectin,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15471,),O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15472,.,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
16055,The,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16056,T,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16057,pattern,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16058,was,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16059,characterized,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16060,by,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16061,low,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16062,dietary,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16063,diversity,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16064,",",O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16065,with,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16066,maize,B,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16067,and,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16068,maize,B,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16069,foods,I,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16070,accounting,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16071,for,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16072,~47,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16073,%,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16074,of,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16075,energy,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16076,intake,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16077,.,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16078,This,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16079,pattern,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16080,had,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16081,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16082,lowest,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16083,contribution,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16084,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16085,most,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16086,food,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16087,groups,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16088,",",O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16089,with,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16090,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16091,exception,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16092,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16093,beans,B,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16094,(,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16095,~4.0,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16096,%,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16097,),O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16098,.,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16327,The,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16328,objective,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16329,of,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16330,this,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16331,study,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16332,was,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16333,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16334,investigate,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16335,the,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16336,liver,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16337,proteome,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16338,of,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16339,postpartum,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16340,cows,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16341,that,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16342,were,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16343,cooled,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16344,or,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16345,heat,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16346,stressed,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16347,during,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16348,the,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16349,dry,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16350,period,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16351,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16352,gain,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16353,insight,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16354,into,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16355,how,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16356,protein,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16357,expression,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16358,is,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16359,altered,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16360,by,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16361,prior,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16362,heat,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16363,stress,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16364,and,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16365,may,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16366,contribute,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16367,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16368,performance,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16369,and,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16370,disease,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16371,outcomes,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16372,.,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16644,The,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16645,addition,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16646,of,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16647,dairy,B,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16648,products,I,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16649,to,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16650,meals,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16651,high,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16652,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16653,carbohydrates,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16654,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16655,fat,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16656,may,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16657,lessen,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16658,these,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16659,risks,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16660,through,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16661,reductions,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16662,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16663,postprandial,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16664,glucose,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16665,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16666,triglyceride,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16667,responses,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16668,.,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16691,The,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16692,current,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16693,review,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16694,evaluates,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16695,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16696,available,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16697,literature,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16698,describing,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16699,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16700,relationships,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16701,between,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16702,metabolic,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16703,dysfunction,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16704,",",O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16705,postprandial,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16706,metabolism,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16707,",",O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16708,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16709,vascular,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16710,dysfunction,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16711,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16712,discusses,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16713,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16714,potential,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16715,role,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16716,of,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16717,milk,B,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16718,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16719,dairy,B,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16720,products,I,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16721,in,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16722,attenuating,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16723,these,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16724,impairments,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16725,.,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16911,Skin,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16912,sensitivity,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16913,to,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16914,apple,B,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16915,",",O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16916,carrot,B,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16917,and,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16918,potato,B,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16919,",",O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16920,clinically,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16921,related,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16922,to,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16923,birch,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16924,pollinosis,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16925,was,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16926,investigated,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16927,.,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
17680,This,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17681,study,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17682,aims,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17683,to,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17684,investigate,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17685,which,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17686,kinds,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17687,of,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17688,dietary,B,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17689,fat,I,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17690,cause,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17691,the,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17692,intestinal,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17693,metaplasia,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17694,onset,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17695,.,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
18256,However,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18257,",",O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18258,results,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18259,are,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18260,contradictory,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18261,and,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18262,confounded,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18263,by,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18264,lack,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18265,of,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18266,detail,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18267,on,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18268,cooking,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18269,methods,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18270,.,O,611.0,"However , results are contradictory and confounded by lack of detail on cooking methods ."
18565,Present,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18566,data,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18567,evidence,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18568,the,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18569,relevance,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18570,of,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18571,the,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18572,timing,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18573,of,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18574,a,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18575,highly,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18576,caloric,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18577,and,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18578,palatable,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18579,meal,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18580,for,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18581,circadian,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18582,synchrony,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18583,and,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18584,metabolic,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18585,function,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18586,.,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18626,Approximately,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18627,1,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18628,%,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18629,of,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18630,the,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18631,world,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18632,'s,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18633,population,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18634,is,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18635,affected,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18636,by,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18637,CD,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18638,",",O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18639,and,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18640,the,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18641,development,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18642,of,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18643,gluten,B,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18644,-,I,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18645,free,I,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18646,beer,I,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18647,is,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18648,imperative,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18649,.,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
19461,For,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19462,381,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19463,cases,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19464,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19465,81.9,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19466,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19467,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19468,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19469,and,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19470,371,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19471,controls,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19472,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19473,76.3,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19474,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19475,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19476,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19477,",",O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19478,total,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19479,fluid,B,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19480,intake,I,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19481,could,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19482,be,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19483,calculated,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19484,.,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19666,Uncontrolled,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19667,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19668,blood,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19669,pressure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19670,may,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19671,lead,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19672,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19673,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19674,shortened,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19675,life,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19676,expectancy,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19677,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19678,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19679,higher,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19680,morbidity,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19681,due,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19682,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19683,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19684,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19685,risk,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19686,of,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19687,cardiovascular,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19688,complications,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19689,such,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19690,as,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19691,coronary,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19692,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19693,disease,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19694,(,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19695,which,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19696,leads,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19697,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19698,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19699,attack,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19700,),O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19701,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19702,stroke,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19703,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19704,congestive,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19705,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19706,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19707,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19708,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19709,rhythm,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19710,irregularities,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19711,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19712,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19713,kidney,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19714,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19715,etc,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19716,.,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19966,Moreover,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19967,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19968,substantial,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19969,experimental,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19970,studies,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19971,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19972,supported,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19973,the,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19974,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19975,role,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19976,of,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19977,fruits,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19978,against,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19979,CVDs,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19980,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19981,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19982,several,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19983,fruits,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19984,(,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19985,grape,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19986,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19987,blueberry,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19988,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19989,pomegranate,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19990,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19991,apple,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19992,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19993,hawthorn,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19994,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19995,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19996,avocado,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19997,),O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19998,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19999,been,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20000,widely,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20001,studied,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20002,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20003,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20004,shown,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20005,potent,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20006,cardiovascular,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20007,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20008,action,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20009,.,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20098,Alzheimer,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20099,disease,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20100,(,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20101,AD,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20102,),O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20103,is,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20104,one,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20105,of,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20106,the,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20107,most,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20108,common,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20109,forms,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20110,of,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20111,dementia,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20112,in,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20113,the,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20114,elderly,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20115,.,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20633,However,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20634,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20635,during,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20636,the,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20637,Enlightment,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20638,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20639,the,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20640,road,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20641,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20642,therapy,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20643,separated,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20644,from,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20645,that,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20646,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20647,taste,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20648,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20649,and,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20650,chocolate,B,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20651,mainly,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20652,maintained,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20653,its,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20654,leading,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20655,role,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20656,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20657,excipient,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20658,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20659,bearing,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20660,the,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20661,burden,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20662,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20663,over,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20664,time,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20665,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20666,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20667,a,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20668,negative,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20669,valence,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20670,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20671,being,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20672,associated,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20673,with,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20674,obesity,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20675,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20676,dental,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20677,problems,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20678,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20679,unhealthy,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20680,lifestyle,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20681,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20682,and,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20683,so,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20684,forth,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20685,.,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20817,After,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20818,allowance,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20819,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20820,non,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20821,-,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20822,dietary,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20823,confounding,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20824,factors,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20825,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20826,total,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20827,energy,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20828,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20829,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20830,significant,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20831,trends,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20832,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20833,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20834,risk,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20835,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20836,colorectal,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20837,cancer,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20838,with,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20839,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20840,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20841,emerged,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20842,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20843,bread,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20844,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20845,cereal,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20846,dishes,I,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20847,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20848,odds,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20849,ratio,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20850,[,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20851,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20852,],O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20853,in,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20854,highest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20855,vs.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20856,lowest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20857,quintile,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20858,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20859,1.7,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20860,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20861,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20862,potatoes,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20863,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20864,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20865,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20866,1.2,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20867,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20868,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20869,cakes,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20870,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20871,desserts,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20872,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20873,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20874,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20875,1.1,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20876,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20877,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20878,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20879,refined,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20880,sugar,I,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20881,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20882,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20883,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20884,1.4,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20885,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20886,.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20925,Consumption,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20926,of,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20927,eggs,B,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20928,and,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20929,meat,B,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20930,(,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20931,white,B,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20932,",",B,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20933,red,I,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20934,or,I,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20935,processed,I,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20936,meats,I,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20937,),O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20938,seemed,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20939,uninfluential,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20940,.,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
21003,The,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21004,beneficial,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21005,role,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21006,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21007,most,B,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21008,vegetables,I,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21009,is,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21010,confirmed,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21011,",",O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21012,with,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21013,more,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21014,than,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21015,20,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21016,%,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21017,reduction,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21018,in,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21019,risk,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21020,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21021,colorectal,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21022,cancer,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21023,from,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21024,the,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21025,addition,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21026,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21027,one,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21028,daily,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21029,serving,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21030,.,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21156,Milk,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21157,yield,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21158,loss,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21159,increased,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21160,as,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21161,the,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21162,number,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21163,of,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21164,test,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21165,days,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21166,with,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21167,SCC,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21168,"≥100,000",O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21169,cells,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21170,/,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21171,mL,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21172,increased,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21173,.,O,702.0,"Milk yield loss increased as the number of test days with SCC ≥100,000 cells / mL increased ."
21966,However,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21967,",",O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21968,for,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21969,many,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21970,fishing,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21971,based,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21972,subsistence,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21973,populations,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21974,",",O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21975,such,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21976,measures,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21977,are,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21978,not,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21979,practical,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
21980,.,O,732.0,"However , for many fishing based subsistence populations , such measures are not practical ."
22119,Liquid,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22120,chromatography,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22121,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22122,mass,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22123,spectrometry,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22124,(,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22125,LC,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22126,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22127,MS,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22128,),O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22129,was,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22130,used,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22131,to,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22132,assess,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22133,compositional,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22134,differences,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22135,between,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22136,mango,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22137,fractions,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22138,in,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22139,flesh,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22140,extracts,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22141,.,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22349,The,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22350,nuclear,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22351,peroxisome,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22352,proliferator,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22353,-,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22354,activated,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22355,receptors,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22356,(,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22357,PPAR,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22358,),O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22359,have,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22360,been,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22361,shown,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22362,to,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22363,play,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22364,crucial,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22365,roles,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22366,in,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22367,regulating,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22368,energy,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22369,homeostasis,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22370,including,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22371,lipid,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22372,and,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22373,carbohydrate,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22374,metabolism,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22375,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22376,inflammatory,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22377,responses,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22378,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22379,and,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22380,cell,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22381,proliferation,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22382,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22383,differentiation,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22384,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22385,and,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22386,survival,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22387,.,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22526,Skim,B,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22527,milk,I,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22528,enhanced,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22529,the,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22530,activity,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22531,of,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22532,PPAR,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22533,to,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22534,a,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22535,lesser,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22536,degree,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22537,than,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22538,regular,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22539,milk,B,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22540,.,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22621,The,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22622,increase,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22623,in,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22624,UCP2,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22625,mRNA,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22626,was,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22627,found,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22628,to,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22629,be,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22630,reduced,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22631,by,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22632,treatment,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22633,with,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22634,PPARdelta,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22635,-,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22636,short,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22637,interfering,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22638,(,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22639,si)RNA,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22640,.,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22691,Consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22692,look,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22693,for,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22694,products,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22695,that,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22696,contribute,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22697,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22698,their,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22699,wellness,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22700,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22701,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22702,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22703,however,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22704,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22705,even,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22706,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22707,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22708,conscious,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22709,consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22710,are,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22711,not,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22712,willing,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22713,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22714,sacrifice,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22715,organoleptic,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22716,properties,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22717,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22718,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22719,intense,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22720,full,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22721,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22722,flavor,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22723,snacks,B,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22724,remain,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22725,an,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22726,important,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22727,trend,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22728,.,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
23738,Conversely,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23739,",",O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23740,what,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23741,is,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23742,available,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23743,on,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23744,the,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23745,shelf,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23746,will,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23747,have,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23748,an,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23749,impact,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23750,on,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23751,the,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23752,choices,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23753,consumers,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23754,make,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23755,",",O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23756,thereby,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23757,affecting,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23758,their,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23759,health,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23760,.,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23761,Historical,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23762,examples,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23763,of,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23764,industrial,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23765,manipulation,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23766,of,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23767,the,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23768,diet,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23769,include,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23770,fortification,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23771,and,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23772,enrichment,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23773,of,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23774,cereal,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23775,grains,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23776,with,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23777,vitamins,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23778,;,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23779,increased,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23780,production,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23781,of,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23782,unsaturated,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23783,vegetable,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23784,oils,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23785,and,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23786,margarine,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23787,as,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23788,substitutions,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23789,for,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23790,hydrogenated,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23791,fat,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23792,",",O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23793,lard,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23794,",",O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23795,and,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23796,butter,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23797,;,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23798,lowered,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23799,cholesterol,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23800,content,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23801,foods,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23802,;,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23803,reduced,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23804,sugar,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23805,content,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23806,foods,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23807,;,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23808,lower,B,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23809,sodium,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23810,foods,I,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23811,;,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23812,decreased,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23813,portion,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23814,sizes,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23815,or,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23816,caloric,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23817,density,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23818,in,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23819,prepackaged,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23820,foods,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23821,for,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23822,use,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23823,in,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23824,weight,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23825,loss,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23826,or,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23827,maintenance,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23828,;,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23829,and,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23830,increased,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23831,calcium,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23832,levels,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23833,to,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23834,prevent,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23835,osteoporosis,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
23836,.,O,798.0,"Historical examples of industrial manipulation of the diet include fortification and enrichment of cereal grains with vitamins ; increased production of unsaturated vegetable oils and margarine as substitutions for hydrogenated fat , lard , and butter ; lowered cholesterol content foods ; reduced sugar content foods ; lower sodium foods ; decreased portion sizes or caloric density in prepackaged foods for use in weight loss or maintenance ; and increased calcium levels to prevent osteoporosis ."
24139,A,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24140,similar,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24141,trend,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24142,was,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24143,observed,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24144,for,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24145,samples,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24146,with,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24147,fat,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24148,added,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24149,",",O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24150,where,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24151,hardness,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24152,increased,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24153,from,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24154,approximately,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24155,50,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24156, ,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24157,g,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24158,force,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24159,to,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24160,approximately,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24161,75,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24162, ,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24163,g,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24164,force,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
24165,.,O,811.0,"A similar trend was observed for samples with fat added , where hardness increased from approximately 50   g force to approximately 75   g force ."
25088,Cereal,B,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25089,foods,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25090,with,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25091,low,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25092,glycaemic,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25093,index,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25094,such,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25095,as,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25096,pasta,B,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25097,and,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25098,oats,B,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25099,are,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25100,beneficial,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25101,for,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25102,people,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25103,with,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25104,diabetes,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25105,and,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25106,might,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25107,lower,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25108,plasma,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25109,lipids,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25110,.,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25931,Both,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25932,olive,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25933,oil,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25934,phenols,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25935,have,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25936,an,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25937,effective,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25938,role,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25939,counter,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25940,to,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25941,cell,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25942,proliferation,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25943,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25944,cell,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25945,growth,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25946,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25947,migration,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25948,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25949,invasion,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25950,",",O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25951,and,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25952,angiogenesis,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
25953,.,O,878.0,"Both olive oil phenols have an effective role counter to cell proliferation , cell growth , migration , invasion , and angiogenesis ."
26038,Since,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26039,ancient,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26040,times,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26041,",",O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26042,people,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26043,have,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26044,attributed,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26045,a,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26046,variety,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26047,of,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26048,health,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26049,benefits,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26050,to,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26051,moderate,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26052,consumption,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26053,of,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26054,fermented,B,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26055,beverages,I,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26056,such,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26057,as,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26058,wine,B,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26059,and,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26060,beer,B,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26061,",",O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26062,often,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26063,without,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26064,any,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26065,scientific,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26066,basis,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26067,.,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26068,There,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26069,is,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26070,evidence,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26071,that,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26072,excessive,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26073,or,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26074,binge,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26075,alcohol,B,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26076,consumption,I,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26077,is,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26078,associated,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26079,with,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26080,increased,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26081,morbidity,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26082,and,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26083,mortality,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26084,",",O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26085,as,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26086,well,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26087,as,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26088,with,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26089,work,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26090,related,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26091,and,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26092,traffic,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26093,accidents,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26094,.,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26455,We,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26456,conducted,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26457,literature,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26458,reviews,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26459,and,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26460,did,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26461,rapid,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26462,needs,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26463,assessments,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26464,in,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26465,both,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26466,countries,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26467,.,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26926,The,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26927,increased,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26928,dietary,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26929,intake,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26930,of,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26931,C18:3,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26932,in,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26933,flaxseed,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26934,-,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26935,supplemented,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26936,cows,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26937,resulted,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26938,in,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26939,increased,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26940,levels,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26941,of,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26942,milk,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26943,C18:1,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26944,trans-11,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26945,and,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26946,increased,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26947,conjugated,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26948,linoleic,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26949,acid,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26950,C18:2,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26951,"cis-9,trans-11",O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26952,by,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26953,Delta(9)-desaturase,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26954,activity,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
26955,.,O,913.0,"The increased dietary intake of C18:3 in flaxseed - supplemented cows resulted in increased levels of milk C18:1 trans-11 and increased conjugated linoleic acid C18:2 cis-9,trans-11 by Delta(9)-desaturase activity ."
27067,Male,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27068,Wistar,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27069,rats,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27070,fed,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27071,lifelong,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27072,on,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27073,diets,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27074,differing,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27075,in,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27076,the,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27077,fat,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27078,source,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27079,were,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27080,killed,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27081,at,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27082,6,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27083,and,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27084,at,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27085,24,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27086,months,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27087,of,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27088,age,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27089,.,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27213,According,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27214,to,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27215,the,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27216,results,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27217,",",O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27218,virgin,B,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27219,olive,I,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27220,oil,I,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27221,might,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27222,be,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27223,considered,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27224,the,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27225,dietary,B,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27226,fat,I,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27227,source,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27228,that,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27229,best,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27230,preserves,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27231,the,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27232,liver,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27233,during,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27234,the,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27235,aging,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27236,process,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27237,.,O,925.0,"According to the results , virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process ."
27502,The,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27503,objective,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27504,of,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27505,this,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27506,study,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27507,was,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27508,to,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27509,derive,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27510,food,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27511,-,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27512,based,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27513,dietary,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27514,guidelines,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27515,for,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27516,the,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27517,Dutch,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27518,population,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27519,.,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27660,Convincing,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27661,evidence,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27662,was,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27663,based,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27664,on,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27665,strong,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27666,evidence,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27667,from,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27668,the,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27669,experimental,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27670,data,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27671,either,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27672,or,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27673,not,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27674,in,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27675,combination,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27676,with,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27677,strong,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27678,evidence,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27679,from,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27680,prospective,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27681,cohort,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27682,studies,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
27683,.,O,938.0,Convincing evidence was based on strong evidence from the experimental data either or not in combination with strong evidence from prospective cohort studies .
28013,A,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28014,high,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28015,proportion,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28016,of,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28017,ethanol,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28018,-,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28019,extractable,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28020,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28021,showed,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28022,that,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28023,As,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28024,bioactivity,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28025,and,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28026,toxic,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28027,effects,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28028,were,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28029,the,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28030,highest,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28031,.,O,951.0,A high proportion of ethanol - extractable As showed that As bioactivity and toxic effects were the highest .
28852,This,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28853,decline,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28854,has,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28855,also,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28856,been,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28857,driven,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28858,by,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28859,declining,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28860,average,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28861,daily,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28862,participation,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28863,in,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28864,the,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28865,school,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28866,meal,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28867,program,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28868,and,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28869,may,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28870,also,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28871,reflect,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28872,children,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28873,'s,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28874,dissatisfaction,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28875,with,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28876,the,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28877,sensory,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28878,characteristics,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28879,and,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28880,the,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28881,form,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28882,of,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28883,milk,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28884,offered,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28885,in,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28886,schools,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28887,.,O,978.0,This decline has also been driven by declining average daily participation in the school meal program and may also reflect children 's dissatisfaction with the sensory characteristics and the form of milk offered in schools .
28923,This,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28924,review,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28925,describes,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28926,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28927,current,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28928,milk,B,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28929,consumption,I,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28930,trends,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28931,among,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28932,children,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28933,;,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28934,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28935,structure,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28936,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28937,basic,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28938,requirements,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28939,of,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28940,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28941,school,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28942,lunch,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28943,program,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28944,in,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28945,total,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28946,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28947,for,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28948,milk,B,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28949,;,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28950,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28951,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28952,intrinsic,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28953,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28954,extrinsic,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28955,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28956,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28957,environmental,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28958,factors,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28959,that,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28960,influence,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28961,child,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28962,perception,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28963,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28964,preference,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28965,",",O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28966,and,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28967,consumption,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28968,of,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28969,fluid,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28970,milk,B,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28971,in,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28972,the,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28973,US,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28974,school,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28975,system,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
28976,.,O,980.0,"This review describes the current milk consumption trends among children ; the structure and basic requirements of the school lunch program in total and for milk ; and the intrinsic , extrinsic , and environmental factors that influence child perception , preference , and consumption of fluid milk in the US school system ."
29234,This,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29235,review,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29236,concludes,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29237,that,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29238,green,B,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29239,tea,I,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29240,consumption,I,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29241,overall,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29242,may,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29243,be,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29244,considered,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29245,beneficial,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29246,for,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29247,human,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29248,health,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29249,.,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29288,Among,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29289,the,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29290,spices,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29291,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29292,black,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29293,pepper,I,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29294,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29295,capsicums,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29296,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29297,cumin,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29298,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29299,cinnamon,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29300,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29301,nutmeg,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29302,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29303,ginger,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29304,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29305,turmeric,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29306,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29307,saffron,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29308,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29309,coriander,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29310,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29311,cloves,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29312,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29313,dill,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29314,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29315,mint,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29316,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29317,thyme,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29318,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29319,sesame,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29320,seed,I,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29321,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29322,mustard,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29323,seed,I,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29324,",",O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29325,and,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29326,curry,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29327,powder,I,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29328,are,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29329,the,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29330,most,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29331,popular,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29332,spices,B,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29333,worldwide,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29334,.,O,993.0,"Among the spices , black pepper , capsicums , cumin , cinnamon , nutmeg , ginger , turmeric , saffron , coriander , cloves , dill , mint , thyme , sesame seed , mustard seed , and curry powder are the most popular spices worldwide ."
29411,We,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29412,examined,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29413,factors,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29414,that,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29415,may,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29416,improve,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29417,liking,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29418,of,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29419,reduced,B,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29420,fat,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29421,and,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29422,reduced,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29423,saturated,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29424,fat,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29425,foods,I,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29426,",",O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29427,including,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29428,the,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29429,addition,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29430,of,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29431,herbs,B,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29432,and,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29433,spices,B,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29434,and,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29435,habitual,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29436,consumption,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29437,of,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29438,different,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29439,high,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29440,-,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29441,fat,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29442,and,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29443,low,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29444,-,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29445,fat,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29446,food,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29447,items,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29448,.,O,998.0,"We examined factors that may improve liking of reduced fat and reduced saturated fat foods , including the addition of herbs and spices and habitual consumption of different high - fat and low - fat food items ."
29449,We,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29450,randomized,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29451,adults,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29452,to,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29453,taste,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29454,3,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29455,different,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29456,conditions,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29457,:,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29458,full,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29459,fat,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29460,(,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29461,FF,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29462,),O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29463,",",O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29464,reduced,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29465,fat,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29466,with,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29467,no,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29468,added,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29469,spice,B,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29470,(,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29471,RF,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29472,),O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29473,",",O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29474,and,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29475,reduced,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29476,fat,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29477,plus,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29478,spice,B,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29479,(,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29480,RFS,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29481,),O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29482,.,O,999.0,"We randomized adults to taste 3 different conditions : full fat ( FF ) , reduced fat with no added spice ( RF ) , and reduced fat plus spice ( RFS ) ."
29732,The,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29733,objective,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29734,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29735,this,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29736,work,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29737,was,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29738,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29739,identify,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29740,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29741,effect,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29742,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29743,tomato,B,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29744,juice,I,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29745,on,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29746,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29747,expression,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29748,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29749,genes,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29750,and,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29751,levels,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29752,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29753,metabolites,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29754,related,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29755,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29756,steatosis,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29757,in,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29758,rats,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29759,.,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
30128,Therefore,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30129,",",O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30130,we,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30131,conclude,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30132,that,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30133,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30134,IgE,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30135,cross,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30136,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30137,reactivity,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30138,in,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30139,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30140,mugwort,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30141,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30142,birch,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30143,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30144,celery,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30145,-,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30146,spice,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30147,syndrome,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30148,to,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30149,the,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30150,spices,B,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30151,pepper,I,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30152,and,I,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30153,paprika,I,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30154,is,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30155,not,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30156,caused,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30157,by,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30158,homologs,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30159,of,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30160,Bet,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30161,v,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30162,1,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30163,and,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30164,profilin,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30165,.,O,1020.0,"Therefore , we conclude that the IgE cross - reactivity in the mugwort - birch - celery - spice syndrome to the spices pepper and paprika is not caused by homologs of Bet v 1 and profilin ."
30580,In,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30581,particular,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30582,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30583,we,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30584,recorded,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30585,modified,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30586,consumption,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30587,of,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30588,fried,B,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30589,food,I,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30590,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30591,sweet,B,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30592,food,I,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30593,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30594,legumes,B,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30595,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30596,vegetables,B,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30597,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30598,and,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30599,fruits,B,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30600,.,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30916,Total,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30917,RNA,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30918,was,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30919,isolated,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30920,and,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30921,microarray,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30922,technology,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30923,was,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30924,used,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30925,to,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30926,measure,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30927,the,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30928,expression,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30929,levels,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30930,of,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30931,602,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30932,genes,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30933,simultaneously,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30934,.,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
31255,Many,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31256,epidemiological,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31257,studies,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31258,suggest,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31259,that,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31260,vegetable,B,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31261,oils,I,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31262,and,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31263,especially,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31264,olive,B,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31265,oil,I,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31266,present,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31267,a,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31268,protective,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31269,effect,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31270,against,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31271,atherosclerosis,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31272,.,O,1057.0,Many epidemiological studies suggest that vegetable oils and especially olive oil present a protective effect against atherosclerosis .
31376,Comparison,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31377,between,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31378,olive,B,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31379,and,I,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31380,seed,I,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31381,oils,I,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31382,supports,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31383,the,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31384,superiority,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31385,of,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31386,olive,B,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31387,oil,I,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31388,as,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31389,high,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31390,levels,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31391,of,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31392,platelet,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31393,activating,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31394,factor,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31395,(,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31396,PAF,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31397,),O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31398,antagonists,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31399,have,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31400,been,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31401,detected,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31402,",",O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31403,mainly,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31404,in,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31405,TPL,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31406,.,O,1061.0,"Comparison between olive and seed oils supports the superiority of olive oil as high levels of platelet activating factor ( PAF ) antagonists have been detected , mainly in TPL ."
31407,In,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31408,addition,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31409,",",O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31410,the,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31411,structure,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31412,of,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31413,the,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31414,most,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31415,active,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31416,fraction,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31417,from,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31418,olive,B,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31419,oil,I,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31420,was,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31421,elucidated,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31422,",",O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31423,as,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31424,a,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31425,glycerol,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31426,-,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31427,glycolipid,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31428,.,O,1062.0,"In addition , the structure of the most active fraction from olive oil was elucidated , as a glycerol - glycolipid ."
31510,Cohort,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31511,studies,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31512,do,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31513,not,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31514,suggest,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31515,a,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31516,protective,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31517,role,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31518,for,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31519,tea,B,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31520,drinking,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31521,in,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31522,the,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31523,total,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31524,risk,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31525,of,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31526,cancer,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31527,.,O,1066.0,Cohort studies do not suggest a protective role for tea drinking in the total risk of cancer .
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,B,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31953,These,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31954,findings,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31955,add,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31956,to,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31957,growing,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31958,evidence,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31959,that,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31960,plant,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31961,foods,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31962,may,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31963,protect,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31964,against,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31965,colon,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31966,cancer,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31967,;,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31968,however,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31969,",",O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31970,the,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31971,effects,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31972,of,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31973,the,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31974,other,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31975,food,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31976,groups,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31977,varied,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31978,by,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31979,ethnic,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31980,group,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31981,and,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31982,energy,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31983,adjustment,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31984,.,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
32255,Currently,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32256,the,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32257,most,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32258,common,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32259,buckwheat,B,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32260,spice,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32261,is,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32262,Fagopyrum,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32263,esculentum,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32264,Moench,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32265,(,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32266,common,B,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32267,buckwheat,I,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32268,or,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32269,sweet,B,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32270,buckwheat,I,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32271,),O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32272,",",O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32273,while,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32274,Fagopyrum,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32275,tartaricum,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32276,is,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32277,also,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32278,available,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32279,in,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32280,some,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32281,mountainous,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32282,regions,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32283,.,O,1096.0,"Currently the most common buckwheat spice is Fagopyrum esculentum Moench ( common buckwheat or sweet buckwheat ) , while Fagopyrum tartaricum is also available in some mountainous regions ."
32583,A,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32584,total,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32585,of,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32586,558,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32587,patients,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32588,with,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32589,ovarian,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32590,cancer,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32591,diagnosed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32592,in,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32593,1993,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32594,-,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32595,1999,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32596,and,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32597,607,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32598,controls,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32599,were,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32600,interviewed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32601,regarding,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32602,their,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32603,diet,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32604,.,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32855,Using,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32856,primarily,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32857,telephone,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32858,counseling,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32859,",",O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32860,the,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32861,intervention,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32862,group,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32863,was,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32864,encouraged,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32865,to,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32866,substantially,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32867,increase,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32868,intakes,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32869,of,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32870,vegetables,B,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32871,",",O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32872,fruits,B,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32873,",",O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32874,and,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32875,fiber,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32876,while,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32877,decreasing,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32878,fat,B,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32879,intake,I,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
32880,.,O,1118.0,"Using primarily telephone counseling , the intervention group was encouraged to substantially increase intakes of vegetables , fruits , and fiber while decreasing fat intake ."
33216,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33217,availability,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33218,was,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33219,estimated,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33220,using,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33221,FAO,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33222,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33223,Balance,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33224,Sheet,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33225,data,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33226,on,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33227,country,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33228,-,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33229,level,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33230,food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33231,supply,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33232,.,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33621,Livers,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33622,from,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33623,rats,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33624,fed,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33625,the,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33626,coconut,B,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33627,oil,I,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33628,diet,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33629,had,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33630,more,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33631,saturated,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33632,phospholipid,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33633,fatty,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33634,acids,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33635,than,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33636,those,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33637,from,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33638,rats,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33639,fed,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33640,the,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33641,corn,B,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33642,oil,I,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33643,diet,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33644,.,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33785,The,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33786,amount,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33787,and,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33788,source,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33789,of,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33790,fat,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33791,in,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33792,the,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33793,diet,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33794,can,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33795,affect,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33796,the,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33797,growth,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33798,response,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33799,.,O,1153.0,The amount and source of fat in the diet can affect the growth response .
33874,By,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33875,expressing,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33876,iron,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33877,bioavailability,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33878,as,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33879,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33880,efficiency,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33881,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33882,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33883,conversion,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33884,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33885,dietary,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33886,iron,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33887,into,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33888,hemoglobin,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33889,",",O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33890,it,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33891,was,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33892,demonstrated,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33893,that,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33894,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33895,amount,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33896,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33897,fat,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33898,in,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33899,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33900,diet,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33901,did,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33902,not,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33903,affect,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33904,the,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33905,bioavailability,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33906,of,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33907,iron,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33908,from,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33909,turkey,B,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33910,meat,I,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33911,or,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33912,from,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33913,ferrous,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33914,sulfate,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33915,.,O,1157.0,"By expressing iron bioavailability as the efficiency of the conversion of dietary iron into hemoglobin , it was demonstrated that the amount of fat in the diet did not affect the bioavailability of iron from turkey meat or from ferrous sulfate ."
33976,The,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33977,incidence,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33978,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33979,mortality,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33980,rates,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33981,of,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33982,testicular,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33983,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33984,prostatic,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33985,cancers,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33986,in,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33987,42,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33988,countries,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33989,were,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33990,correlated,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33991,with,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33992,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33993,dietary,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33994,practices,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33995,in,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33996,these,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33997,countries,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33998,using,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33999,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34000,cancer,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34001,rates,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34002,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34003,1988,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34004,-,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34005,92,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34006,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34007,provided,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34008,by,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34009,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34010,International,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34011,Agency,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34012,for,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34013,Research,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34014,on,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34015,Cancer,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34016,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34017,IARC,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34018,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34019,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34020,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34021,food,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34022,supply,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34023,data,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34024,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34025,1961,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34026,-,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34027,90,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34028,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34029,provided,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34030,by,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34031,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34032,Food,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34033,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34034,Agriculture,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34035,Organization,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34036,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34037,FAO,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34038,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34039,.,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34040,Among,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34041,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34042,food,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34043,items,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34044,we,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34045,examined,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34046,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34047,cheese,B,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34048,was,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34049,most,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34050,closely,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34051,correlated,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34052,with,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34053,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34054,incidence,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34055,of,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34056,testicular,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34057,cancer,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34058,at,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34059,ages,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34060,20,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34061,-,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34062,39,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34063,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34064,followed,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34065,by,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34066,animal,B,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34067,fats,I,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34068,and,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34069,milk,B,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34070,.,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34809,The,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34810,10,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34811,spread,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34812,formulations,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34813,",",O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34814,prepared,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34815,following,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34816,a,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34817,3,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34818,-,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34819,component,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34820,constrained,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34821,simplex,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34822,lattice,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34823,mixture,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34824,design,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34825,",",O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34826,were,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34827,subjected,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34828,to,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34829,a,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34830,consumer,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34831,acceptance,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34832,test,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34833,to,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34834,identify,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34835,sensory,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34836,attributes,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34837,driving,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34838,consumer,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34839,acceptance,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34840,and,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34841,purchase,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34842,intent,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34843,.,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
35430, ,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35431,Conversely,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35432,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35433,Hong,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35434,Kong,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35435,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35436,Japan,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35437,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35438,Shanghai,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35439,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35440,and,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35441,Singapore,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35442,have,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35443,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35444,ovarian,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35445,cancer,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35446,risk,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35447,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35448,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35449,consumption,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35450,of,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35451,milk,B,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35452,",",O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35453,and,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35454,low,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35455,levels,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35456,of,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35457,lactase,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35458,persistence,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35459,.,O,1209.0,"  Conversely , Hong Kong , Japan , Shanghai , and Singapore have low ovarian cancer risk , low consumption of milk , and low levels of lactase persistence ."
35618, ,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35619,1,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35620,problem,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35621,with,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35622,these,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35623,studies,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35624,is,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35625,that,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35626,dietary,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35627,fat,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35628,confounds,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35629,the,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35630,association,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35631,.,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35656, ,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35657,Another,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35658,problem,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35659,is,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35660,that,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35661,the,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35662,subsets,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35663,of,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35664,exposure,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35665,or,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35666,subgroups,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35667,of,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35668,the,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35669,population,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35670,are,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35671,unpredictable,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35672,.,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
36650,The,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36651,plasticity,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36652,of,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36653,cancer,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36654,patterns,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36655,implicates,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36656,environmental,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36657,factors,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36658,as,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36659,determinants,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36660,of,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36661,cancer,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36662,",",O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36663,and,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36664,nutrition,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36665,influences,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36666,key,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36667,cellular,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36668,and,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36669,molecular,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36670,processes,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36671,that,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36672,characterise,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36673,cancer,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36674,.,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36917,Approximately,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36918,30,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36919,million,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36920,people,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36921,in,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36922,the,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36923,USA,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36924,and,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36925,29,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36926,million,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36927,people,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36928,in,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36929,the,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36930,European,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36931,Union,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36932,suffer,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36933,from,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36934,chronic,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36935,liver,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36936,disease,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36937,.,O,1263.0,Approximately 30 million people in the USA and 29 million people in the European Union suffer from chronic liver disease .
36992,Among,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36993,their,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36994,bioactive,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36995,components,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36996,",",O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36997,flavonoids,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36998,have,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36999,been,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37000,found,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37001,to,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37002,be,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37003,active,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37004,against,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37005,liver,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37006,dysfunction,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37007,and,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37008,damage,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37009,caused,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37010,by,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37011,liver,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37012,diseases,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37013,.,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37200,Individual,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37201,NOAELs,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37202,and,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37203,LOAELs,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37204,were,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37205,obtained,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37206,from,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37207,clinical,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37208,challenges,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37209,of,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37210,food,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37211,-,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37212,allergic,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37213,subjects,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37214,.,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37215,Statistical,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37216,dose,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37217,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37218,distribution,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37219,models,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37220,(,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37221,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37222,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37223,normal,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37224,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37225,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37226,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37227,logistic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37228,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37229,Weibull,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37230,),O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37231,were,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37232,applied,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37233,to,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37234,the,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37235,individual,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37236,NOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37237,and,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37238,LOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37239,for,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37240,each,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37241,allergenic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37242,food,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37243,.,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37410,The,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37411,relationship,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37412,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37413,selected,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37414,bone,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37415,-,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37416,related,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37417,nutrients,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37418,to,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37419,these,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37420,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37421,fluxes,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37422,exhibits,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37423,both,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37424,constructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37425,and,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37426,destructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37427,interactions,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37428,that,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37429,affect,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37430,the,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37431,overall,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37432,state,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37433,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37434,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37435,balance,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37436,.,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37437,The,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37438,basis,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37439,of,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37440,the,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37441,calcium,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37442,requirement,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37443,and,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37444,the,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37445,impact,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37446,of,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37447,vitamin,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37448,D,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37449,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37450,protein,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37451,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37452,phosphorus,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37453,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37454,sodium,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37455,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37456,and,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37457,caffeine,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37458,on,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37459,the,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37460,calcium,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37461,economy,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37462,are,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37463,reviewed,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37464,.,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37559,To,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37560,the,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37561,extent,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37562,that,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37563,fruit,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37564,and,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37565,vegetable,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37566,potassium,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37567,is,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37568,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37569,surrogate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37570,for,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37571,high,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37572,bicarbonate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37573,",",O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37574,this,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37575,cohort,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37576,did,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37577,not,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37578,have,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37579,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37580,dietary,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37581,intake,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37582,pattern,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37583,allowing,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37584,for,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37585,measurement,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37586,or,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37587,interpretation,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37588,of,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37589,the,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37590,potential,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37591,effect,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37592,of,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37593,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37594,high,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37595,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37596,bicarbonate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37597,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37598,containing,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37599,diet,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37600,on,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37601,long,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37602,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37603,term,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37604,steady,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37605,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37606,state,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37607,calcium,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37608,balance,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37609,.,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37691,The,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37692,hypothesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37693,that,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37694,meat,B,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37695,intake,I,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37696,can,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37697,increase,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37698,fecal,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37699,NOC,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37700,levels,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37701,and,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37702,colon,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37703,carcinogenesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37704,was,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37705,tested,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37706,in,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37707,175,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37708,Fischer,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37709,344,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37710,rats,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37711,.,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
38151,Key,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38152,to,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38153,this,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38154,response,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38155,is,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38156,the,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38157,activation,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38158,of,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38159,the,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38160,Nrf2,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38161,(,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38162,Nuclear,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38163,factor,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38164,erythroid,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38165,2,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38166,-,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38167,related,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38168,factor-2,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38169,),O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38170,system,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38171,by,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38172,phenolic,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38173,phytochemicals,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38174,",",O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38175,which,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38176,induces,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38177,the,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38178,expression,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38179,of,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38180,cell,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38181,defense,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38182,genes,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38183,.,O,1310.0,"Key to this response is the activation of the Nrf2 ( Nuclear factor erythroid 2 - related factor-2 ) system by phenolic phytochemicals , which induces the expression of cell defense genes ."
38365,The,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38366,age,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38367,-,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38368,adjusted,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38369,data,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38370,suggest,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38371,a,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38372,U,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38373,-,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38374,shape,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38375,curve,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38376,for,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38377,female,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38378,smokers,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38379,",",O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38380,although,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38381,this,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38382,was,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38383,not,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38384,confirmed,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38385,by,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38386,the,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38387,Cox,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38388,analysis,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38389,.,O,1318.0,"The age - adjusted data suggest a U - shape curve for female smokers , although this was not confirmed by the Cox analysis ."
38546,β,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38547,-,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38548,Carotene,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38549,",",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38550,total,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38551,phenolics,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38552,and,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38553,gallic,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38554,acid,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38555,contents,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38556,and,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38557,the,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38558,antioxidant,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38559,capacity,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38560,",",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38561,measured,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38562,by,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38563,the,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38564,ferric,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38565,reducing,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38566,/,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38567,antioxidant,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38568,power,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38569,and,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38570,the,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38571,"2,2",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38572,-,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38573,"diphenyl-1,1",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38574,-,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38575,picrylhydrazyl,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38576,radical,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38577,scavenging,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38578,assays,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38579,",",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38580,were,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38581,analyzed,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38582,in,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38583,each,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38584,aqueous,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38585,extract,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38586,.,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38827,Alcohol,B,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38828,consumption,I,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38829,was,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38830,inversely,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38831,associated,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38832,with,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38833,lung,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38834,cancer,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38835,risk,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38836,with,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38837,evidence,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38838,most,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38839,strongly,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38840,supporting,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38841,lower,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38842,risk,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38843,for,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38844,light,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38845,and,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38846,moderate,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38847,drinkers,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38848,relative,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38849,to,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38850,non,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38851,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38852,drinkers,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38853,(,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38854,>,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38855,0,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38856,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38857,4.9,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38858,g,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38859,per,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38860,day,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38861,:,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38862,OR,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38863, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38864,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38865, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38866,0.80,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38867,",",O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38868,95,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38869,%,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38870,CI,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38871, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38872,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38873, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38874,0.70,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38875,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38876,0.90,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38877,;,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38878,5,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38879,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38880,9.9,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38881,g,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38882,per,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38883,day,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38884,:,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38885,OR,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38886, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38887,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38888, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38889,0.82,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38890,",",O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38891,95,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38892,%,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38893,CI,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38894, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38895,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38896, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38897,0.69,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38898,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38899,0.99,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38900,;,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38901,10,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38902,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38903,19.9,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38904,g,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38905,per,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38906,day,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38907,:,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38908,OR,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38909, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38910,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38911, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38912,0.79,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38913,",",O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38914,95,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38915,%,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38916,CI,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38917, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38918,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38919, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38920,0.65,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38921,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38922,0.96,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38923,),O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38924,.,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
39415,The,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39416,value,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39417,of,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39418,so,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39419,-,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39420,called,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39421,day,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39422,-,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39423,case,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39424,care,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39425,bundles,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39426,to,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39427,reduce,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39428,high,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39429,hospital,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39430,readmission,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39431,rates,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39432,with,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39433,greater,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39434,care,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39435,in,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39436,the,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39437,community,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39438,is,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39439,described,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39440,",",O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39441,along,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39442,with,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39443,examples,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39444,of,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39445,locally,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39446,derived,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39447,schemes,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39448,for,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39449,the,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39450,early,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39451,detection,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39452,of,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39453,disease,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39454,and,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39455,",",O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39456,in,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39457,particular,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39458,",",O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39459,schemes,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39460,to,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39461,allow,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39462,general,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39463,practitioners,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39464,to,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39465,refer,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39466,patients,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39467,directly,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39468,for,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39469,elastography,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39470,assessment,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39471,.,O,1355.0,"The value of so - called day - case care bundles to reduce high hospital readmission rates with greater care in the community is described , along with examples of locally derived schemes for the early detection of disease and , in particular , schemes to allow general practitioners to refer patients directly for elastography assessment ."
39875,The,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39876,effect,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39877,of,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39878,the,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39879,fatty,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39880,acid,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39881,composition,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39882,of,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39883,reduced,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39884,-,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39885,fat,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39886,diets,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39887,on,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39888,the,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39889,in,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39890,vitro,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39891,oxidation,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39892,of,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39893,LDL,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39894,was,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39895,examined,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39896,in,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39897,14,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39898,moderately,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39899,hypercholesterolemic,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39900,[,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39901,low,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39902,density,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39903,lipoprotein,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39904,(,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39905,LDL,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39906,),O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39907,>,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39908,3.36,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39909,mmol,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39910,/,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39911,L,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39912,],O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39913,postmenopausal,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39914,female,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39915,and,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39916,male,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39917,subjects,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39918,(,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39919,age,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39920,44,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39921,-,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39922,78,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39923,y,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39924,),O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
39925,.,O,1371.0,The effect of the fatty acid composition of reduced - fat diets on the in vitro oxidation of LDL was examined in 14 moderately hypercholesterolemic [ low density lipoprotein ( LDL ) > 3.36 mmol / L ] postmenopausal female and male subjects ( age 44 - 78 y ) .
40013,LDL,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40014,lag,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40015,times,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40016,were,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40017,93.2,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40018,+,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40019,/-,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40020,25.8,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40021,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40022,95.9,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40023,+,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40024,/-,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40025,26.4,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40026,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40027,104.2,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40028,+,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40029,/-,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40030,32.7,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40031,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40032,108.0,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40033,+,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40034,/-,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40035,26.6,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40036,and,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40037,113.1,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40038,+,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40039,/-,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40040,24.0,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40041,min,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40042,for,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40043,corn,B,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40044,oil,I,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40045,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40046,beef,B,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40047,tallow,I,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40048,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40049,rice,B,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40050,bran,I,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40051,oil,I,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40052,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40053,canola,B,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40054,oil,I,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40055,and,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40056,olive,B,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40057,oil,I,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40058,periods,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40059,",",O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40060,respectively,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40061,.,O,1374.0,"LDL lag times were 93.2 + /- 25.8 , 95.9 + /- 26.4 , 104.2 + /- 32.7 , 108.0 + /- 26.6 and 113.1 + /- 24.0 min for corn oil , beef tallow , rice bran oil , canola oil and olive oil periods , respectively ."
40324,Cox,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40325,proportional,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40326,hazard,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40327,models,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40328,were,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40329,used,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40330,to,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40331,estimate,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40332,hazard,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40333,ratios,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40334,and,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40335,95,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40336,%,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40337,confidence,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40338,intervals,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40339,for,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40340,mortality,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40341,using,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40342,the,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40343,non,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40344,-,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40345,consumers,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40346,as,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40347,reference,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40348,groups,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40349,and,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40350,three,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40351,categories,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40352,of,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40353,consumption,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40354,.,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
41006,We,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41007,report,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41008,on,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41009,an,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41010,association,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41011,between,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41012,coffee,B,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41013,consumption,I,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41014,and,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41015,the,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41016,concentration,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41017,of,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41018,total,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41019,homocysteine,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41020,(,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41021,tHcy,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41022,),O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41023,in,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41024,plasma,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41025,",",O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41026,a,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41027,risk,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41028,factor,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41029,for,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41030,cardiovascular,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41031,disease,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41032,and,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41033,for,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41034,adverse,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41035,pregnancy,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41036,outcome,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41037,.,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41800,Flavonoid,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41801,consumption,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41802,was,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41803,not,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41804,associated,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41805,with,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41806,diabetes,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41807,risk,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41808,after,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41809,multivariable,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41810,adjustment,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41811,.,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
42274,The,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42275,purpose,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42276,of,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42277,this,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42278,study,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42279,was,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42280,to,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42281,assess,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42282,the,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42283,effect,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42284,of,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42285,garlic,B,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42286,on,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42287,the,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42288,liver,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42289,phosphatidate,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42290,phosphohydrolase,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42291,(,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42292,PAP,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42293,),O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42294,activity,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42295,",",O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42296,plasma,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42297,lipid,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42298,levels,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42299,",",O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42300,malondialdehyde,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42301,(,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42302,MDA,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42303,),O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42304,and,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42305,plasma,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42306,antioxidant,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42307,in,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42308,rats,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42309,fed,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42310,either,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42311,by,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42312,normal,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42313,or,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42314,high,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42315,-,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42316,lipogenic,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42317,diet,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42318,with,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42319,or,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42320,without,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42321,garlic,B,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42322,.,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42545,A,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42546,control,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42547,for,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42548,each,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42549,case,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42550,",",O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42551,matched,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42552,by,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42553,age,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42554,",",O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42555,sex,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42556,and,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42557,area,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42558,of,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42559,residence,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42560,",",O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42561,was,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42562,selected,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42563,from,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42564,the,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42565,same,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42566,hospital,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42567,as,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42568,the,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42569,case,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42570,.,O,1457.0,"A control for each case , matched by age , sex and area of residence , was selected from the same hospital as the case ."
42651,Simultaneous,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42652,intake,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42653,of,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42654,2,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42655,groups,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42656,of,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42657,food,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42658,which,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42659,increase,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42660,or,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42661,decrease,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42662,the,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42663,risk,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42664,of,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42665,cancer,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42666,strengthens,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42667,the,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42668,respective,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42669,individual,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42670,effect,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42671,.,O,1462.0,Simultaneous intake of 2 groups of food which increase or decrease the risk of cancer strengthens the respective individual effect .
42805,Overall,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42806,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42807,we,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42808,recommend,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42809,breast,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42810,cancer,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42811,patients,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42812,consume,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42813,a,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42814,diet,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42815,naturally,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42816,high,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42817,in,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42818,flavonol,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42819,polyphenols,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42820,including,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42821,tea,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42822,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42823,vegetables,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42824,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42825,onion,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42826,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42827,broccoli,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42828,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42829,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42830,and,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42831,fruit,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42832,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42833,apples,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42834,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42835,citrus,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42836,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42837,.,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
43138,On,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43139,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43140,basis,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43141,of,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43142,these,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43143,results,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43144,",",O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43145,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43146,bioactivity,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43147,index,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43148,(,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43149,BI,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43150,),O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43151,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43152,dietary,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43153,cancer,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43154,prevention,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43155,is,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43156,proposed,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43157,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43158,provide,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43159,a,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43160,simple,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43161,reference,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43162,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43163,consumers,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43164,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43165,choose,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43166,vegetables,B,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43167,in,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43168,accordance,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43169,with,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43170,their,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43171,beneficial,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43172,activities,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43173,.,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43422,For,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43423,these,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43424,populations,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43425,",",O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43426,food,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43427,",",O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43428,especially,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43429,rice,B,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43430,",",O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43431,is,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43432,a,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43433,major,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43434,source,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43435,of,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43436,exposure,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43437,.,O,1491.0,"For these populations , food , especially rice , is a major source of exposure ."
43721,Research,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43722,using,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43723,urinary,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43724,arsenic,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43725,is,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43726,needed,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43727,to,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43728,assess,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43729,potential,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43730,CVD,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43731,effects,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43732,of,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43733,low,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43734,-,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43735,level,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43736,arsenic,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43737,exposure,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43738,.,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43761,A,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43762,diet,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43763,rich,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43764,in,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43765,fruits,B,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43766,",",O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43767,vegetables,B,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43768,and,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43769,minimally,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43770,refined,B,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43771,cereals,I,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43772,is,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43773,associated,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43774,with,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43775,lower,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43776,risk,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43777,for,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43778,chronic,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43779,degenerative,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43780,diseases,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43781,.,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43805,Every,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43806,dietary,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43807,plant,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43808,contains,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43809,numerous,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43810,types,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43811,of,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43812,antioxidants,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43813,with,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43814,different,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43815,properties,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43816,.,O,1506.0,Every dietary plant contains numerous types of antioxidants with different properties .
43881,Of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43882,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43883,tree,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43884,nuts,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43885,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43886,walnuts,B,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43887,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43888,pecans,B,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43889,and,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43890,chestnuts,B,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43891,have,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43892,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43893,highest,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43894,contents,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43895,of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43896,antioxidants,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43897,.,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
44193,In,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44194,analyses,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44195,focusing,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44196,on,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44197,nutrients,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44198,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44199,rather,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44200,than,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44201,foods,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44202,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44203,polyunsaturated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44204,fats,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44205,were,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44206,positively,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44207,and,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44208,vitamin,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44209,E,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44210,inversely,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44211,associated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44212,with,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44213,prostate,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44214,cancer,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44215,.,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44622,No,O,1538.0,No bands were detected from paprika extract .
44623,bands,O,1538.0,No bands were detected from paprika extract .
44624,were,O,1538.0,No bands were detected from paprika extract .
44625,detected,O,1538.0,No bands were detected from paprika extract .
44626,from,O,1538.0,No bands were detected from paprika extract .
44627,paprika,O,1538.0,No bands were detected from paprika extract .
44628,extract,O,1538.0,No bands were detected from paprika extract .
44629,.,O,1538.0,No bands were detected from paprika extract .
44733,In,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44734,contrast,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44735,",",O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44736,consumption,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44737,of,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44738,white,B,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44739,meat,I,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44740,(,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44741,chicken,B,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44742,),O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44743,is,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44744,not,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44745,associated,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44746,with,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44747,risk,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44748,and,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44749,might,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44750,even,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44751,reduce,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44752,the,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44753,occurrence,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44754,of,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44755,colorectal,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44756,cancer,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44757,.,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44801,),O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44802,",",O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44803,then,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44804,randomized,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44805,to,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44806,10,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44807,different,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44808,AIN-76,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44809,-,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44810,based,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44811,diets,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44812,.,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44962,In,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44963,contrast,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44964,",",O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44965,compared,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44966,with,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44967,lard-,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44968,and,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44969,casein,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44970,-,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44971,fed,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44972,controls,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44973,",",O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44974,the,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44975,ACF,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44976,multiplicity,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44977,was,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44978,reduced,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44979,by,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44980,12,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44981,%,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44982,in,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44983,rats,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44984,fed,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44985,a,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44986,diet,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44987,with,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44988,30,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44989,%,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44990,bacon,B,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44991,and,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44992,by,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44993,20,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44994,%,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44995,in,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44996,rats,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44997,fed,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44998,a,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
44999,diet,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45000,with,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45001,60,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45002,%,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45003,bacon,B,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45004,(,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45005,p,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45006,<,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45007,0.001,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45008,),O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45009,.,O,1552.0,"In contrast , compared with lard- and casein - fed controls , the ACF multiplicity was reduced by 12 % in rats fed a diet with 30 % bacon and by 20 % in rats fed a diet with 60 % bacon ( p < 0.001 ) ."
45138,Dairy,B,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45139,products,I,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45140,are,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45141,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45142,main,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45143,source,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45144,of,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45145,calcium,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45146,(,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45147,Ca,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45148,),O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45149,",",O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45150,but,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45151,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45152,loss,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45153,of,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45154,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45155,consumption,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45156,habit,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45157,contributes,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45158,to,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45159,low,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45160,consumption,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45161,in,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45162,adulthood,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45163,",",O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45164,which,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45165,leads,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45166,to,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45167,osteoporosis,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45168,and,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45169,increased,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45170,fracture,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45171,risk,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45172,.,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45190,This,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45191,paper,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45192,proposes,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45193,the,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45194,development,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45195,of,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45196,an,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45197,enriched,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45198,Ca,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45199,reduced,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45200,lactose,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45201,milk,B,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45202,using,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45203,eggshell,B,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45204,and,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45205,kefir,B,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45206,.,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45495,etc,O,1573.0,etc .
45496,.,O,1573.0,etc .
46014,Acute,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46015,postprandial,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46016,GR,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46017,tests,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46018,and,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46019,subjective,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46020,satiety,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46021,tests,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46022,were,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46023,carried,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46024,out,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46025,for,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46026,each,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46027,test,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46028,food,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46029,.,O,1591.0,Acute postprandial GR tests and subjective satiety tests were carried out for each test food .
46104,Prevention,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46105,is,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46106,a,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46107,more,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46108,effective,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46109,strategy,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46110,than,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46111,is,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46112,treatment,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46113,of,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46114,chronic,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46115,diseases,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46116,.,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46734,Dietary,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46735,oxalate,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46736,can,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46737,contribute,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46738,considerably,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46739,to,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46740,the,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46741,amount,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46742,of,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46743,urinary,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46744,oxalate,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46745,excretion,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46746,.,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
47149,Similarly,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47150,consumption,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47151,of,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47152,milky,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47153,tea,B,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47154,produced,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47155,no,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47156,change,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47157,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47158,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47159,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47160,9.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47161,a.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47162,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47163,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47164,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47165,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47166,the,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47167,50,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47168,%,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47169,increase,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47170,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47171,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47172,noted,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47173,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47174,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47175,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47176,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47177,15.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47178,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47179,was,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47180,not,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47181,statistically,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47182,significant,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47183,.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47184,When,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47185,the,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47186,subjects,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47187,consumed,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47188,black,B,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47189,tea,I,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47190,without,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47191,milk,B,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47192,FRAP,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47193,increased,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47194,by,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47195,65,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47196,%,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47197,between,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47198,9.00,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47199,a.m.,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47200,and,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47201,12.00,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47202,p.m.,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47203,(,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47204,P,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47205,=,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47206,0.02,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47207,),O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47208,and,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47209,at,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47210,15.00,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47211,p.m.,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47212,was,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47213,76,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47214,%,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47215,higher,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47216,than,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47217,at,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47218,9.00,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47219,a.m.,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47220,(,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47221,P,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47222,=,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47223,0.002,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47224,),O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47225,.,O,1633.0,When the subjects consumed black tea without milk FRAP increased by 65 % between 9.00 a.m. and 12.00 p.m. ( P = 0.02 ) and at 15.00 p.m. was 76 % higher than at 9.00 a.m. ( P = 0.002 ) .
47544,Baseline,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47545,FFQ,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47546,data,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47547,were,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47548,used,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47549,to,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47550,generate,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47551,thirty,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47552,-,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47553,four,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47554,food,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47555,groups,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47556,.,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
48012,When,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48013,either,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48014,protein,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48015,was,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48016,ingested,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48017,with,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48018,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48019,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48020,the,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48021,insulin,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48022,area,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48023,response,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48024,was,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48025,greater,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48026,than,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48027,the,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48028,sum,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48029,of,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48030,the,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48031,individual,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48032,responses,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48033,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48034,indicating,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48035,a,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48036,synergistic,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48037,effect,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48038,(,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48039,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48040,alone,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48041,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48042,732,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48043,pmol,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48044,/,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48045,L.h,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48046,;,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48047,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48048,with,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48049,cottage,B,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48050,cheese,I,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48051,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48052,"1,637",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48053,pmol,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48054,/,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48055,L.h,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48056,;,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48057,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48058,with,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48059,egg,B,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48060,white,I,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48061,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48062,"1,213",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48063,pmol,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48064,/,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48065,L.h,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48066,),O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48067,.,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48221,We,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48222,conducted,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48223,a,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48224,multicentre,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48225,case,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48226,-,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48227,control,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48228,study,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48229,in,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48230,3,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48231,regions,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48232,expected,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48233,to,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48234,have,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48235,different,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48236,diet,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48237,and,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48238,drinking,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48239,habits,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48240,(,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48241,Normandy,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48242,",",O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48243,Burgundy,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48244,and,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48245,Midi,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48246,Pyrénées,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48247,),O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48248,.,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
49507,Our,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49508,data,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49509,suggest,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49510,that,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49511,IMI,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49512,with,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49513,NAS,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49514,(,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49515,as,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49516,a,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49517,group,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49518,),O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49519,present,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49520,shortly,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49521,after,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49522,calving,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49523,do,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49524,not,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49525,have,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49526,an,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49527,adverse,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49528,effect,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49529,on,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49530,later,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49531,production,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49532,.,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
50247,In,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50248,addition,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50249,",",O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50250,many,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50251,clinical,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50252,observational,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50253,studies,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50254,have,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50255,demonstrated,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50256,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50257,absence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50258,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50259,a,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50260,relationship,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50261,between,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50262,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50263,frequency,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50264,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50265,miso,B,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50266,soup,I,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50267,intake,I,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50268,and,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50269,blood,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50270,pressure,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50271,levels,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50272,or,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50273,hypertension,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50274,incidence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50275,.,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50464,Repeated,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50465,measure,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50466,mixed,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50467,model,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50468,analysis,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50469,compared,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50470,reported,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50471,food,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50472,PS,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50473,at,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50474,the,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50475,total,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50476,population,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50477,level,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50478,as,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50479,well,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50480,as,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50481,subdivided,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50482,by,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50483,sex,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50484,",",O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50485,age,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50486,",",O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50487,BMI,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50488,and,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50489,social,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50490,class,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50491,.,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50658,The,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50659,induction,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50660,of,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50661,these,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50662,protective,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50663,enzymes,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50664,appears,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50665,to,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50666,be,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50667,mediated,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50668,by,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50669,genetic,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50670,regulatory,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50671,elements,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50672,in,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50673,their,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50674,promoter,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50675,regions,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50676,known,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50677,as,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50678,the,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50679,antioxidant,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50680,response,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50681,element,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50682,(,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50683,ARE,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50684,),O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50685,.,O,1745.0,The induction of these protective enzymes appears to be mediated by genetic regulatory elements in their promoter regions known as the antioxidant response element ( ARE ) .
50686,The,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50687,aim,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50688,of,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50689,this,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50690,study,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50691,was,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50692,to,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50693,identify,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50694,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50695,through,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50696,an,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50697,in,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50698,vitro,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50699,study,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50700,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50701,which,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50702,of,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50703,the,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50704,30,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50705,fruits,B,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50706,and,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50707,vegetables,B,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50708,commonly,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50709,consumed,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50710,in,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50711,Catalonia,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50712,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50713,Spain,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50714,",",O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50715,contain,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50716,MIs,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50717,of,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50718,NQO1,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50719,.,O,1746.0,"The aim of this study was to identify , through an in vitro study , which of the 30 fruits and vegetables commonly consumed in Catalonia , Spain , contain MIs of NQO1 ."
50795,We,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50796,also,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50797,used,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50798,a,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50799,third,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50800,cell,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50801,line,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50802,",",O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50803,papiloma,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50804,(,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50805,PE,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50806,),O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50807,murine,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50808,keratinocytes,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50809,",",O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50810,a,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50811,stably,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50812,transfected,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50813,cell,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50814,line,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50815,with,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50816,an,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50817,ARE,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50818,-,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50819,luc+,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50820,plasmid,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50821,(,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50822,AREPE,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50823,cell,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50824,line,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50825,),O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50826,for,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50827,verifying,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50828,induction,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50829,through,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50830,the,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50831,ARE,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50832,with,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50833,a,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50834,simple,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50835,luminescence,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50836,screening,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50837,assay,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
50838,.,O,1748.0,"We also used a third cell line , papiloma ( PE ) murine keratinocytes , a stably transfected cell line with an ARE - luc+ plasmid ( AREPE cell line ) for verifying induction through the ARE with a simple luminescence screening assay ."
51140,The,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51141,"""",O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51142,vegetable,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51143,"""",O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51144,pattern,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51145,loaded,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51146,high,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51147,on,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51148,different,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51149,vegetables,B,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51150,",",O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51151,whereas,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51152,the,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51153,third,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51154,pattern,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51155,named,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51156,"""",O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51157,bean,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51158,"""",O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51159,was,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51160,high,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51161,in,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51162,legumes,B,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51163,",",O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51164,tofu,B,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51165,and,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51166,soy,B,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51167,protein,I,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
51168,.,O,1756.0,"The "" vegetable "" pattern loaded high on different vegetables , whereas the third pattern named "" bean "" was high in legumes , tofu and soy protein ."
52178,The,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52179,effect,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52180,of,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52181,the,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52182,FA,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52183,fortification,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52184,program,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52185,on,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52186,the,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52187,occurrence,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52188,of,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52189,NTD,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52190,is,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52191,currently,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52192,being,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52193,assessed,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52194,.,O,1789.0,The effect of the FA fortification program on the occurrence of NTD is currently being assessed .
52266,Details,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52267,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52268,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52269,studies,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52270,are,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52271,presented,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52272,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52273,and,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52274,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52275,potential,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52276,impact,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52277,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52278,measurement,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52279,error,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52280,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52281,publication,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52282,bias,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52283,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52284,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52285,form,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52286,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52287,tea,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52288,consumed,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52289,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52290,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52291,appropriateness,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52292,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52293,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52294,outcomes,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52295,studied,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52296,and,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52297,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52298,adjustment,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52299,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52300,confounders,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52301,related,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52302,to,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52303,both,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52304,tea,B,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52305,consumption,I,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52306,and,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52307,risk,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52308,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52309,colorectal,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52310,cancer,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52311,or,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52312,polyps,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52313,in,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52314,various,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52315,countries,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52316,are,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52317,explored,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52318,.,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52335,Particularly,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52336,with,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52337,green,B,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52338,tea,I,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52339,",",O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52340,the,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52341,doses,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52342,consumed,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52343,do,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52344,get,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52345,into,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52346,a,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52347,perceived,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52348,protective,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52349,range,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52350,in,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52351,a,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52352,significant,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52353,subset,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52354,of,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52355,the,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52356,population,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52357,.,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52436,The,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52437,Mediterranean,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52438,diet,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52439,is,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52440,a,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52441,healthy,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52442,eating,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52443,pattern,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52444,with,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52445,protective,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52446,effects,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52447,on,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52448,chronic,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52449,diseases,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52450,.,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52896,and,O,1816.0,and Lactobacillus spp .
52897,Lactobacillus,O,1816.0,and Lactobacillus spp .
52898,spp,O,1816.0,and Lactobacillus spp .
52899,.,O,1816.0,and Lactobacillus spp .
53137,Capillary,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53138,blood,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53139,samples,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53140,were,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53141,then,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53142,drawn,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53143,for,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53144,2,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53145,h,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53146,",",O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53147,and,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53148,glucose,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53149,and,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53150,insulin,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53151,were,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53152,analysed,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53153,.,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53154,The,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53155,2,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53156,h,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53157,glycaemic,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53158,responses,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53159,to,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53160,six,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53161,mashed,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53162,potato,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53163,-,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53164,containing,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53165,meals,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53166,varied,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53167,more,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53168,than,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53169,twofold,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53170,.,O,1827.0,The 2 h glycaemic responses to six mashed potato - containing meals varied more than twofold .
53227,The,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53228,insulinaemic,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53229,indices,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53230,of,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53231,the,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53232,mashed,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53233,potato,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53234,-,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53235,based,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53236,meals,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53237,varied,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53238,between,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53239,94,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53240,and,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53241,148,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53242,.,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53611,Thus,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53612,",",O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53613,a,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53614,skilled,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53615,nutritionist,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53616,should,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53617,be,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53618,an,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53619,integral,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53620,part,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53621,of,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53622,the,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53623,multidisciplinary,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53624,management,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53625,of,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53626,GEP,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53627,-,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53628,NET,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53629,patients,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
53630,.,O,1845.0,"Thus , a skilled nutritionist should be an integral part of the multidisciplinary management of GEP - NET patients ."
54222,It,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54223,is,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54224,known,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54225,that,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54226,patients,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54227,with,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54228,pollinosis,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54229,may,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54230,display,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54231,clinical,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54232,characteristics,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54233,caused,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54234,by,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54235,allergy,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54236,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54237,certain,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54238,fruits,B,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54239,and,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54240,vegetables,B,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54241,",",O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54242,but,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54243,subjects,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54244,allergic,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54245,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54246,Artemisia,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54247,seem,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54248,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54249,show,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54250,particularly,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54251,peculiar,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54252,characteristics,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54253,.,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54293,The,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54294,mean,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54295,age,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54296,for,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54297,the,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54298,beginning,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54299,of,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54300,symptoms,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54301,was,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54302,30.2,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54303,years,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54304,",",O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54305,and,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54306,this,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54307,was,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54308,higher,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54309,than,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54310,in,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54311,the,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54312,control,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54313,group,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54314,(,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54315,P,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54316,<,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54317,0.05,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54318,),O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54319,.,O,1874.0,"The mean age for the beginning of symptoms was 30.2 years , and this was higher than in the control group ( P < 0.05 ) ."
54677,Brassica,B,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54678,vegetables,I,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54679,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54680,cooked,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54681,leafy,B,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54682,vegetables,I,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54683,showed,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54684,inverse,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54685,associations,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54686,for,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54687,both,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54688,men,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54689,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54690,women,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54691,.,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54864,Among,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54865,the,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54866,spices,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54867,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54868,fenugreek,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54869,seeds,I,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54870,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54871,Trigonella,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54872,foenumgraecum,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54873,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54874,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54875,garlic,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54876,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54877,Allium,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54878,sativum,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54879,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54880,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54881,onion,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54882,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54883,Allium,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54884,cepa,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54885,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54886,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54887,and,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54888,turmeric,B,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54889,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54890,Curcuma,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54891,longa,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54892,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54893,have,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54894,been,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54895,experimentally,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54896,documented,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54897,to,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54898,possess,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54899,antidiabetic,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54900,potential,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54901,.,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
55206,However,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55207,",",O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55208,individual,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55209,flavonoid,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55210,or,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55211,isoflavonoid,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55212,compounds,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55213,appear,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55214,to,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55215,have,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55216,no,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55217,therapeutic,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55218,effect,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55219,on,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55220,diabetes,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55221,",",O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55222,based,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55223,on,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55224,the,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55225,limited,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55226,clinical,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55227,data,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55228,.,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55296,The,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55297,usual,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55298,choice,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55299,of,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55300,spread,B,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55301,used,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55302,on,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55303,bread,B,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55304,",",O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55305,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55306,the,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55307,calculated,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55308,total,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55309,amount,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55310,of,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55311,fat,B,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55312,spread,I,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55313,on,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55314,bread,B,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55315,per,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55316,day,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55317,",",O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55318,were,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55319,related,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55320,to,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55321,socio,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55322,-,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55323,economic,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55324,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55325,coronary,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55326,artery,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55327,disease,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55328,risk,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55329,factors,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55330,in,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55331,9003,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55332,respondents,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55333,in,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55334,the,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55335,Health,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55336,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55337,Lifestyle,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55338,Survey,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55339,.,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55340,Butter,B,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55341,was,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55342,the,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55343,most,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55344,popular,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55345,spread,B,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55346,",",O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55347,regardless,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55348,of,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55349,social,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55350,group,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55351,or,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55352,income,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55353,.,O,1913.0,"Butter was the most popular spread , regardless of social group or income ."
55502,Smokers,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55503,in,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55504,each,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55505,group,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55506,consumed,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55507,significantly,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55508,more,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55509,than,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55510,non,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55511,-,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55512,smokers,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55513,.,O,1920.0,Smokers in each group consumed significantly more than non - smokers .
55634,BALB,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55635,/,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55636,c,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55637,mice,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55638,were,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55639,fed,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55640,a,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55641,synthetic,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55642,diet,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55643,supplemented,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55644,with,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55645,uncooked,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55646,and,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55647,polished,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55648,white,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55649,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55650,powder,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55651,prepared,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55652,from,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55653,one,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55654,of,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55655,four,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55656,different,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55657,cultivars,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55658,:,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55659,Yukihikari,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55660,",",O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55661,rice,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55662,A,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55663,(,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55664,common,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55665,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55666,),O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55667,",",O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55668,rice,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55669,B,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55670,(,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55671,brewery,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55672,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55673,),O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55674,and,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55675,rice,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55676,C,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55677,(,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55678,waxy,B,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55679,rice,I,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55680,),O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55681,.,O,1925.0,"BALB / c mice were fed a synthetic diet supplemented with uncooked and polished white rice powder prepared from one of four different cultivars : Yukihikari , rice A ( common rice ) , rice B ( brewery rice ) and rice C ( waxy rice ) ."
55748,The,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55749,incidence,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55750,of,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55751,allergic,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55752,diarrhoea,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55753,induced,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55754,by,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55755,oral,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55756,administration,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55757,of,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55758,ovalbumin,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55759,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55760,systemically,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55761,immunised,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55762,mice,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55763,was,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55764,lower,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55765,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55766,mice,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55767,fed,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55768,Yukihikari,B,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55769,",",O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55770,albeit,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55771,with,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55772,no,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55773,difference,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55774,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55775,serum,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55776,antibodies,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55777,specific,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55778,to,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55779,ovalbumin,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55780,.,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55835,These,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55836,data,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55837,indicate,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55838,that,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55839,changes,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55840,in,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55841,the,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55842,gut,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55843,microbiota,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55844,of,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55845,mice,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55846,fed,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55847,Yukihikari,B,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55848,could,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55849,be,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55850,advantageous,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55851,in,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55852,the,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55853,prevention,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55854,of,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55855,food,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55856,allergy,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55857,.,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
56025,Micronutrient,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56026,inadequacies,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56027,were,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56028,also,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56029,observed,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56030,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56031,particularly,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56032,for,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56033,calcium,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56034,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56035,iron,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56036,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56037,zinc,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56038,and,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56039,vitamins,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56040,A,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56041,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56042,D,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56043,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56044,C,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56045,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56046,and,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56047,folate,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56048,.,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56049,Acknowledging,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56050,the,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56051,impact,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56052,that,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56053,nutrition,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56054,may,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56055,have,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56056,on,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56057,building,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56058,societies,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56059,and,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56060,transforming,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56061,the,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56062,lives,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56063,of,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56064,children,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56065,",",O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56066,adolescents,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56067,and,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56068,their,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56069,families,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56070,",",O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56071,there,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56072,is,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56073,a,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56074,crucial,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56075,need,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56076,for,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56077,a,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56078,food,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56079,system,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56080,approach,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56081,in,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56082,developing,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56083,and,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56084,implementing,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56085,national,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56086,and,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56087,regional,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56088,policies,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56089,and,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56090,interventions,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56091,aimed,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56092,at,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56093,improving,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56094,the,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56095,diet,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56096,of,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56097,children,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56098,and,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56099,adolescents,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56100,.,O,1936.0,"Acknowledging the impact that nutrition may have on building societies and transforming the lives of children , adolescents and their families , there is a crucial need for a food system approach in developing and implementing national and regional policies and interventions aimed at improving the diet of children and adolescents ."
56375,Oxidized,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56376,starches,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56377,have,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56378,been,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56379,utilized,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56380,in,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56381,many,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56382,coating,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56383,applications,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56384,for,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56385,their,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56386,adhesion,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56387,ability,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56388,.,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56389,However,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56390,",",O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56391,it,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56392,is,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56393,not,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56394,known,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56395,if,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56396,they,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56397,perform,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56398,similarly,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56399,in,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56400,bake,B,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56401,-,I,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56402,only,I,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56403,products,I,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56404,.,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
57093,Red,B,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57094,meat,I,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57095,intake,I,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57096,correlates,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57097,with,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57098,increased,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57099,CVD,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57100,risk,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57101,",",O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57102,mainly,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57103,because,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57104,of,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57105,its,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57106,non,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57107,-,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57108,protein,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57109,ingredients,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57110,(,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57111,saturated,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57112,fats,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57113,),O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57114,.,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57247,Teaching,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57248,teams,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57249,",",O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57250,consisting,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57251,of,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57252,an,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57253,extension,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57254,agent,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57255,and,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57256,a,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57257,registered,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57258,dietitian,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57259,",",O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57260,were,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57261,used,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57262,in,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57263,course,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57264,delivery,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57265,.,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
58356,We,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58357,aimed,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58358,to,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58359,estimate,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58360,the,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58361,associations,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58362,between,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58363,consumption,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58364,of,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58365,UPF,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58366,(,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58367,total,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58368,",",O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58369,liquid,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58370,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58371,solid,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58372,),O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58373,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58374,UPF,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58375,subgroups,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58376,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58377,incident,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58378,hypertension,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58379,in,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58380,a,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58381,prospective,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58382,cohort,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58383,study,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58384,.,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
59297,Estimated,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59298,daily,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59299,intake,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59300,of,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59301,protein,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59302,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59303,plant,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59304,fat,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59305,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59306,garlic,B,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59307,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59308,onion,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59309,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59310,allicin,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59311,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59312,and,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59313,quercetin,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59314,was,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59315,greater,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59316,in,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59317,the,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59318,TD,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59319,compared,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59320,to,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59321,the,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59322,RD,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59323,.,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
60162,However,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60163,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60164,a,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60165,diet,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60166,based,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60167,on,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60168,vegetables,B,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60169,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60170,fruits,B,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60171,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60172,whole,B,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60173,grains,I,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60174,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60175,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60176,legumes,B,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60177,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60178,supplemented,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60179,with,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60180,vitamin,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60181,B-12,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60182,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60183,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60184,nutritionally,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60185,superior,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60186,to,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60187,diets,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60188,including,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60189,animal,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60190,products,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60191,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60192,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60193,healthful,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60194,for,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60195,children,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60196,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60197,adults,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60198,.,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60213,We,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60214,investigated,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60215,the,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60216,effect,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60217,of,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60218,red,B,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60219,wine,I,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60220,intake,I,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60221,on,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60222,the,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60223,risk,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60224,of,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60225,prostate,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60226,cancer,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60227,using,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60228,data,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60229,prospectively,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60230,collected,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60231,in,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60232,the,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60233,California,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60234,Men,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60235,'s,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60236,Health,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60237,Study,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60238,(,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60239,CMHS,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60240,),O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60241,.,O,2085.0,We investigated the effect of red wine intake on the risk of prostate cancer using data prospectively collected in the California Men 's Health Study ( CMHS ) .
60242,CMHS,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60243,is,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60244,a,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60245,multiethnic,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60246,cohort,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60247,of,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60248,"84,170",O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60249,men,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60250,aged,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60251,45,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60252,-,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60253,69,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60254,years,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60255,who,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60256,were,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60257,members,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60258,of,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60259,the,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60260,Kaiser,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60261,Permanente,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60262,Southern,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60263,and,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60264,Northern,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60265,California,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60266,Health,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60267,Plans,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60268,.,O,2086.0,"CMHS is a multiethnic cohort of 84,170 men aged 45 - 69 years who were members of the Kaiser Permanente Southern and Northern California Health Plans ."
60285,We,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60286,used,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60287,Cox,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60288,models,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60289,to,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60290,estimate,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60291,the,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60292,effect,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60293,of,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60294,red,B,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60295,wine,I,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60296,on,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60297,prostate,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60298,cancer,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60299,risk,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60300,",",O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60301,adjusting,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60302,for,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60303,potential,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60304,confounders,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60305,.,O,2088.0,"We used Cox models to estimate the effect of red wine on prostate cancer risk , adjusting for potential confounders ."
60739,Silymarin,B,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60740,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60741,a,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60742,natural,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60743,acknowledged,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60744,hepatoprotector,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60745,used,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60746,in,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60747,humans,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60748,to,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60749,treat,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60750,liver,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60751,diseases,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60752,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60753,has,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60754,been,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60755,tested,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60756,in,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60757,dairy,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60758,cows,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60759,during,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60760,peripartum,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60761,",",O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60762,a,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60763,period,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60764,during,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60765,which,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60766,animals,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60767,are,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60768,subject,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60769,to,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60770,subclinical,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60771,fatty,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60772,liver,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
60773,.,O,2108.0,"Silymarin , a natural acknowledged hepatoprotector used in humans to treat liver diseases , has been tested in dairy cows during peripartum , a period during which animals are subject to subclinical fatty liver ."
61383,This,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61384,review,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61385,considers,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61386,whether,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61387,current,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61388,intakes,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61389,of,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61390,sugar,B,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61391,are,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61392,harmful,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61393,to,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61394,health,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61395,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61396,and,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61397,analyses,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61398,recent,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61399,literature,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61400,using,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61401,a,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61402,systematic,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61403,approach,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61404,to,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61405,collate,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61406,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61407,rank,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61408,",",O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61409,and,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61410,evaluate,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61411,published,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61412,studies,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61413,from,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61414,1995,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61415,-,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61416,2006,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61417,.,O,2130.0,"This review considers whether current intakes of sugar are harmful to health , and analyses recent literature using a systematic approach to collate , rank , and evaluate published studies from 1995 - 2006 ."
61537,There,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61538,was,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61539,no,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61540,credible,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61541,evidence,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61542,linking,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61543,sugar,B,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61544,with,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61545,attention,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61546,-,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61547,deficit,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61548,",",O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61549,dementia,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61550,",",O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61551,or,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61552,depression,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61553,.,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61748,The,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61749,main,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61750,pharmacological,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61751,actions,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61752,of,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61753,ginger,B,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61754,and,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61755,compounds,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61756,isolated,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61757,therefrom,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61758,include,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61759,immuno,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61760,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61761,modulatory,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61762,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61763,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61764,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61765,tumorigenic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61766,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61767,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61768,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61769,inflammatory,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61770,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61771,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61772,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61773,apoptotic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61774,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61775,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61776,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61777,hyperglycemic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61778,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61779,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61780,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61781,lipidemic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61782,and,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61783,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61784,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61785,emetic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61786,actions,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61787,.,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61788,Ginger,B,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61789,is,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61790,a,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61791,strong,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61792,anti,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61793,-,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61794,oxidant,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61795,substance,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61796,and,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61797,may,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61798,either,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61799,mitigate,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61800,or,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61801,prevent,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61802,generation,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61803,of,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61804,free,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61805,radicals,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61806,.,O,2143.0,Ginger is a strong anti - oxidant substance and may either mitigate or prevent generation of free radicals .
61865,Several,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61866,epidemiological,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61867,studies,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61868,suggested,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61869,the,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61870,inverse,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61871,correlation,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61872,between,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61873,the,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61874,intake,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61875,of,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61876,vegetables,B,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61877,and,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61878,fruits,B,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61879,and,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61880,the,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61881,incidence,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61882,of,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61883,breast,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61884,cancer,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61885,.,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
63732,PRACTICAL,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63733,APPLICATION,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63734,:,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63735,Rice,B,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63736,has,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63737,a,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63738,high,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63739,glycemic,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63740,index,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63741,(,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63742,GI,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63743,),O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63744,that,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63745,makes,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63746,it,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63747,unsuitable,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63748,for,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63749,consumption,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63750,by,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63751,many,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63752,people,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63753,with,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63754,type,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63755,2,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63756,diabetes,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63757,and,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63758,obesity,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63759,.,O,2212.0,PRACTICAL APPLICATION : Rice has a high glycemic index ( GI ) that makes it unsuitable for consumption by many people with type 2 diabetes and obesity .
63807,Baseline,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63808,data,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63809,of,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63810,"3,372",O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63811,women,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63812,and,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63813,"3,191",O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63814,men,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63815,(,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63816,30,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63817,-,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63818,60,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63819,years,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63820,old,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63821,),O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63822,from,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63823,the,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63824,population,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63825,-,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63826,based,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63827,survey,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63828,Inter99,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63829,was,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63830,used,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63831,.,O,2215.0,"Baseline data of 3,372 women and 3,191 men ( 30 - 60 years old ) from the population - based survey Inter99 was used ."
63859,Confirmatory,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63860,factor,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63861,analysis,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63862,and,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63863,Bland,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63864,Altman,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63865,plots,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63866,were,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63867,used,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63868,to,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63869,assess,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63870,the,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63871,reproducibility,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63872,of,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63873,the,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63874,dietary,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63875,patterns,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63876,identified,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
63877,.,O,2218.0,Confirmatory factor analysis and Bland Altman plots were used to assess the reproducibility of the dietary patterns identified .
64057,Pearson,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64058,'s,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64059,correlation,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64060,was,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64061,>,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64062,0.89,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64063,(,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64064,P,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64065,<,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64066,0.0001,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64067,),O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64068,.,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64317,Continued,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64318,attention,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64319,to,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64320,increasing,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64321,fruit,B,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64322,and,I,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64323,vegetable,I,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64324,consumption,I,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64325,is,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64326,a,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64327,practical,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64328,and,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64329,important,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64330,way,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64331,to,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64332,optimize,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64333,nutrition,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64334,to,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64335,reduce,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64336,disease,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64337,risk,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64338,and,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64339,maximize,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64340,good,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64341,health,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64342,.,O,2235.0,Continued attention to increasing fruit and vegetable consumption is a practical and important way to optimize nutrition to reduce disease risk and maximize good health .
64360,Milk,B,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64361,in,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64362,the,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64363,rumen,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64364,may,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64365,cause,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64366,indigestion,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64367,",",O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64368,diarrhea,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64369,",",O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64370,and,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64371,reduced,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64372,growth,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64373,.,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64436,Our,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64437,hypothesis,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64438,was,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64439,that,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64440,cold,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64441,milk,B,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64442,drunk,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64443,at,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64444,high,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64445,speed,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64446,would,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64447,cause,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64448,insufficient,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64449,closure,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64450,of,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64451,the,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64452,esophageal,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64453,groove,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64454,and,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64455,hence,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64456,milk,B,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64457,in,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64458,the,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64459,rumen,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64460,.,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64984,Cases,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64985,(,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64986,399,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64987,),O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64988,and,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64989,a,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64990,corresponding,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64991,number,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64992,of,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64993,controls,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64994,",",O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64995,matched,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64996,for,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64997,age,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64998,and,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64999,sex,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65000,",",O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65001,were,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65002,included,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65003,",",O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65004,the,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65005,controls,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65006,being,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65007,selected,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65008,from,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65009,patients,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65010,undergoing,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65011,functional,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65012,re,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65013,-,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65014,education,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65015,for,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65016,injuries,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65017,or,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65018,trauma,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65019,which,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65020,reduced,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65021,their,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65022,mobility,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65023,.,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65220,We,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65221,assessed,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65222,wine,B,2271.0,"We assessed wine , beer , and spirits intake separately ."
65223,",",O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65224,beer,B,2271.0,"We assessed wine , beer , and spirits intake separately ."
65225,",",O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65226,and,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65227,spirits,B,2271.0,"We assessed wine , beer , and spirits intake separately ."
65228,intake,I,2271.0,"We assessed wine , beer , and spirits intake separately ."
65229,separately,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65230,.,O,2271.0,"We assessed wine , beer , and spirits intake separately ."
65231,France,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65232,had,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65233,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65234,highest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65235,wine,B,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65236,intake,I,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65237,and,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65238,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65239,highest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65240,total,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65241,alcohol,B,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65242,intake,I,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65243,",",O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65244,and,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65245,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65246,second,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65247,lowest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65248,CHD,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65249,mortality,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65250,rate,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65251,.,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65271,In,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65272,multivariate,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65273,analyses,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65274,",",O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65275,animal,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65276,fat,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65277,tended,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65278,to,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65279,be,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65280,positively,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65281,correlated,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65282,",",O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65283,and,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65284,fruit,B,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65285,consumption,I,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65286,inversely,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65287,correlated,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65288,",",O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65289,with,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65290,CHD,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65291,.,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65319,However,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65320,",",O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65321,wine,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65322,ethanol,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65323,was,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65324,unrelated,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65325,to,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65326,total,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65327,mortality,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65328,.,O,2277.0,"However , wine ethanol was unrelated to total mortality ."
65579,In,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65580,addition,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65581,the,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65582,effect,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65583,of,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65584,cooking,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65585,and,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65586,proteolytic,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65587,digestion,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65588,on,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65589,the,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65590,corn,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65591,allergens,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65592,was,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65593,investigated,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65594,.,O,2286.0,In addition the effect of cooking and proteolytic digestion on the corn allergens was investigated .
65980,While,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65981,Plenish,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65982,induced,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65983,less,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65984,insulin,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65985,resistance,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65986,than,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65987,conventional,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65988,soybean,B,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65989,oil,I,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65990,",",O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65991,it,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65992,resulted,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65993,in,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65994,hepatomegaly,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65995,and,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65996,liver,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65997,dysfunction,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65998,as,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65999,did,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66000,olive,B,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66001,oil,I,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66002,",",O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66003,which,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66004,has,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66005,a,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66006,similar,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66007,fatty,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66008,acid,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66009,composition,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66010,.,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66031,Increasing,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66032,evidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66033,suggest,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66034,that,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66035,low,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66036,-,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66037,dose,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66038,alcohol,B,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66039,consumption,I,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66040,(,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66041,LAC,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66042,),O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66043,reduces,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66044,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66045,incidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66046,and,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66047,improves,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66048,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66049,functional,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66050,outcome,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66051,of,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66052,ischemic,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66053,stroke,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66054,.,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66156,Cerebral,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66157,ischemia,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66158,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66159,reperfusion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66160,(,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66161,I,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66162,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66163,R,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66164,),O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66165,injury,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66166,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66167,expression,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66168,of,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66169,adhesion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66170,molecules,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66171,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66172,pro-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66173,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66174,anti,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66175,-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66176,inflammatory,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66177,cytokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66178,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66179,chemokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66180,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66181,microglial,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66182,activation,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66183,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66184,neutrophil,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66185,infiltration,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66186,were,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66187,evaluated,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66188,.,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66189,The,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66190,total,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66191,infarct,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66192,volume,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66193,and,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66194,neurological,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66195,deficits,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66196,were,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66197,significantly,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66198,reduced,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66199,in,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66200,red,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66201,wine-,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66202,and,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66203,ethanol,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66204,-,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66205,fed,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66206,rats,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66207,compared,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66208,to,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66209,control,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66210,rats,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66211,.,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66212,Both,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66213,red,B,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66214,wine,I,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66215,and,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66216,ethanol,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66217,suppressed,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66218,post,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66219,-,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66220,ischemic,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66221,expression,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66222,of,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66223,adhesion,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66224,molecules,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66225,and,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66226,microglial,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66227,activation,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66228,.,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66904,Red,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66905,wine,I,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66906,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66907,liquor,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66908,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66909,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66910,beer,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66911,were,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66912,not,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66913,associated,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66914,with,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66915,prostate,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66916,cancer,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66917,nor,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66918,was,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66919,total,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66920,alcohol,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66921,consumed,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66922,at,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66923,ages,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66924,18,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66925,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66926,30,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66927,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66928,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66929,45,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66930,.,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66931,Associations,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66932,of,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66933,alcohol,B,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66934,use,I,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66935,with,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66936,prostate,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66937,cancer,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66938,are,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66939,modest,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66940,and,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66941,complex,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66942,.,O,2337.0,Associations of alcohol use with prostate cancer are modest and complex .
66974,This,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66975,study,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66976,aimed,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66977,to,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66978,assess,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66979,the,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66980,starch,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66981,digestibility,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66982,of,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66983,white,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66984,and,I,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66985,red,I,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66986,rice,I,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66987,prepared,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66988,with,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66989,2,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66990,oil,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66991,types,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66992,:,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66993,vegetable,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66994,oil,I,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66995,(,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66996,unsaturated,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66997,fat,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66998,),O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
66999,and,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67000,ghee,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67001,(,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67002,clarified,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67003,butter,I,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67004,",",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67005,saturated,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67006,fat,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67007,),O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67008,added,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67009,at,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67010,3,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67011,different,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67012,time,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67013,points,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67014,during,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67015,the,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67016,cooking,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67017,process,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67018,(,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67019,"""",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67020,before,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67021,"""",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67022,:,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67023,frying,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67024,raw,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67025,rice,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67026,in,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67027,oil,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67028,before,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67029,boiling,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67030,",",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67031,"""",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67032,during,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67033,"""",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67034,:,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67035,adding,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67036,oil,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67037,during,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67038,boiling,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67039,",",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67040,and,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67041,"""",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67042,after,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67043,"""",O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67044,:,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67045,stir,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67046,-,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67047,frying,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67048,cooked,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67049,rice,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67050,in,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67051,oil,B,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67052,),O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67053,.,O,2340.0,"This study aimed to assess the starch digestibility of white and red rice prepared with 2 oil types : vegetable oil ( unsaturated fat ) and ghee ( clarified butter , saturated fat ) added at 3 different time points during the cooking process ( "" before "" : frying raw rice in oil before boiling , "" during "" : adding oil during boiling , and "" after "" : stir - frying cooked rice in oil ) ."
67084,Adding,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67085,oil,B,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67086,"""",O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67087,after,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67088,"""",O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67089,(,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67090,stir,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67091,-,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67092,frying,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67093,),O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67094,to,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67095,white,B,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67096,or,I,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67097,red,I,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67098,rice,I,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67099,resulted,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67100,in,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67101,higher,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67102,slowly,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67103,digestible,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67104,starch,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67105,.,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67180,White,B,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67181,rice,I,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67182,with,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67183,oil,B,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67184,added,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67185,"""",O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67186,after,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67187,"""",O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67188,(,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67189,stir,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67190,-,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67191,fried,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67192,),O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67193,may,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67194,provide,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67195,a,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67196,source,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67197,of,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67198,sustained,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67199,glucose,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67200,and,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67201,stabilize,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67202,blood,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67203,glucose,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67204,levels,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67205,.,O,2347.0,"White rice with oil added "" after "" ( stir - fried ) may provide a source of sustained glucose and stabilize blood glucose levels ."
67542,A,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67543,significant,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67544,reduction,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67545,in,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67546,risk,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67547,was,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67548,linked,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67549,to,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67550,daily,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67551,tea,B,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67552,drinking,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67553,among,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67554,women,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67555,",",O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67556,but,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67557,not,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67558,among,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67559,men,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67560,.,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67664,Recent,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67665,animal,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67666,studies,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67667,have,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67668,investigated,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67669,tomatoes,B,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67670,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67671,lycopene,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67672,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67673,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67674,prostate,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67675,cancer,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67676,using,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67677,the,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67678,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67679,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67680,methyl,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67681,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67682,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67683,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67684,nitrosourea,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67685,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67686,Dunning,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67687,rat,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67688,models,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67689,.,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
68305,Egg,B,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68306,consumption,I,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68307,is,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68308,a,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68309,major,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68310,source,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68311,of,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68312,dietary,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68313,cholesterol,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68314,",",O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68315,a,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68316,nutrient,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68317,that,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68318,may,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68319,disrupt,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68320,glucose,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68321,metabolism,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68322,.,O,2384.0,"Egg consumption is a major source of dietary cholesterol , a nutrient that may disrupt glucose metabolism ."
68469,When,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68470,comparing,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68471,women,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68472,who,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68473,consumed,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68474,at,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68475,least,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68476,five,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68477,eggs,B,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68478,per,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68479,week,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68480,with,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68481,non,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68482,-,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68483,consumers,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68484,",",O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68485,the,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68486,multivariable,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68487,hazard,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68488,ratio,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68489,(,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68490,HR,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68491,),O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68492,was,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68493,found,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68494,to,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68495,be,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68496,1·00,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68497,(,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68498,95,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68499,%,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68500,CI,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68501,0·78,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68502,",",O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68503,1·29,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68504,;,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68505,across,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68506,categories,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68507,",",O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68508,P,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68509,trend=0·11,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68510,),O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68511,.,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68702,This,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68703,study,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68704,estimated,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68705,the,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68706,potential,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68707,reductions,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68708,in,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68709,body,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68710,weight,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68711,",",O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68712,obesity,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68713,-,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68714,related,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68715,disease,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68716,incidence,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68717,",",O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68718,and,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68719,healthcare,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68720,cost,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68721,savings,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68722,associated,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68723,with,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68724,consumption,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68725,of,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68726,one,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68727,less,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68728,serving,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68729,per,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68730,week,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68731,of,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68732,different,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68733,discretionary,B,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68734,foods,I,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68735,.,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68906,A,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68907,decrease,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68908,of,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68909,one,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68910,serving,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68911,of,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68912,sweet,B,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68913,biscuits,I,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68914,had,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68915,the,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68916,second,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68917,largest,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68918,potential,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68919,impact,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68920,on,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68921,weight,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68922,change,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68923,overall,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68924,",",O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68925,with,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68926,healthcare,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68927,cost,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68928,savings,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68929,of,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68930,$,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68931,640.7,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68932,M,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68933,(,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68934,95,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68935,%,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68936,CI,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68937,:,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68938,$,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68939,402.6,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68940,M,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68941,to,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68942,$,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68943,885.8,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68944,M,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68945,),O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68946,and,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68947,the,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68948,largest,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68949,potential,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68950,weight,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68951,reduction,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68952,amongst,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68953,those,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68954,aged,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68955,75,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68956,years,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68957,and,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68958,over,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68959,(,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68960,mean,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68961,0.21,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68962,kg,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68963,",",O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68964,95,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68965,%,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68966,UI,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68967,:,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68968,0.14,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68969,kg,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68970,to,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68971,0.27,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68972,kg,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68973,),O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68974,.,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
69198,The,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69199,glycemic,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69200,index,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69201,concept,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69202,neglects,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69203,the,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69204,insulin,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69205,secretion,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69206,factor,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69207,and,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69208,has,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69209,not,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69210,been,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69211,systematically,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69212,studied,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69213,during,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69214,mixed,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69215,meals,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69216,.,O,2412.0,The glycemic index concept neglects the insulin secretion factor and has not been systematically studied during mixed meals .
69244,These,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69245,test,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69246,meals,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69247,were,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69248,randomly,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69249,assigned,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69250,using,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69251,a,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69252,three,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69253,factor,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69254,experiment,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69255,design,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69256,.,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69391,The,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69392,glycemic,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69393,index,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69394,concept,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69395,remains,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69396,discriminating,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69397,",",O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69398,even,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69399,in,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69400,the,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69401,context,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69402,of,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69403,an,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69404,iso,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69405,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69406,glucido,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69407,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69408,lipido,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69409,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69410,protidic,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69411,meal,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69412,.,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69723,Thus,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69724,far,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69725,",",O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69726,L.,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69727,monocytogenes,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69728,has,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69729,been,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69730,responsible,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69731,for,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69732,well,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69733,over,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69734,300,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69735,reported,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69736,cases,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69737,of,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69738,food,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69739,-,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69740,borne,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69741,listeriosis,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69742,",",O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69743,including,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69744,about,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69745,100,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69746,deaths,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69747,",",O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69748,and,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69749,has,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69750,cost,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69751,the,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69752,dairy,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69753,industry,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69754,alone,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69755,more,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69756,than,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69757,66,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69758,million,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69759,dollars,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69760,as,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69761,a,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69762,result,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69763,of,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69764,product,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69765,recalls,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69766,.,O,2431.0,"Thus far , L. monocytogenes has been responsible for well over 300 reported cases of food - borne listeriosis , including about 100 deaths , and has cost the dairy industry alone more than 66 million dollars as a result of product recalls ."
69891,Although,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69892,known,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69893,for,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69894,many,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69895,years,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69896,",",O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69897,Campylobacter,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69898,jejuni,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69899,has,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69900,only,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69901,recently,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69902,been,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69903,recognized,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69904,as,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69905,a,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69906,food,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69907,-,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69908,borne,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69909,pathogen,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69910,and,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69911,a,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69912,leading,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69913,cause,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69914,of,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69915,gastroenteritis,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69916,in,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69917,the,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69918,United,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69919,States,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69920,.,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
70379,We,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70380,investigated,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70381,the,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70382,dietary,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70383,effects,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70384,of,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70385,egg,B,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70386,white,I,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70387,(,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70388,EW,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70389,),O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70390,and,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70391,its,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70392,hydrolysate,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70393,(,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70394,EWH,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70395,),O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70396,on,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70397,fat,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70398,metabolism,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70399,in,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70400,rats,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70401,.,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70555,It,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70556,has,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70557,been,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70558,hypothesized,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70559,that,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70560,milk,B,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70561,consumption,I,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70562,increases,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70563,the,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70564,risk,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70565,of,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70566,ovarian,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70567,cancer,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70568,because,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70569,of,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70570,a,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70571,possible,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70572,association,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70573,of,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70574,lactose,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70575,with,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70576,human,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70577,ovarian,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70578,failure,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70579,.,O,2459.0,It has been hypothesized that milk consumption increases the risk of ovarian cancer because of a possible association of lactose with human ovarian failure .
70580,Milk,B,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70581,is,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70582,also,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70583,a,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70584,source,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70585,of,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70586,animal,B,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70587,fats,I,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70588,in,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70589,the,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70590,diet,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70591,",",O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70592,and,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70593,animal,B,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70594,fat,I,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70595,intake,I,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70596,is,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70597,associated,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70598,with,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70599,ovarian,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70600,cancer,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70601,risk,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70602,.,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70662,Total,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70663,frequency,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70664,of,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70665,usual,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70666,milk,B,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70667,intake,I,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70668,was,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70669,not,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70670,associated,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70671,with,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70672,increased,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70673,risk,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70674,.,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
71340,Therefore,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71341,",",O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71342,various,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71343,metabolites,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71344,produced,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71345,by,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71346,cocobiota,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71347,can,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71348,mimic,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71349,some,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71350,medicinal,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71351,effects,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71352,of,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71353,dark,B,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71354,chocolate,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71355,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71356,other,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71357,cocoa,B,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71358,-,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71359,derived,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71360,products,I,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71361,previously,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71362,attributed,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71363,to,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71364,cocoa,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71365,flavonoids,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71366,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71367,methylxanthines,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71368,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71369,need,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71370,to,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71371,be,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71372,thoroughly,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71373,investigated,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71374,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71375,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71376,vitro,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71377,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71378,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71379,vivo,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71380,systems,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71381,.,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71575,Compared,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71576,with,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71577,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71578,study,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71579,participants,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71580,in,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71581,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71582,first,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71583,tertile,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71584,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71585,T1,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71586,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71587,lowest,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71588,consumption,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71589,),O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71590,of,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71591,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71592,prudent,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71593,pattern,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71594,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71595,participants,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71596,in,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71597,the,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71598,third,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71599,tertile,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71600,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71601,T3,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71602,),O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71603,had,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71604,a,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71605,lower,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71606,prevalence,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71607,of,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71608,low,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71609,BMD,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71610,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71611,prevalence,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71612,ratio,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71613,(,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71614,PR)=0·52,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71615,;,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71616,95,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71617,%,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71618,CI,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71619,0·33,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71620,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71621,0·83,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71622,),O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71623,after,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71624,adjusting,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71625,for,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71626,socio,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71627,-,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71628,demographic,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71629,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71630,lifestyle,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71631,and,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71632,behavioural,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71633,characteristics,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71634,",",O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71635,chronic,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71636,conditions,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71637,and,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71638,energy,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71639,intake,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
71640,.,O,2490.0,"Compared with the study participants in the first tertile ( T1 , lowest consumption ) of the prudent pattern , participants in the third tertile ( T3 ) had a lower prevalence of low BMD ( prevalence ratio ( PR)=0·52 ; 95 % CI 0·33 , 0·83 ) after adjusting for socio - demographic , lifestyle and behavioural characteristics , chronic conditions and energy intake ."
72223,Quality,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72224,of,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72225,life,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72226,(,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72227,QoL,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72228,),O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72229,is,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72230,an,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72231,important,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72232,clinical,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72233,outcome,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72234,in,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72235,cancer,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72236,patients,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72237,.,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72313,We,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72314,identified,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72315,four,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72316,major,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72317,dietary,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72318,patterns,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72319,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72320,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72321,Western,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72322,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72323,dietary,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72324,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72325,characterized,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72326,by,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72327,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72328,consumption,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72329,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72330,potatoes,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72331,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72332,red,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72333,and,I,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72334,processed,I,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72335,meat,I,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72336,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72337,poultry,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72338,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72339,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72340,cakes,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72341,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72342,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72343,fruit&vegetable,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72344,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72345,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72346,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72347,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72348,intake,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72349,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72350,vegetables,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72351,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72352,fruits,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72353,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72354,vegetable,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72355,oils,I,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72356,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72357,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72358,soy,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72359,products,I,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72360,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72361,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72362,bread&butter,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72363,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72364,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72365,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72366,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72367,intake,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72368,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72369,bread,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72370,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72371,butter,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72372,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72373,margarine,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72374,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72375,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72376,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72377,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72378,-,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72379,carb,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72380,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72381,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72382,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72383,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72384,consumption,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72385,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72386,pasta,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72387,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72388,grains,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72389,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72390,nonalcoholic,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72391,beverages,I,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72392,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72393,sauces,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72394,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72395,condiments,B,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72396,.,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
73023,Within,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73024,a,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73025,sample,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73026,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73027,obese,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73028,adults,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73029,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73030,consumption,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73031,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73032,dairy,B,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73033,products,I,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73034,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73035,dairy,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73036,protein,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73037,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73038,and,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73039,calcium,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73040,was,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73041,associated,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73042,with,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73043,more,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73044,favourable,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73045,body,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73046,composition,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73047,.,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73222,Moreover,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73223,",",O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73224,some,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73225,studies,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73226,indicated,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73227,that,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73228,different,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73229,people,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73230,might,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73231,have,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73232,a,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73233,different,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73234,response,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73235,to,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73236,garlic,B,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73237,",",O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73238,and,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73239,thus,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73240,garlic,B,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73241,may,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73242,be,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73243,more,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73244,beneficial,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73245,for,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73246,some,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73247,specific,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73248,groups,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73249,.,O,2543.0,"Moreover , some studies indicated that different people might have a different response to garlic , and thus garlic may be more beneficial for some specific groups ."
73415,The,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73416,medians,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73417,of,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73418,milk,B,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73419,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73420,yogurt,B,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73421,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73422,cheese,B,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73423,consumption,I,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73424,were,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73425,293,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73426,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73427,interquartile,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73428,range,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73429,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73430,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73431,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73432,146,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73433,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73434,439,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73435,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73436,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73437,35·3,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73438,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73439,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73440,8·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73441,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73442,71·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73443,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73444,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73445,14·6,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73446,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73447,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73448,4·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73449,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73450,26·9,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73451,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73452,g,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73453,/,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73454,d,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73455,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73456,respectively,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73457,.,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73538,Our,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73539,findings,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73540,suggest,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73541,that,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73542,the,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73543,influence,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73544,of,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73545,milk,B,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73546,consumption,I,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73547,on,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73548,lean,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73549,mass,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73550,and,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73551,of,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73552,low,B,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73553,-,I,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73554,fat,I,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73555,dairy,I,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73556,consumption,I,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73557,on,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73558,fat,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73559,mass,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73560,distribution,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73561,may,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73562,be,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73563,potential,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73564,pathways,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73565,for,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73566,the,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73567,link,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73568,between,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73569,dairy,B,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73570,consumption,I,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73571,and,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73572,metabolic,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73573,risk,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73574,.,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
74020,A,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74021,1,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74022,-,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74023,SD,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74024,increase,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74025,in,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74026,the,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74027,scores,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74028,on,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74029,the,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74030,high,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74031,-,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74032,protein,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74033,/,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74034,fruit,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74035,pattern,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74036,was,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74037,associated,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74038,with,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74039,decreased,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74040,likelihood,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74041,of,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74042,preterm,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74043,birth,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74044,(,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74045,adjusted,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74046,OR,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74047,:,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74048,0.31,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74049,;,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74050,95,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74051,%,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74052,CI,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74053,:,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74054,0.13,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74055,",",O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74056,0.72,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74057,;,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74058,P,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74059,=,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74060,0.007,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74061,),O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74062,",",O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74063,whereas,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74064,the,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74065,reverse,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74066,direction,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74067,was,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74068,apparent,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74069,for,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74070,the,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74071,high,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74072,-,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74073,fat,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74074,/,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74075,sugar,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74076,/,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74077,takeaway,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74078,pattern,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74079,(,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74080,adjusted,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74081,OR,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74082,:,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74083,1.54,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74084,;,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74085,95,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74086,%,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74087,CI,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74088,:,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74089,1.10,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74090,",",O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74091,2.15,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74092,;,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74093,P,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74094,=,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74095,0.011,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74096,),O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74097,.,O,2572.0,"A 1 - SD increase in the scores on the high - protein / fruit pattern was associated with decreased likelihood of preterm birth ( adjusted OR : 0.31 ; 95 % CI : 0.13 , 0.72 ; P = 0.007 ) , whereas the reverse direction was apparent for the high - fat / sugar / takeaway pattern ( adjusted OR : 1.54 ; 95 % CI : 1.10 , 2.15 ; P = 0.011 ) ."
74172,A,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74173,dietary,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74174,pattern,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74175,containing,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74176,several,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74177,protein,B,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74178,-,I,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74179,rich,I,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74180,food,I,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74181,sources,I,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74182,",",O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74183,fruit,B,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74184,",",O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74185,and,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74186,some,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74187,whole,B,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74188,grains,I,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74189,is,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74190,associated,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74191,with,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74192,reduced,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74193,likelihood,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74194,for,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74195,preterm,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74196,delivery,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74197,",",O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74198,whereas,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74199,a,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74200,dietary,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74201,pattern,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74202,mainly,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74203,consisting,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74204,of,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74205,discretionary,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74206,items,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74207,is,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74208,associated,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74209,with,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74210,preterm,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74211,delivery,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74212,",",O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74213,shorter,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74214,birth,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74215,length,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74216,",",O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74217,and,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74218,earlier,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74219,gestation,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74220,.,O,2575.0,"A dietary pattern containing several protein - rich food sources , fruit , and some whole grains is associated with reduced likelihood for preterm delivery , whereas a dietary pattern mainly consisting of discretionary items is associated with preterm delivery , shorter birth length , and earlier gestation ."
74294,This,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74295,study,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74296,investigated,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74297,the,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74298,prevalence,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74299,and,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74300,clinical,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74301,significance,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74302,of,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74303,latex,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74304,sensitization,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74305,in,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74306,children,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74307,seen,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74308,in,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74309,a,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74310,university,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74311,hospital,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74312,allergy,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74313,clinic,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74314,.,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74479,Latex,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74480,challenge,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74481,was,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74482,positive,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74483,in,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74484,3/9,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74485,positive,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74486,-,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74487,latex,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74488,-,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74489,SPT,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74490,children,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74491,.,O,2586.0,Latex challenge was positive in 3/9 positive - latex - SPT children .
74492,None,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74493,of,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74494,the,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74495,nonatopic,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74496,children,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74497,had,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74498,positive,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74499,skin,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74500,test,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74501,to,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74502,latex,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74503,or,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74504,symptoms,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74505,to,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74506,latex,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74507,exposure,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74508,.,O,2587.0,None of the nonatopic children had positive skin test to latex or symptoms to latex exposure .
74628,The,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74629,natural,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74630,history,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74631,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74632,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74633,positive,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74634,-,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74635,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74636,-,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74637,SPT,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74638,children,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74639,without,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74640,clinical,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74641,reactions,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74642,to,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74643,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74644,exposure,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74645,and,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74646,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74647,clinical,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74648,significance,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74649,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74650,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74651,association,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74652,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74653,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74654,and,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74655,fruit,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74656,sensitivity,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74657,require,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74658,further,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74659,studies,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74660,.,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74715,In,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74716,recent,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74717,years,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74718,",",O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74719,many,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74720,articles,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74721,have,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74722,reported,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74723,the,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74724,detection,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74725,of,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74726,PAs,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74727,in,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74728,various,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74729,foods,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74730,",",O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74731,including,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74732,honey,B,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74733,",",O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74734,milk,B,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74735,",",O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74736,meat,B,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74737,",",O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74738,eggs,B,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74739,",",O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74740,tea,B,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74741,and,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74742,salad,B,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74743,.,O,2597.0,"In recent years , many articles have reported the detection of PAs in various foods , including honey , milk , meat , eggs , tea and salad ."
74990,The,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74991,intake,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74992,estimates,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74993,indicated,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74994,an,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74995,increase,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74996,in,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74997,mean,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74998,folic,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74999,acid,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75000,intake,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75001,of,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75002,159,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75003, ,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75004,μg,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75005,per,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75006,day,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75007,for,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75008,the,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75009,target,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75010,group,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75011,.,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75441,Some,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75442,weeks,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75443,later,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75444,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75445,approximately,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75446,200,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75447,infants,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75448,(,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75449,fed,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75450,exclusively,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75451,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75452,formula,B,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75453,milks,I,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75454,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75455,a,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75456,chloride,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75457,content,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75458,of,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75459,only,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75460,2,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75461,-,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75462,4,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75463,mmol,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75464,/,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75465,L,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75466,),O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75467,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75468,were,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75469,admitted,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75470,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75471,failure,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75472,to,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75473,thrive,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75474,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75475,constipation,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75476,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75477,food,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75478,refusal,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75479,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75480,muscular,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75481,weakness,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75482,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75483,and,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75484,delayed,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75485,psychomotor,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75486,development,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75487,.,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75551,It,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75552,is,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75553,therefore,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75554,concluded,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75555,that,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75556,the,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75557,dietary,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75558,intake,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75559,of,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75560,chloride,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75561,",",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75562,which,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75563,was,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75564,previously,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75565,considered,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75566,a,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75567,"""",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75568,mendicant,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75569,"""",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75570,ion,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75571,",",O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75572,plays,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75573,a,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75574,crucial,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75575,role,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75576,in,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75577,acid,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75578,-,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75579,base,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75580,and,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75581,salt,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75582,balance,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75583,.,O,2627.0,"It is therefore concluded that the dietary intake of chloride , which was previously considered a "" mendicant "" ion , plays a crucial role in acid - base and salt balance ."
75763,Nevertheless,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75764,",",O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75765,we,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75766,suggest,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75767,dietary,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75768,guidelines,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75769,for,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75770,prevention,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75771,of,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75772,CHD,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75773,in,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75774,Spain,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75775,.,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
76697,In,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76698,our,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76699,study,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76700,",",O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76701,relative,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76702,risks,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76703,(,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76704,RRs,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76705,),O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76706,of,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76707,developing,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76708,HER-2,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76709,-,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76710,positive,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76711,and,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76712,HER-2,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76713,-,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76714,negative,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76715,breast,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76716,cancers,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76717,by,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76718,tertiles,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76719,of,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76720,dietary,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76721,pattern,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76722,factor,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76723,scores,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76724,were,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76725,assessed,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76726,by,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76727,multinomial,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76728,logistic,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76729,regression,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
76730,.,O,2665.0,"In our study , relative risks ( RRs ) of developing HER-2 - positive and HER-2 - negative breast cancers by tertiles of dietary pattern factor scores were assessed by multinomial logistic regression ."
77155,Industrial,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77156,and,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77157,municipal,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77158,solid,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77159,wastes,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77160,",",O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77161,noise,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77162,",",O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77163,pesticides,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77164,",",O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77165,fertilizers,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77166,and,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77167,vehicular,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77168,emission,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77169,are,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77170,visible,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77171,pollutants,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77172,responsible,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77173,for,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77174,environmental,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77175,contamination,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77176,and,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77177,ill,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77178,-,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77179,effects,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77180,on,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77181,health,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77182,of,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77183,all,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77184,living,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77185,systems,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77186,.,O,2678.0,"Industrial and municipal solid wastes , noise , pesticides , fertilizers and vehicular emission are visible pollutants responsible for environmental contamination and ill - effects on health of all living systems ."
77260,Usage,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77261,of,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77262,these,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77263,reproductive,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77264,drugs,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77265,in,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77266,humans,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77267,is,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77268,increased,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77269,manifold,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77270,to,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77271,manage,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77272,reproductive,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77273,problems,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77274,and/or,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77275,for,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77276,birth,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77277,control,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77278,with,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77279,changing,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77280,lifestyles,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77281,.,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77282,These,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77283,drugs,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77284,are,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77285,excreted,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77286,in,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77287,urine,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77288,and,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77289,faeces,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77290,as,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77291,metabolite,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77292,or,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77293,conjugated,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77294,forms,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77295,",",O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77296,leading,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77297,to,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77298,contamination,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77299,of,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77300,water,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77301,",",O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77302,milk,B,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77303,and,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77304,animal,B,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77305,produce,I,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77306,",",O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77307,which,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77308,are,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77309,consumed,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77310,directly,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77311,by,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77312,humans,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77313,as,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77314,well,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77315,as,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77316,animals,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77317,.,O,2683.0,"These drugs are excreted in urine and faeces as metabolite or conjugated forms , leading to contamination of water , milk and animal produce , which are consumed directly by humans as well as animals ."
77604,The,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77605,decreasing,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77606,mortality,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77607,rates,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77608,from,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77609,cerebrovascular,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77610,disease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77611,are,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77612,thought,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77613,to,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77614,reflect,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77615,the,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77616,increases,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77617,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77618,animal,B,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77619,foods,I,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77620,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77621,milk,B,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77622,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77623,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77624,dairy,B,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77625,products,I,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77626,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77627,consequently,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77628,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77629,saturated,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77630,fatty,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77631,acids,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77632,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77633,calcium,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77634,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77635,together,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77636,with,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77637,a,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77638,decrease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77639,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77640,salt,B,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77641,intake,I,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77642,which,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77643,may,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77644,have,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77645,led,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77646,to,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77647,a,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77648,decrease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77649,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77650,blood,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77651,pressure,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77652,.,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77964,These,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77965,data,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77966,did,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77967,not,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77968,show,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77969,a,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77970,significant,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77971,association,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77972,between,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77973,tea,B,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77974,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77975,coffee,B,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77976,consumption,I,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77977,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77978,EC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77979,",",O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77980,EAC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77981,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77982,ESCC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77983,",",O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77984,although,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77985,a,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77986,decreased,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77987,risk,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77988,of,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77989,ESCC,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77990,among,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77991,men,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77992,and,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77993,current,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77994,smokers,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77995,is,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77996,suggested,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77997,",",O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77998,but,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
77999,need,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78000,to,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78001,be,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78002,confirmed,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78003,in,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78004,further,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78005,prospective,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78006,studies,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78007,including,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78008,more,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78009,cases,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78010,.,O,2705.0,"These data did not show a significant association between tea and coffee consumption and EC , EAC and ESCC , although a decreased risk of ESCC among men and current smokers is suggested , but need to be confirmed in further prospective studies including more cases ."
78011,Ovarian,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78012,cancer,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78013,is,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78014,commonly,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78015,a,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78016,fatal,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78017,disease,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78018,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78019,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78020,despite,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78021,advances,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78022,in,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78023,screening,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78024,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78025,treatment,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78026,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78027,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78028,lack,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78029,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78030,understanding,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78031,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78032,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78033,underlying,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78034,etiology,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78035,has,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78036,limited,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78037,prevention,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78038,strategies,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78039,.,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78169,However,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78170,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78171,evidence,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78172,for,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78173,associations,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78174,of,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78175,foods,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78176,such,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78177,as,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78178,fish,B,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78179,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78180,grains,B,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78181,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78182,milk,B,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78183,products,I,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78184,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78185,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78186,fats,B,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78187,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78188,oils,B,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78189,with,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78190,EOC,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78191,risk,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78192,is,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78193,limited,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78194,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78195,inconsistent,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78196,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78197,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78198,further,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78199,examination,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78200,of,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78201,these,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78202,dietary,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78203,determinants,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78204,of,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78205,EOC,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78206,are,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78207,warranted,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78208,.,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78209,In,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78210,conclusion,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78211,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78212,a,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78213,typical,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78214,Western,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78215,diet,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78216,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78217,which,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78218,is,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78219,high,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78220,in,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78221,meats,B,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78222,and,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78223,low,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78224,in,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78225,vegetables,B,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78226,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78227,may,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78228,be,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78229,positively,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78230,associated,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78231,with,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78232,ovarian,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78233,cancer,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78234,incidence,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78235,.,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78517,Although,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78518,the,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78519,inverse,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78520,association,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78521,between,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78522,coffee,B,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78523,consumption,I,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78524,and,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78525,risk,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78526,of,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78527,diabetes,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78528,has,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78529,been,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78530,reported,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78531,numerous,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78532,times,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78533,",",O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78534,the,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78535,role,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78536,of,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78537,caffeine,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78538,intake,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78539,in,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78540,this,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78541,association,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78542,has,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78543,remained,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78544,unclear,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78545,.,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78613,At,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78614,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78615,follow,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78616,-,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78617,up,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78618,survey,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78619,in,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78620,2002,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78621,",",O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78622,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78623,development,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78624,of,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78625,diabetes,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78626,and,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78627,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78628,time,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78629,of,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78630,diagnosis,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78631,were,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78632,reported,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78633,.,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
79071,Raisins,B,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79072,are,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79073,dried,B,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79074,grapes,I,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79075,consumed,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79076,worldwide,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79077,that,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79078,contain,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79079,beneficial,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79080,components,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79081,for,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79082,human,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79083,health,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79084,.,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79402,PD,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79403,cases,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79404,were,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79405,identified,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79406,through,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79407,linkage,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79408,with,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79409,the,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79410,Swedish,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79411,National,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79412,Patient,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79413,and,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79414,Cause,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79415,of,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79416,Death,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79417,Registers,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79418,.,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
92874,The,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92875,outcomes,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92876,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92877,such,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92878,interventions,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92879,led,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92880,to,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92881,widespread,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92882,acceptance,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92883,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92884,functional,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92885,and,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92886,nutraceutical,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92887,foods,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92888,;,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92889,however,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92890,",",O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92891,augmenting,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92892,immunity,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92893,is,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92894,a,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92895,major,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92896,concern,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92897,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92898,dietary,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92899,regimens,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92900,.,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
93023,These,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93024,plants,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93025,are,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93026,bestowed,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93027,with,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93028,functional,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93029,ingredients,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93030,that,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93031,may,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93032,provide,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93033,protection,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93034,against,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93035,various,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93036,menaces,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93037,.,O,3228.0,These plants are bestowed with functional ingredients that may provide protection against various menaces .
93128,A,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93129,dietary,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93130,case,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93131,-,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93132,control,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93133,study,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93134,based,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93135,on,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93136,818,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93137,newly,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93138,diagnosed,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93139,breast,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93140,cancer,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93141,(,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93142,BC,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93143,),O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93144,patients,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93145,was,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93146,conducted,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93147,in,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93148,Israel,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93149,between,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93150,1975,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93151,and,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93152,1978,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93153,.,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93422,Participants,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93423,were,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93424,requested,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93425,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93426,select,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93427,the,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93428,specific,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93429,diet,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93430,that,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93431,they,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93432,wished,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93433,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93434,follow,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93435,during,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93436,the,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93437,12,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93438,h,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93439,prior,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93440,to,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93441,collection,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93442,of,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93443,urine,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93444,.,O,3240.0,Participants were requested to select the specific diet that they wished to follow during the 12 h prior to collection of urine .
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93613,This,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93614,study,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93615,deals,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93616,with,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93617,a,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93618,34,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93619,-,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93620,year,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93621,-,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93622,old,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93623,female,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93624,cook,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93625,with,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93626,no,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93627,previous,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93628,history,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93629,of,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93630,atopy,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93631,",",O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93632,who,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93633,was,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93634,studied,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93635,because,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93636,of,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93637,allergic,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93638,rhinoconjunctivitis,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93639,and,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93640,contact,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93641,urticaria,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93642,in,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93643,both,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93644,hands,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93645,associated,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93646,with,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93647,severe,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93648,itching,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93649,when,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93650,she,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93651,handled,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93652,raw,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93653,carrot,B,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93654,.,O,3248.0,"This study deals with a 34 - year - old female cook with no previous history of atopy , who was studied because of allergic rhinoconjunctivitis and contact urticaria in both hands associated with severe itching when she handled raw carrot ."
93696,Total,O,3251.0,Total IgE was 411 UI / ml .
93697,IgE,O,3251.0,Total IgE was 411 UI / ml .
93698,was,O,3251.0,Total IgE was 411 UI / ml .
93699,411,O,3251.0,Total IgE was 411 UI / ml .
93700,UI,O,3251.0,Total IgE was 411 UI / ml .
93701,/,O,3251.0,Total IgE was 411 UI / ml .
93702,ml,O,3251.0,Total IgE was 411 UI / ml .
93703,.,O,3251.0,Total IgE was 411 UI / ml .
94388,In,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94389,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94390,aortic,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94391,arch,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94392,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94393,lesion,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94394,size,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94395,decreased,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94396,linearly,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94397,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94398,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94399,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94400,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94401,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94402,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94403,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94404,0.001,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94405,for,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94406,coconut,B,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94407,oil,I,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94408,and,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94409,olive,B,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94410,oil,I,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94411,respectively,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94412,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94413,with,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94414,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94415,greatest,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94416,reduction,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94417,being,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94418,seen,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94419,in,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94420,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94421,olive,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94422,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94423,oil,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94424,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94425,fed,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94426,animals,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94427,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94428,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94429,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94430,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94431,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94432,.,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94944,Substances,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94945,present,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94946,in,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94947,vegetables,B,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94948,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94949,fruit,B,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94950,that,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94951,may,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94952,help,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94953,protect,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94954,against,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94955,cancer,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94956,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94957,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94958,their,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94959,mechanisms,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94960,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94961,are,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94962,also,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94963,briefly,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94964,reviewed,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94965,;,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94966,these,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94967,include,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94968,dithiolthiones,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94969,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94970,isothiocyanates,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94971,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94972,indole-3,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94973,-,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94974,carbinol,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94975,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94976,allium,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94977,compounds,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94978,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94979,isoflavones,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94980,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94981,protease,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94982,inhibitors,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94983,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94984,saponins,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94985,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94986,phytosterols,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94987,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94988,inositol,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94989,hexaphosphate,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94990,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94991,vitamin,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94992,C,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94993,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94994,D,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94995,-,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94996,limonene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94997,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94998,lutein,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94999,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95000,folic,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95001,acid,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95002,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95003,beta,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95004,carotene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95005,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95006,lycopene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95007,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95008,selenium,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95009,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95010,vitamin,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95011,E,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95012,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95013,flavonoids,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95014,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95015,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95016,dietary,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95017,fiber,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95018,.,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
96135,Controlled,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96136,field,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96137,experiments,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96138,with,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96139,potatoes,B,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96140,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96141,beans,B,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96142,and,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96143,lettuce,B,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96144,(,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96145,Solanum,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96146,tuberosum,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96147,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96148,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96149,Phaseolus,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96150,vulgaris,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96151,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96152,and,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96153,Lactuca,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96154,sativa,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96155,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96156,),O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96157,were,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96158,carried,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96159,out,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96160,in,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96161,a,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96162,contaminated,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96163,soil,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96164,used,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96165,by,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96166,local,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96167,farmers,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96168,located,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96169,near,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96170,a,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96171,closed,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96172,Portuguese,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96173,uranium,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96174,mine,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96175,(,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96176,Cunha,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96177,Baixa,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96178,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96179,Mangualde,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96180,),O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96181,.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96444,Among,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96445,the,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96446,various,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96447,types,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96448,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96449,animal,B,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96450,-,I,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96451,based,I,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96452,protein,I,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96453,foods,I,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96454,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96455,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96456,higher,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96457,intake,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96458,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96459,dairy,B,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96460,products,I,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96461,(,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96462,such,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96463,as,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96464,milk,B,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96465,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96466,yogurt,B,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96467,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96468,cheese,B,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96469,and,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96470,whey,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96471,protein,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96472,),O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96473,consistently,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96474,shows,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96475,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96476,beneficial,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96477,relationship,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96478,with,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96479,glucose,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96480,regulation,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96481,and/or,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96482,type,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96483,2,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96484,diabetes,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96485,risk,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96486,reduction,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96487,.,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96488,Intervention,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96489,studies,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96490,provide,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96491,evidence,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96492,that,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96493,dairy,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96494,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96495,have,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96496,more,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96497,potent,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96498,effects,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96499,on,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96500,insulin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96501,and,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96502,incretin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96503,secretion,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96504,compared,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96505,to,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96506,other,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96507,commonly,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96508,consumed,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96509,animal,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96510,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96511,.,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96701,Discovering,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96702,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96703,nutritional,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96704,properties,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96705,of,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96706,wine,B,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96707,is,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96708,a,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96709,challenging,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96710,task,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96711,",",O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96712,which,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96713,requires,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96714,that,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96715,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96716,biological,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96717,actions,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96718,and,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96719,bioavailability,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96720,of,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96721,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96722,>,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96723,200,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96724,individual,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96725,phenolic,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96726,compounds,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96727,be,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96728,documented,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96729,and,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96730,interpreted,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96731,within,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96732,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96733,societal,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96734,factors,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96735,that,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96736,stratify,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96737,wine,B,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96738,consumption,I,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96739,and,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96740,the,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96741,myriad,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96742,effects,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96743,of,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96744,alcohol,B,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96745,alone,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96746,.,O,3350.0,"Discovering the nutritional properties of wine is a challenging task , which requires that the biological actions and bioavailability of the > 200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone ."
96794,Scientific,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96795,research,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96796,has,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96797,demonstrated,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96798,that,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96799,the,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96800,molecules,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96801,present,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96802,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96803,grapes,B,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96804,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96805,in,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96806,wine,B,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96807,alter,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96808,cellular,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96809,metabolism,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96810,and,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96811,signaling,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96812,",",O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96813,which,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96814,is,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96815,consistent,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96816,mechanistically,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96817,with,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96818,reducing,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96819,arterial,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96820,disease,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96821,.,O,3353.0,"Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling , which is consistent mechanistically with reducing arterial disease ."
96822,Future,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96823,research,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96824,must,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96825,address,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96826,specific,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96827,mechanisms,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96828,both,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96829,of,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96830,alcohol,B,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96831,and,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96832,of,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96833,polyphenolic,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96834,action,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96835,and,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96836,develop,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96837,biomarkers,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96838,of,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96839,their,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96840,role,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96841,in,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96842,disease,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96843,prevention,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96844,in,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96845,individuals,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
96846,.,O,3354.0,Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals .
97628,The,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97629,metabolic,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97630,syndrome,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97631,and,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97632,its,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97633,individual,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97634,components,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97635,induce,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97636,a,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97637,proinflammatory,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97638,state,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97639,that,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97640,damages,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97641,blood,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97642,vessels,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
97643,.,O,3382.0,The metabolic syndrome and its individual components induce a proinflammatory state that damages blood vessels .
98099,Avoidance,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98100,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98101,saturated,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98102,fat,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98103,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98104,cholesterol,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98105,by,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98106,"1,210",O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98107,Mexican,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98108,Americans,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98109,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98110,866,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98111,non,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98112,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98113,Hispanic,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98114,whites,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98115,was,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98116,assessed,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98117,as,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98118,part,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98119,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98120,a,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98121,population,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98122,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98123,based,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98124,survey,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98125,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98126,diabetes,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98127,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98128,cardiovascular,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98129,risk,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98130,factors,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98131,.,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98377,We,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98378,conducted,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98379,a,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98380,case,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98381,-,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98382,control,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98383,study,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98384,to,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98385,evaluate,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98386,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98387,association,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98388,between,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98389,coffee,B,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98390,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98391,tea,B,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98392,consumption,I,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98393,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98394,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98395,risk,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98396,of,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98397,UADT,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98398,cancer,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98399,.,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98549,Similarly,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98550,",",O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98551,the,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98552,association,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98553,of,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98554,green,B,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98555,tea,I,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98556,consumption,I,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98557,was,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98558,observed,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98559,among,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98560,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98561,smokers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98562,and,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98563,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98564,alcohol,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98565,drinkers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98566,.,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
99051,Postprandial,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99052,blood,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99053,samples,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99054,were,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99055,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99056,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99057,assess,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99058,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99059,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99060,insulin,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99061,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99062,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99063,triglyceride,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99064,responses,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99065,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99066,feeding,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99067,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99068,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99069,24,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99070,-,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99071,h,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99072,urine,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99073,was,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99074,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99075,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99076,quantify,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99077,urinary,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99078,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99079,excretion,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99080,.,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99213,Two,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99214,groups,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99215,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99216,cows,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99217,received,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99218,either,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99219,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99220,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99221,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99222,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99223,as,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99224,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99225,control,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99226,diet,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99227,or,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99228,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99229,same,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99230,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99231,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99232,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99233,supplemented,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99234,with,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99235,1,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99236,%,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99237,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99238,GSGME,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99239,over,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99240,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99241,period,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99242,from,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99243,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99244,3,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99245,prepartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99246,to,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99247,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99248,9,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99249,postpartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99250,.,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99251,Dry,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99252,matter,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99253,intake,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99254,during,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99255,wk,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99256,3,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99257,to,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99258,9,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99259,postpartum,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99260,was,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99261,not,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99262,different,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99263,between,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99264,the,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99265,2,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99266,groups,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99267,.,O,3440.0,Dry matter intake during wk 3 to 9 postpartum was not different between the 2 groups .
99268,However,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99269,",",O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99270,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99271,cows,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99272,fed,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99273,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99274,diet,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99275,supplemented,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99276,with,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99277,GSGME,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99278,had,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99279,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99280,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99281,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99282,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99283,and,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99284,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99285,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99286,daily,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99287,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99288,protein,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99289,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99290,.,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99514,Treatments,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99515,continued,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99516,until,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99517,7,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99518,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99519,after,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99520,cows,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99521,received,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99522,an,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99523,infusion,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99524,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99525,10,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99526,microg,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99527,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99528,LPS,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99529,into,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99530,one,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99531,quarter,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99532,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99533,the,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99534,mammary,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99535,gland,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99536,(,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99537,on,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99538,average,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99539,",",O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99540,this,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99541,occurred,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99542,32,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99543,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99544,postcalving,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99545,),O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99546,.,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99695,Celiac,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99696,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99697,is,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99698,an,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99699,autoimmune,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99700,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99701,that,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99702,affects,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99703,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99704,villi,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99705,of,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99706,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99707,small,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99708,intestine,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99709,causing,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99710,abdominal,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99711,pain,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99712,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99713,gas,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99714,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99715,diarrhea,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99716,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99717,or,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99718,bad,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99719,absorption,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99720,due,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99721,to,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99722,gluten,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99723,intolerance,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99724,.,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
100094,Olive,B,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100095,oil,I,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100096,is,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100097,also,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100098,implicated,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100099,in,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100100,preventing,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100101,certain,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100102,cancers,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100103,",",O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100104,with,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100105,the,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100106,most,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100107,promising,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100108,findings,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100109,for,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100110,breast,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100111,and,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100112,digestive,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100113,tract,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100114,cancers,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100115,",",O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100116,although,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100117,the,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100118,data,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100119,are,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100120,still,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100121,not,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100122,entirely,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100123,consistent,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100124,and,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100125,mainly,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100126,from,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100127,case,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100128,-,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100129,control,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100130,studies,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100131,.,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100357,The,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100358,reported,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100359,anticancer,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100360,properties,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100361,were,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100362,found,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100363,to,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100364,arise,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100365,through,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100366,the,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100367,molecular,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100368,changes,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100369,in,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100370,the,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100371,multiple,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100372,-,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100373,stage,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100374,process,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100375,of,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100376,cancer,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100377,development,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100378,",",O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100379,which,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100380,are,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100381,dose,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100382,related,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100383,and,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100384,not,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100385,tissue,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100386,or,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100387,species,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100388,specific,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100389,.,O,3477.0,"The reported anticancer properties were found to arise through the molecular changes in the multiple - stage process of cancer development , which are dose related and not tissue or species specific ."
100677,The,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100678,ED01,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100679,and,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100680,ED05,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100681,values,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100682,presented,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100683,here,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100684,are,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100685,valuable,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100686,in,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100687,the,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100688,risk,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100689,assessment,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100690,and,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100691,subsequent,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100692,risk,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100693,management,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100694,of,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100695,allergenic,B,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100696,foods,I,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
100697,.,O,3489.0,The ED01 and ED05 values presented here are valuable in the risk assessment and subsequent risk management of allergenic foods .
101614,Mean,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101615,per,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101616,capita,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101617,daily,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101618,consumption,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101619,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101620,calcium,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101621,for,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101622,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101623,total,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101624,U.S.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101625,population,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101626,was,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101627,737,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101628,mg,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101629,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101630,varied,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101631,by,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101632,region,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101633,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101634,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101635,country,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101636,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101637,household,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101638,income,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101639,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101640,ethnic,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101641,group,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101642,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101643,sex,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101644,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101645,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101646,age,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101647,.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101993,These,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101994,results,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101995,suggest,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101996,that,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101997,each,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101998,incremental,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
101999,increase,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102000,in,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102001,chocolate,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102002,'s,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102003,sugar,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102004,content,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102005,enhances,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102006,its,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102007,psychoactive,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102008,effects,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102009,.,O,3539.0,These results suggest that each incremental increase in chocolate 's sugar content enhances its psychoactive effects .
102175,This,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102176,review,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102177,summarizes,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102178,comprehensive,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102179,recent,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102180,findings,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102181,on,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102182,the,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102183,beneficial,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102184,actions,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102185,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102186,cocoa,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102187,-,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102188,driven,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102189,phytochemicals,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102190,in,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102191,molecular,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102192,mechanisms,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102193,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102194,human,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102195,health,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102196,.,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102638,The,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102639,survey,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102640,included,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102641,588,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102642,participants,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102643,aged,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102644,25,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102645,to,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102646,65,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102647,years,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102648,who,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102649,were,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102650,selected,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102651,using,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102652,convenience,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102653,samples,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102654,in,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102655,the,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102656,urban,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102657,areas,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102658,of,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102659,Benin,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102660,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102661,Guinea,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102662,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102663,Kenya,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102664,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102665,Mozambique,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102666,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102667,and,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102668,Seychelles,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102669,.,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
103140,Dietary,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103141,intakes,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103142,of,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103143,nutrients,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103144,were,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103145,estimated,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103146,at,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103147,baseline,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103148,(,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103149,1990,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103150,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103151,1994,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103152,),O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103153,using,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103154,a,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103155,121,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103156,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103157,item,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103158,food,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103159,frequency,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103160,questionnaire,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103161,.,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103221,For,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103222,thiamine,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103223,",",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103224,heterogeneity,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103225,by,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103226,subtype,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103227,(,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103228,cardia,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103229,and,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103230,non,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103231,-,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103232,cardia,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103233,),O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103234,was,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103235,found,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103236,(,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103237,P,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103238,The,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103239,reported,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103240,milk,B,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103241,consumption,I,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103242,habits,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103243,of,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103244,"3,334",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103245,cancer,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103246,patients,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103247,and,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103248,"1,300",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103249,comparable,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103250,control,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103251,subjects,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103252,seen,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103253,at,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103254,Roswell,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103255,Park,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103256,Memorial,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103257,Institute,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103258,were,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103259,studied,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103260,.,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103332,Relative,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103333,risks,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103334,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103335,different,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103336,patterns,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103337,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103338,milk,B,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103339,consumption,I,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103340,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103341,specific,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103342,cancer,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103343,diagnoses,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103344,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103345,adjusted,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103346,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103347,sex,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103348,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103349,age,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103350,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103351,smoking,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103352,history,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103353,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103354,education,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103355,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103356,and,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103357,county,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103358,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103359,residence,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103360,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103361,were,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103362,calculated,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103363,with,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103364,multiple,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103365,logistic,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103366,regression,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103367,analysis,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103368,.,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103952,It,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103953,is,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103954,formed,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103955,as,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103956,an,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103957,intermediate,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103958,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103959,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103960,course,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103961,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103962,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103963,conversion,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103964,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103965,linoleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103966,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103967,to,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103968,oleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103969,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103970,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103971,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103972,rumen,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103973,.,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
104050,The,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104051,inhibition,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104052,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104053,mammary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104054,tumours,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104055,in,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104056,rats,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104057,is,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104058,effective,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104059,regardless,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104060,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104061,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104062,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104063,carcinogen,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104064,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104065,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104066,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104067,amount,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104068,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104069,dietary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104070,fat,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104071,.,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104154,Its,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104155,effect,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104156,on,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104157,growth,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104158,(,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104159,less,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104160,fat,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104161,",",O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104162,more,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104163,protein,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104164,),O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104165,is,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104166,also,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104167,a,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104168,subject,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104169,of,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104170,active,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104171,research,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104172,.,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104388,The,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104389,Dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104390,Quality,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104391,Index,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104392,was,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104393,reduced,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104394,from,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104395,42.4,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104396,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104397,4.1,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104398,to,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104399,37.8,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104400,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104401,4.7,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104402,(,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104403,Low,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104404,dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104405,fat,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104406,intake,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104407,may,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104408,reduce,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104409,the,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104410,risk,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104411,of,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104412,developing,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104413,atherosclerosis,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104414,.,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
105139,All,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105140,three,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105141,chocolates,B,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105142,led,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105143,to,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105144,a,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105145,similar,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105146,sustained,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105147,rise,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105148,in,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105149,serum,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105150,triglyceride,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105151,levels,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105152,.,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105908,Lifestyle,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105909,factors,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105910,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105911,including,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105912,nutrition,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105913,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105914,play,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105915,an,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105916,important,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105917,role,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105918,in,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105919,the,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105920,etiology,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105921,of,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105922,Cardiovascular,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105923,Disease,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105924,(,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105925,CVD,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105926,),O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105927,.,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105972,The,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105973,nutritional,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105974,information,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105975,is,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105976,divided,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105977,into,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105978,three,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105979,main,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105980,sections,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105981,:,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105982,dietary,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105983,patterns,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105984,",",O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105985,individual,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105986,food,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105987,items,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105988,",",O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105989,and,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105990,nutritional,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105991,supplements,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105992,.,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105993,The,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105994,dietary,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105995,patterns,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105996,reviewed,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105997,include,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105998,low,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105999,carbohydrate,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106000,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106001,",",O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106002,low,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106003,-,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106004,fat,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106005,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106006,",",O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106007,Mediterranean,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106008,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106009,",",O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106010,and,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106011,the,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106012,DASH,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106013,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106014,.,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106941,The,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106942,role,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106943,of,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106944,fat,B,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106945,intake,I,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106946,as,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106947,a,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106948,risk,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106949,factor,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106950,for,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106951,stroke,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106952,remains,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106953,uncertain,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106954,",",O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106955,whereas,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106956,the,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106957,association,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106958,between,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106959,stroke,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106960,and,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106961,cholesterol,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106962,has,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106963,more,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106964,convincingly,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106965,been,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106966,demonstrated,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106967,by,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106968,the,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106969,recent,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106970,intervention,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106971,trials,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106972,using,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106973,statins,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106974,.,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
107150,The,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107151,role,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107152,of,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107153,the,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107154,intestinal,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107155,microbiome,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107156,in,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107157,cardiovascular,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107158,risk,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107159,is,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107160,emerging,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107161,;,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107162,high,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107163,levels,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107164,of,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107165,toxic,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107166,metabolites,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107167,produced,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107168,by,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107169,intestinal,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107170,bacteria,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107171,from,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107172,meat,B,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107173,(,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107174,particularly,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107175,red,B,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107176,meat,I,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107177,),O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107178,and,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107179,egg,B,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107180,yolk,I,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107181,are,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107182,renally,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107183,excreted,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107184,.,O,3725.0,The role of the intestinal microbiome in cardiovascular risk is emerging ; high levels of toxic metabolites produced by intestinal bacteria from meat ( particularly red meat ) and egg yolk are renally excreted .
107607,Although,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107608,OTA,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107609,has,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107610,been,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107611,shown,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107612,to,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107613,cause,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107614,kidney,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107615,disease,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107616,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107617,including,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107618,kidney,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107619,cancer,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107620,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107621,in,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107622,multiple,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107623,animal,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107624,species,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107625,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107626,the,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107627,impact,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107628,of,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107629,dietary,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107630,OTA,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107631,on,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107632,human,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107633,health,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107634,from,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107635,a,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107636,global,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107637,perspective,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107638,has,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107639,been,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107640,less,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107641,clear,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107642,.,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107643,Several,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107644,epidemiological,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107645,studies,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107646,suggest,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107647,an,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107648,association,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107649,between,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107650,OTA,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107651,exposure,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107652,and,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107653,human,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107654,kidney,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107655,disease,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107656,",",O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107657,but,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107658,evidence,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107659,of,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107660,causality,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107661,has,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107662,been,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107663,limited,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107664,.,O,3742.0,"Several epidemiological studies suggest an association between OTA exposure and human kidney disease , but evidence of causality has been limited ."
107798,We,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107799,analyzed,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107800,591,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107801,incident,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107802,cases,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107803,of,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107804,gastric,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107805,adenocarcinoma,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107806,and,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107807,"1,463",O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107808,community,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107809,controls,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
107810,.,O,3747.0,"We analyzed 591 incident cases of gastric adenocarcinoma and 1,463 community controls ."
108208,In,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108209,all,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108210,eight,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108211,cases,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108212,the,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108213,skin,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108214,tests,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108215,were,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108216,positive,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108217,to,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108218,egg,B,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108219,yolk,I,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108220,",",O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108221,and,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108222,in,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108223,five,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108224,of,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108225,them,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108226,also,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108227,to,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108228,egg,B,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108229,white,I,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108230,and,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108231,chicken,B,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108232,meat,I,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108233,.,O,3762.0,"In all eight cases the skin tests were positive to egg yolk , and in five of them also to egg white and chicken meat ."
108393,Hepatic,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108394,LDL,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108395,receptor,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108396,activity,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108397,may,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108398,be,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108399,regulated,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108400,by,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108401,the,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108402,messenger,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108403,RNA,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108404,concentration,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108405,of,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108406,the,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108407,LDL,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108408,receptor,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108409,.,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108524,The,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108525,evidence,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108526,suggests,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108527,that,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108528,caproic,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108529,acid,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108530,(,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108531,6:0,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108532,),O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108533,",",O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108534,caprylic,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108535,acid,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108536,(,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108537,8:0,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108538,),O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108539,",",O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108540,and,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108541,capric,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108542,acid,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108543,(,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108544,10:0,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108545,),O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108546,are,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108547,neutral,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108548,with,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108549,respect,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108550,to,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108551,their,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108552,LDL,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108553,-,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108554,C,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108555,-,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108556,raising,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108557,properties,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108558,and,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108559,their,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108560,ability,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108561,to,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108562,modulate,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108563,LDL,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108564,metabolism,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108565,.,O,3772.0,"The evidence suggests that caproic acid ( 6:0 ) , caprylic acid ( 8:0 ) , and capric acid ( 10:0 ) are neutral with respect to their LDL - C - raising properties and their ability to modulate LDL metabolism ."
108822,For,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108823,vegetable,B,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108824,subgroups,I,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108825,",",O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108826,the,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108827,HR,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108828,was,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108829,0.93,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108830,(,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108831,95,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108832,%,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108833,CI,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108834,:,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108835,0.77,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108836,",",O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108837,1.13,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108838,),O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108839,for,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108840,replacement,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108841,of,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108842,potatoes,B,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108843,with,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108844,fruiting,B,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108845,vegetables,I,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108846,and,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108847,0.91,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108848,(,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108849,95,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108850,%,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108851,CI,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108852,:,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108853,0.77,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108854,",",O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108855,1.07,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108856,),O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108857,for,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108858,replacement,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108859,of,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108860,potatoes,B,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108861,with,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108862,other,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108863,root,B,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108864,vegetables,I,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
108865,.,O,3784.0,"For vegetable subgroups , the HR was 0.93 ( 95 % CI : 0.77 , 1.13 ) for replacement of potatoes with fruiting vegetables and 0.91 ( 95 % CI : 0.77 , 1.07 ) for replacement of potatoes with other root vegetables ."
109815,Dietary,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109816,habits,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109817,appear,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109818,to,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109819,modify,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109820,the,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109821,risk,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109822,of,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109823,thyroid,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109824,carcinoma,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
109825,.,O,3823.0,Dietary habits appear to modify the risk of thyroid carcinoma .
110103,The,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110104,DNA,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110105,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110106,based,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110107,allergen,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110108,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110109,MLPA,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110110,method,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110111,will,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110112,constitute,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110113,a,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110114,complementary,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110115,method,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110116,to,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110117,the,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110118,traditional,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110119,protein,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110120,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110121,based,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110122,methods,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110123,.,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110459,A,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110460,calibration,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110461,study,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110462,in,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110463,a,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110464,subsample,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110465,was,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110466,used,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110467,to,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110468,control,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110469,for,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110470,dietary,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110471,measurement,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110472,errors,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110473,.,O,3849.0,A calibration study in a subsample was used to control for dietary measurement errors .
110686,In,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110687,an,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110688,effort,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110689,to,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110690,disseminate,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110691,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110692,explore,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110693,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110694,discuss,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110695,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110696,state,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110697,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110698,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110699,science,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110700,on,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110701,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110702,relationship,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110703,between,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110704,regular,B,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110705,fat,I,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110706,dairy,I,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110707,products,I,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110708,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110709,health,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110710,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110711,symposia,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110712,were,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110713,programmed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110714,by,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110715,dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110716,industry,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110717,organizations,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110718,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110719,Europe,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110720,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110721,North,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110722,America,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110723,at,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110724,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110725,Eurofed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110726,Lipids,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110727,Congress,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110728,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110729,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110730,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110731,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110732,France,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110733,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110734,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110735,Dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110736,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110737,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110738,Symposium,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110739,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110740,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110741,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110742,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110743,Canada,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110744,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110745,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110746,American,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110747,Society,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110748,for,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110749,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110750,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110751,Meeting,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110752,held,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110753,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110754,conjunction,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110755,with,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110756,Experimental,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110757,Biology,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110758,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110759,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110760,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110761,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110762,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110763,United,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110764,States,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110765,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110766,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110767,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110768,Federation,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110769,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110770,European,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110771,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110772,Societies,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110773,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110774,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110775,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110776,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110777,Germany,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110778,.,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
111111,The,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111112,recent,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111113,isolation,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111114,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111115,a,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111116,larger,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111117,number,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111118,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111119,novel,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111120,presumably,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111121,viral,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111122,DNAs,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111123,from,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111124,serum,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111125,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111126,meat,B,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111127,and,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111128,dairy,B,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111129,products,I,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111130,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111131,healthy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111132,dairy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111133,cows,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111134,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111135,at,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111136,least,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111137,part,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111138,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111139,them,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111140,infectious,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111141,for,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111142,human,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111143,cells,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111144,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111145,deserves,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111146,further,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111147,investigation,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111148,.,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111228,Moreover,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111229,",",O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111230,40,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111231,%,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111232,of,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111233,the,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111234,SMEs,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111235,were,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111236,micro,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111237,entities,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111238,.,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111288,The,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111289,As,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111290,concentration,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111291,exceeded,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111292,10,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111293,μg,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111294,/,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111295,L,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111296,in,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111297,74,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111298,%,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111299,of,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111300,the,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111301,water,B,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111302,samples,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111303,taken,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111304,from,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111305,SMEs,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111306,.,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111544,The,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111545,ORs,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111546,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111547,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111548,highest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111549,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111550,relative,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111551,to,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111552,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111553,lowest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111554,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111555,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111556,total,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111557,vegetable,B,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111558,and,I,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111559,fruit,I,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111560,intake,I,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111561,were,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111562,0.28,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111563,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111564,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111565,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111566,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111567,0.18,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111568,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111569,0.43,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111570,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111571,and,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111572,0.53,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111573,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111574,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111575,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111576,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111577,0.34,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111578,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111579,0.82,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111580,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111581,",",O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111582,respectively,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111583,.,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111671,The,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111672,aim,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111673,of,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111674,this,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111675,study,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111676,was,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111677,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111678,investigate,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111679,if,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111680,grape,B,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111681,or,I,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111682,apple,I,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111683,juices,I,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111684,are,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111685,able,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111686,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111687,protect,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111688,bone,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111689,tissue,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111690,of,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111691,rats,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111692,exposed,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111693,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111694,cadmium,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111695,.,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111958,Although,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111959,soy,B,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111960,foods,I,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111961,are,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111962,recommended,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111963,to,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111964,prevent,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111965,hyperlipidemia,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111966,and,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111967,related,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111968,diseases,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111969,",",O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111970,it,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111971,is,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111972,unclear,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111973,how,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111974,their,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111975,active,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111976,ingredients,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111977,exert,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111978,their,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111979,effects,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
111980,.,O,3910.0,"Although soy foods are recommended to prevent hyperlipidemia and related diseases , it is unclear how their active ingredients exert their effects ."
112010,Tofu,B,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112011,and,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112012,soy,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112013,protein,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112014,significantly,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112015,lowered,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112016,serum,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112017,triacylglycerol,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112018,and,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112019,cholesterol,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112020,levels,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112021,compared,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112022,to,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112023,casein,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112024,and,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112025,",",O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112026,through,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112027,microarray,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112028,analyses,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112029,",",O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112030,were,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112031,found,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112032,to,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112033,exclusively,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112034,alter,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112035,transcriptomes,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112036,involved,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112037,in,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112038,fatty,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112039,acid,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112040,and/or,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112041,steroid,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112042,synthesis,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112043,in,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112044,the,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112045,liver,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112046,",",O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112047,where,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112048,most,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112049,of,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112050,the,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112051,serum,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112052,lipids,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112053,are,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112054,synthesized,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112055,.,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112082,The,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112083,importance,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112084,of,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112085,the,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112086,proteinaceous,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112087,components,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112088,was,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112089,further,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112090,confirmed,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112091,by,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112092,the,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112093,lower,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112094,activity,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112095,of,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112096,enzymes,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112097,involved,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112098,in,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112099,lipogenesis,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112100,.,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112101,From,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112102,these,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112103,findings,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112104,it,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112105,was,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112106,concluded,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112107,that,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112108,the,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112109,protein,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112110,",",O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112111,not,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112112,isoflavone,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112113,",",O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112114,fraction,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112115,of,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112116,soy,B,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112117,reduces,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112118,lipogenesis,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112119,in,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112120,liver,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112121,through,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112122,gene,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112123,expression,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112124,and,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112125,that,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112126,this,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112127,may,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112128,result,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112129,in,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112130,lower,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112131,serum,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112132,lipid,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112133,levels,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112134,.,O,3915.0,"From these findings it was concluded that the protein , not isoflavone , fraction of soy reduces lipogenesis in liver through gene expression and that this may result in lower serum lipid levels ."
112210,After,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112211,41,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112212,wk,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112213,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112214,cumulative,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112215,survival,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112216,of,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112217,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112218,mice,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112219,given,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112220,20,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112221,mg,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112222,ethyl,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112223,carbamate,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112224,/,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112225,kg,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112226,in,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112227,water,B,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112228,was,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112229,depressed,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112230,compared,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112231,with,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112232,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112233,mice,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112234,drinking,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112235,wines,B,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112236,or,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112237,ethanol,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112238,solution,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112239,with,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112240,this,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112241,ethyl,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112242,carbamate,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112243,level,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112244,.,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112245,Both,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112246,ethanol,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112247,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112248,wine,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112249,treatments,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112250,reduced,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112251,the,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112252,incidence,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112253,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112254,lung,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112255,Clara,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112256,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112257,cell,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112258,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112259,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112260,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112261,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112262,10,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112263,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112264,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112265,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112266,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112267,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112268,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112269,reduced,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112270,the,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112271,frequency,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112272,(,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112273,number,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112274,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112275,specific,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112276,tumours,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112277,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112278,number,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112279,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112280,tumour,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112281,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112282,bearing,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112283,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112284,),O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112285,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112286,both,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112287,Clara,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112288,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112289,cell,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112290,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112291,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112292,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112293,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112294,10,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112295,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112296,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112297,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112298,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112299,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112300,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112301,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112302,alveolar,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112303,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112304,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112305,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112306,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112307,20,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112308,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112309,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112310,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112311,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112312,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112313,.,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112390,The,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112391,mean,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112392,weight,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112393,gains,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112394,of,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112395,mice,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112396,on,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112397,all,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112398,the,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112399,wine,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112400,treatments,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112401,were,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112402,lower,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112403,than,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112404,those,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112405,of,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112406,water,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112407,-,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112408,treated,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112409,mice,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112410,and,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112411,this,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112412,may,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112413,have,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112414,been,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112415,a,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112416,factor,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112417,in,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112418,tumour,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112419,inhibition,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112420,;,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112421,however,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112422,",",O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112423,it,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112424,is,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112425,also,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112426,possible,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112427,that,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112428,wine,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112429,components,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112430,other,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112431,than,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112432,ethanol,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112433,may,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112434,play,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112435,a,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112436,role,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112437,in,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112438,the,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112439,inhibition,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112440,of,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112441,tumour,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112442,development,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112443,.,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112543,Logistic,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112544,regression,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112545,models,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112546,were,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112547,used,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112548,to,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112549,evaluate,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112550,the,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112551,association,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112552,between,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112553,FPS,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112554,and,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112555,EBW,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112556,.,O,3928.0,Logistic regression models were used to evaluate the association between FPS and EBW .
112704,From,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112705,1984,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112706,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112707,1988,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112708,a,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112709,population,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112710,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112711,based,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112712,case,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112713,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112714,control,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112715,study,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112716,was,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112717,carried,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112718,out,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112719,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112720,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112721,Netherlands,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112722,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112723,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112724,collaboration,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112725,with,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112726,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112727,International,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112728,Agency,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112729,for,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112730,Research,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112731,on,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112732,Cancer,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112733,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112734,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112735,examine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112736,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112737,possible,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112738,relationship,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112739,between,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112740,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112741,habitual,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112742,lifetime,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112743,consumption,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112744,of,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112745,alcohol,B,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112746,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112747,coffee,B,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112748,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112749,tea,B,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112750,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112751,exocrine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112752,pancreatic,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112753,carcinoma,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112754,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112755,176,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112756,cases,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112757,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112758,487,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112759,controls,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112760,.,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
113623,Further,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113624,studies,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113625,are,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113626,needed,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113627,to,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113628,define,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113629,the,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113630,optimal,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113631,dose,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113632,and,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113633,duration,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113634,of,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113635,strawberry,B,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113636,intake,I,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113637,in,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113638,affecting,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113639,levels,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113640,of,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113641,biomarkers,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113642,or,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113643,pathways,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113644,related,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113645,to,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113646,chronic,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113647,diseases,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113648,.,O,3958.0,Further studies are needed to define the optimal dose and duration of strawberry intake in affecting levels of biomarkers or pathways related to chronic diseases .
113674,Gene,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113675,expression,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113676,of,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113677,PTHrP,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113678,in,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113679,the,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113680,mammary,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113681,gland,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113682,increases,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113683,markedly,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113684,during,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113685,parturition,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113686,and,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113687,with,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113688,the,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113689,onset,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113690,of,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113691,lactation,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113692,.,O,3960.0,Gene expression of PTHrP in the mammary gland increases markedly during parturition and with the onset of lactation .
113744,In,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113745,previous,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113746,studies,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113747,that,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113748,determined,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113749,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113750,PTHrP,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113751,concentrations,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113752,in,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113753,milk,B,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113754,",",O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113755,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113756,pretreatments,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113757,and,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113758,diluent,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113759,composition,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113760,were,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113761,not,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113762,standardized,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113763,.,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113838,We,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113839,measured,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113840,the,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113841,PTHrP,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113842,concentrations,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113843,in,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113844,normal,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113845,liquid,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113846,milk,B,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113847,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113848,processed,B,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113849,milk,I,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113850,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113851,milk,B,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113852,drinks,I,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113853,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113854,formulated,B,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113855,milk,I,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113856,powders,I,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113857,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113858,and,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113859,skim,B,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113860,milk,I,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113861,powder,I,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113862,by,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113863,using,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113864,the,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113865,appropriate,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113866,combination,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113867,of,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113868,pretreatment,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113869,(,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113870,acidification,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113871,),O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113872,and,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113873,diluent,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113874,(,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113875,plasma,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113876,treated,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113877,with,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113878,protease,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113879,inhibitors,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113880,),O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113881,.,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
114262,Milk,B,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114263,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114264,cheese,B,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114265,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114266,yogurt,B,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114267,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114268,and,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114269,other,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114270,dairy,B,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114271,products,I,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114272,have,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114273,long,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114274,been,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114275,known,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114276,to,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114277,provide,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114278,good,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114279,nutrition,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114280,.,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114281,Major,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114282,healthful,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114283,contributors,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114284,to,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114285,the,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114286,diets,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114287,of,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114288,many,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114289,people,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114290,include,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114291,the,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114292,protein,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114293,",",O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114294,minerals,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114295,",",O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114296,vitamins,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114297,",",O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114298,and,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114299,fatty,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114300,acids,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114301,present,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114302,in,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114303,milk,B,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114304,.,O,3980.0,"Major healthful contributors to the diets of many people include the protein , minerals , vitamins , and fatty acids present in milk ."
114477,We,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114478,analysed,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114479,data,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114480,from,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114481,REGARDS,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114482,",",O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114483,a,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114484,population,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114485,-,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114486,based,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114487,cohort,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114488,of,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114489,30,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114490,239,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114491,community,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114492,-,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114493,dwelling,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114494,adults,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114495,age,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114496,≥45,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114497,years,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114498,.,O,3987.0,"We analysed data from REGARDS , a population - based cohort of 30 239 community - dwelling adults age ≥45 years ."
114661,There,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114662,were,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114663,1109,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114664,(,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114665,5·2,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114666,%,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114667,),O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114668,first,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114669,sepsis,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114670,events,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114671,.,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114797,Poor,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114798,metabolic,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114799,health,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114800,is,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114801,a,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114802,common,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114803,characteristic,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114804,of,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114805,overweight,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114806,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114807,obesity,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114808,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114809,aging,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114810,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114811,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114812,is,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114813,the,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114814,forerunner,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114815,of,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114816,T2DM,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114817,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114818,cardiovascular,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114819,disease,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114820,(,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114821,CVD,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114822,),O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114823,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114824,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114825,an,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114826,ever,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114827,increasing,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114828,global,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114829,health,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114830,issue,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114831,.,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
115042,It,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115043,has,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115044,been,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115045,postulated,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115046,that,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115047,the,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115048,components,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115049,in,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115050,olive,B,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115051,oil,I,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115052,in,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115053,the,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115054,Mediterranean,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115055,diet,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115056,",",O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115057,a,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115058,diet,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115059,which,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115060,is,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115061,largely,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115062,vegetarian,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115063,in,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115064,nature,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115065,",",O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115066,can,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115067,contribute,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115068,to,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115069,the,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115070,lower,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115071,incidence,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115072,of,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115073,coronary,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115074,heart,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115075,disease,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115076,and,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115077,prostate,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115078,and,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115079,colon,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115080,cancers,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115081,.,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115082,The,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115083,Mediterranean,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115084,diet,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115085,includes,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115086,the,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115087,consumption,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115088,of,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115089,large,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115090,amounts,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115091,of,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115092,olive,B,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115093,oil,I,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115094,.,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115221,It,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115222,has,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115223,recently,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115224,been,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115225,found,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115226,that,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115227,hydroxytyosol,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115228,is,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115229,renally,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115230,excreted,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115231,unchanged,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115232,and,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115233,as,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115234,the,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115235,following,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115236,metabolites,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115237,as,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115238,its,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115239,glucuronide,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115240,conjugate,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115241,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115242,sulfate,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115243,conjugate,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115244,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115245,homovanillic,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115246,acid,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115247,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115248,homovanillic,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115249,alcohol,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115250,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115251,"3,4",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115252,-,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115253,dihydroxyphenylacetic,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115254,acid,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115255,and,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115256,"3,4",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115257,-,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115258,dihydroxyphenylacetaldehyde,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115259,.,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115303,Well,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115304,-,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115305,planned,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115306,vegetarian,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115307,diets,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115308,are,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115309,considered,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115310,adequate,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115311,for,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115312,all,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115313,stages,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115314,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115315,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115316,life,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115317,cycle,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115318,",",O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115319,despite,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115320,limited,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115321,data,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115322,on,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115323,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115324,zinc,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115325,status,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115326,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115327,vegetarians,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115328,during,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115329,early,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115330,childhood,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115331,.,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
116021,The,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116022,chocolate,B,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116023,with,I,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116024,tagatose,I,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116025,was,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116026,perceived,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116027,as,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116028,more,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116029,similar,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116030,to,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116031,the,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116032,chocolate,B,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116033,with,I,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116034,sugar,I,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116035,than,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116036,with,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116037,stevia,B,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116038,on,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116039,overall,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116040,liking,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116041,",",O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116042,texture,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116043,",",O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116044,bitterness,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116045,",",O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116046,duration,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116047,of,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116048,aftertaste,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116049,and,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116050,intensity,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116051,of,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116052,aftertaste,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116053,.,O,4043.0,"The chocolate with tagatose was perceived as more similar to the chocolate with sugar than with stevia on overall liking , texture , bitterness , duration of aftertaste and intensity of aftertaste ."
116101,Garlic,B,4046.0,Garlic has been used medicinally since antiquity .
116102,has,O,4046.0,Garlic has been used medicinally since antiquity .
116103,been,O,4046.0,Garlic has been used medicinally since antiquity .
116104,used,O,4046.0,Garlic has been used medicinally since antiquity .
116105,medicinally,O,4046.0,Garlic has been used medicinally since antiquity .
116106,since,O,4046.0,Garlic has been used medicinally since antiquity .
116107,antiquity,O,4046.0,Garlic has been used medicinally since antiquity .
116108,.,O,4046.0,Garlic has been used medicinally since antiquity .
116250,Preventive,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116251,and,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116252,therapeutic,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116253,trials,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116254,of,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116255,garlic,B,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116256,are,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116257,still,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116258,in,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116259,early,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116260,stages,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116261,.,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116542,Raw,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116543,garlic,B,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116544,had,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116545,a,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116546,profound,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116547,effect,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116548,in,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116549,reducing,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116550,the,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116551,glucose,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116552,",",O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116553,cholesterol,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116554,",",O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116555,and,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116556,triglyceride,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116557,levels,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116558,",",O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116559,whereas,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116560,boiled,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116561,garlic,B,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116562,had,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116563,little,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116564,effect,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116565,in,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116566,controlling,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116567,these,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116568,parameters,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
116569,.,O,4064.0,"Raw garlic had a profound effect in reducing the glucose , cholesterol , and triglyceride levels , whereas boiled garlic had little effect in controlling these parameters ."
117062,Thus,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117063,it,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117064,is,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117065,clear,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117066,that,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117067,nuts,B,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117068,have,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117069,a,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117070,beneficial,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117071,impact,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117072,on,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117073,many,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117074,cardiovascular,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117075,risk,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117076,factors,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117077,.,O,4085.0,Thus it is clear that nuts have a beneficial impact on many cardiovascular risk factors .
117986,Using,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117987,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117988,UBM,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117989,protocol,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117990,(,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117991,unified,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117992,BARGE,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117993,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117994,method,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117995,),O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117996,",",O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117997,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117998,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117999,of,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118000,Cd,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118001,was,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118002,measured,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118003,in,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118004,raw,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118005,/,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118006,cooked,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118007,vegetables,B,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118008,.,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118265,There,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118266,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118267,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118268,suppresses,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118269,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118270,proinflammatory,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118271,transcription,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118272,factors,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118273,nuclear,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118274,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118275,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118276,kappa,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118277,B,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118278,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118279,signal,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118280,transducer,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118281,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118282,activators,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118283,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118284,transcription-3,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118285,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118286,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118287,Wnt,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118288,/,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118289,beta,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118290,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118291,catenin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118292,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118293,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118294,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118295,activates,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118296,peroxisome,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118297,proliferator,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118298,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118299,activated,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118300,receptor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118301,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118302,gamma,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118303,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118304,Nrf2,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118305,cell,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118306,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118307,signaling,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118308,pathways,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118309,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118310,thus,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118311,leading,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118312,to,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118313,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118314,downregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118315,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118316,adipokines,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118317,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118318,including,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118319,tumor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118320,necrosis,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118321,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118322,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118323,interleukin-6,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118324,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118325,resistin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118326,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118327,leptin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118328,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118329,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118330,monocyte,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118331,chemotactic,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118332,protein-1,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118333,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118334,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118335,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118336,upregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118337,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118338,adiponectin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118339,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118340,other,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118341,gene,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118342,products,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118343,.,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118477,The,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118478,present,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118479,comprehensive,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118480,review,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118481,summarized,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118482,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118483,latest,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118484,studies,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118485,on,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118486,shellfish,B,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118487,consumption,I,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118488,and,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118489,synthesized,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118490,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118491,available,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118492,evidence,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118493,on,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118494,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118495,potential,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118496,health,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118497,benefits,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118498,or,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118499,risks,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118500,of,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118501,shellfish,B,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118502,consumption,I,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118503,.,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118574,Raw,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118575,shellfish,B,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118576,consumption,I,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118577,may,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118578,cause,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118579,gastroenteritis,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118580,and,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118581,other,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118582,diseases,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118583,infected,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118584,by,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118585,bacteria,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118586,or,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118587,viruses,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118588,.,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118615,Traditional,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118616,analysis,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118617,of,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118618,food,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118619,intake,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118620,usually,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118621,fails,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118622,to,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118623,show,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118624,an,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118625,association,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118626,between,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118627,energy,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118628,and,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118629,nutrient,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118630,intake,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118631,and,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118632,indicators,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118633,of,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118634,obesity,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118635,.,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
119038,Findings,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119039,from,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119040,individual,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119041,studies,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119042,confirm,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119043,that,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119044,acute,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119045,and,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119046,chronic,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119047,cocoa,B,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119048,intake,I,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119049,have,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119050,a,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119051,positive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119052,effect,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119053,on,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119054,several,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119055,cognitive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119056,outcomes,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119057,.,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119442,Females,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119443,consumed,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119444,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119445,on,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119446,average,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119447,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119448,1·5,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119449,times,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119450,more,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119451,fruit,B,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119452,and,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119453,vegetables,B,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119454,combined,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119455,when,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119456,compared,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119457,with,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119458,males,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119459,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119460,largely,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119461,explaining,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119462,the,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119463,sex,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119464,differences,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119465,in,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119466,DED,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119467,estimates,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119468,.,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119508,The,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119509,aim,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119510,was,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119511,to,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119512,compare,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119513,the,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119514,effect,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119515,on,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119516,atherogenesis,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119517,of,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119518,dietary,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119519,monounsaturated,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119520,and,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119521,saturated,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119522,fatty,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119523,acids,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119524,in,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119525,cholesterol,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119526,-,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119527,clamped,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119528,rabbits,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
119529,.,O,4166.0,The aim was to compare the effect on atherogenesis of dietary monounsaturated and saturated fatty acids in cholesterol - clamped rabbits .
120056,To,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120057,evaluate,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120058,the,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120059,possible,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120060,effects,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120061,on,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120062,insulin,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120063,function,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120064,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120065,49,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120066,herb,B,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120067,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120068,spice,B,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120069,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120070,and,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120071,medicinal,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120072,plant,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120073,extracts,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120074,were,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120075,tested,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120076,in,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120077,the,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120078,insulin,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120079,-,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120080,dependent,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120081,utilization,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120082,of,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120083,glucose,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120084,using,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120085,a,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120086,rat,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120087,epididymal,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120088,adipocyte,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120089,assay,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120090,.,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120091,Cinnamon,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120092,was,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120093,the,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120094,most,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120095,bioactive,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120096,product,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120097,followed,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120098,by,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120099,witch,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120100,hazel,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120101,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120102,green,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120103,and,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120104,black,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120105,teas,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120106,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120107,allspice,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120108,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120109,bay,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120110,leaves,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120111,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120112,nutmeg,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120113,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120114,cloves,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120115,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120116,mushrooms,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120117,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120118,and,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120119,brewer,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120120,'s,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120121,yeast,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120122,.,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120309,Yogurt,B,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120310,",",O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120311,a,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120312,fermented,B,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120313,milk,I,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120314,product,I,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120315,",",O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120316,has,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120317,a,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120318,similar,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120319,composition,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120320,to,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120321,milk,B,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120322,but,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120323,is,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120324,a,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120325,more,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120326,concentrated,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120327,product,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120328,in,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120329,terms,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120330,of,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120331,group,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120332,B,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120333,vitamins,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120334,",",O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120335,minerals,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120336,",",O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120337,and,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120338,proteins,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120339,.,O,4191.0,"Yogurt , a fermented milk product , has a similar composition to milk but is a more concentrated product in terms of group B vitamins , minerals , and proteins ."
120340,It,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120341,is,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120342,known,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120343,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120344,bioactive,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120345,metabolites,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120346,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120347,live,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120348,enzymes,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120349,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120350,occur,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120351,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120352,fermentation,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120353,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120354,digestion,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120355,",",O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120356,affect,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120357,the,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120358,health,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120359,positively,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120360,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120361,improving,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120362,gut,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120363,microbiota,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120364,.,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120638,Sex,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120639,specific,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120640,standardized,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120641,mortality,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120642,ratio,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120643,(,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120644,SMR,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120645,),O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120646,of,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120647,stroke,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120648,(,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120649,1969,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120650,-,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120651,83,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120652,),O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120653,was,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120654,calculated,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120655,for,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120656,each,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120657,trichotomized,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120658,food,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120659,expenditure,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120660,subgroup,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120661,and,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120662,compared,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120663,.,O,4204.0,Sex specific standardized mortality ratio ( SMR ) of stroke ( 1969 - 83 ) was calculated for each trichotomized food expenditure subgroup and compared .
120940,In,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120941,addition,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120942,",",O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120943,cheese,B,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120944,",",O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120945,fish,B,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120946,and,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120947,tea,B,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120948,had,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120949,a,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120950,protective,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120951,effect,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120952,during,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120953,adolescence,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120954,.,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
121309,Taken,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121310,together,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121311,",",O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121312,the,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121313,present,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121314,findings,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121315,provided,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121316,a,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121317,novel,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121318,insight,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121319,into,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121320,the,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121321,proteomes,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121322,of,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121323,milk,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121324,sEV,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121325,from,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121326,BLV,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121327,-,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121328,infected,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121329,cattle,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121330,.,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121461,Chocolate,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121462,consumers,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121463,(,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121464,81·8,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121465,%,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121466,),O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121467,were,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121468,more,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121469,likely,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121470,to,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121471,be,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121472,younger,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121473,",",O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121474,physically,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121475,active,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121476,",",O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121477,affluent,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121478,people,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121479,with,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121480,higher,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121481,education,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121482,levels,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121483,and,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121484,fewer,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121485,chronic,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121486,co,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121487,-,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121488,morbidities,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121489,.,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121702,The,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121703,aim,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121704,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121705,this,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121706,review,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121707,was,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121708,to,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121709,compile,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121710,evidence,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121711,on,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121712,the,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121713,effects,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121714,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121715,extracted,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121716,protein,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121717,from,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121718,a,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121719,wide,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121720,range,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121721,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121722,traditional,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121723,and,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121724,novel,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121725,plant,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121726,sources,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121727,on,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121728,glycemic,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121729,responses,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121730,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121731,appetite,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121732,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121733,body,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121734,weight,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121735,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121736,metabolic,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121737,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121738,cardiovascular,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121739,and,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121740,muscle,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121741,health,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121742,.,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
122121,PE,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122122,significantly,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122123,increased,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122124,plasma,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122125,antioxidant,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122126,capacity,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122127,by,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122128,9,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122129,%,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122130,in,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122131,Group,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122132,E,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122133,+,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122134,PE,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122135,and,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122136,18,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122137,%,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122138,in,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122139,Group,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122140,W,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122141,+,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122142,PE,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122143,compared,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122144,with,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122145,their,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122146,respective,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122147,controls,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122148,.,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
123129,Recently,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123130,",",O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123131,we,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123132,demonstrated,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123133,that,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123134,dietary,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123135,beef,B,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123136,causes,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123137,greater,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123138,colonic,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123139,DNA,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123140,strand,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123141,breakage,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123142,than,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123143,equivalent,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123144,levels,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123145,of,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123146,chicken,B,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123147,in,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123148,rats,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123149,and,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123150,that,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123151,resistant,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123152,starch,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123153,(,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123154,RS,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123155,),O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123156,as,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123157,20,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123158,%,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123159,high,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123160,amylose,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123161,maize,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123162,starch,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123163,(,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123164,HAMS,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123165,),O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123166,attenuated,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123167,the,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123168,damage,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123169,.,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123236,MDA,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123237,levels,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123238,were,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123239,increased,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123240,by,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123241,beef,B,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123242,diets,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123243,relative,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123244,to,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123245,the,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123246,chicken,B,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123247,diets,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123248,.,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123416,Enzyme,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123417,-,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123418,linked,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123419,immunosorbent,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123420,assay,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123421,(,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123422,ELISA,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123423,),O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123424,is,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123425,a,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123426,commonly,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123427,used,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123428,method,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123429,for,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123430,the,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123431,detection,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123432,of,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123433,trace,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123434,amounts,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123435,of,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123436,potentially,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123437,allergenic,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123438,protein,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123439,residues,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123440,in,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123441,foods,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123442,.,O,4302.0,Enzyme - linked immunosorbent assay ( ELISA ) is a commonly used method for the detection of trace amounts of potentially allergenic protein residues in foods .
123443,However,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123444,",",O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123445,food,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123446,matrices,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123447,and,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123448,processing,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123449,conditions,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123450,can,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123451,affect,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123452,the,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123453,detection,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123454,of,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123455,protein,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123456,residues,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123457,.,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123516,When,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123517,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123518,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123519,of,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123520,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123521,salad,B,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123522,dressing,I,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123523,was,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123524,adjusted,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123525,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123526,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123527,7,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123528,prior,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123529,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123530,spiking,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123531,with,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123532,mustard,B,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123533,",",O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123534,recovery,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123535,improved,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123536,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123537,94.1%+/-,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123538,7.6,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123539,%,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123540,.,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
124736,The,O,4350.0,The liver plays an outsized role in oncology .
124737,liver,O,4350.0,The liver plays an outsized role in oncology .
124738,plays,O,4350.0,The liver plays an outsized role in oncology .
124739,an,O,4350.0,The liver plays an outsized role in oncology .
124740,outsized,O,4350.0,The liver plays an outsized role in oncology .
124741,role,O,4350.0,The liver plays an outsized role in oncology .
124742,in,O,4350.0,The liver plays an outsized role in oncology .
124743,oncology,O,4350.0,The liver plays an outsized role in oncology .
124744,.,O,4350.0,The liver plays an outsized role in oncology .
125483,Despite,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125484,having,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125485,these,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125486,types,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125487,of,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125488,compounds,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125489,",",O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125490,it,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125491,is,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125492,not,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125493,possible,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125494,to,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125495,assimilate,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125496,them,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125497,",",O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125498,their,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125499,use,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125500,in,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125501,the,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125502,food,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125503,industry,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125504,has,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125505,been,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125506,limited,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125507,",",O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125508,since,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125509,sorghum,B,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125510,is,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125511,considered,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125512,a,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125513,food,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125514,of,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125515,low,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125516,nutritional,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125517,value,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125518,",",O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125519,due,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125520,to,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125521,the,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125522,presence,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125523,of,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125524,anti,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125525,-,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125526,nutritional,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125527,factors,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125528,such,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125529,as,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125530,strong,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125531,tannins,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125532,which,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125533,form,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125534,complexes,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125535,with,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125536,proteins,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125537,and,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125538,iron,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125539,",",O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125540,thus,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125541,reducing,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125542,their,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125543,digestibility,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125544,.,O,4378.0,"Despite having these types of compounds , it is not possible to assimilate them , their use in the food industry has been limited , since sorghum is considered a food of low nutritional value , due to the presence of anti - nutritional factors such as strong tannins which form complexes with proteins and iron , thus reducing their digestibility ."
125956,We,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125957,examined,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125958,these,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125959,associations,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125960,with,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125961,risk,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125962,of,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125963,incident,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125964,rectal,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125965,cancer,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125966,in,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125967,a,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125968,population,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125969,-,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125970,based,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125971,case,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125972,-,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125973,control,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125974,study,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125975,of,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125976,952,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125977,cases,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125978,and,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125979,"1,205",O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125980,controls,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125981,living,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125982,in,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125983,northern,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125984,California,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125985,and,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125986,Utah,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125987,.,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
126287,The,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126288,interactions,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126289,of,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126290,fiber,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126291,with,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126292,water,B,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126293,intake,I,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126294,suggest,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126295,that,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126296,bowel,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126297,motility,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126298,may,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126299,be,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126300,the,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126301,mechanism,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126302,responsible,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126303,for,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126304,modification,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126305,of,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126306,rectal,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126307,cancer,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126308,risk,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126309,for,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126310,water,B,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126311,.,O,4400.0,The interactions of fiber with water intake suggest that bowel motility may be the mechanism responsible for modification of rectal cancer risk for water .
126312,Associations,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126313,of,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126314,alcohol,B,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126315,to,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126316,risk,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126317,for,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126318,rectal,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126319,cancer,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126320,may,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126321,be,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126322,related,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126323,to,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126324,cellular,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126325,hyperproliferation,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126326,and,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126327,may,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126328,be,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126329,modified,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126330,by,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126331,NSAID,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126332,use,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126333,.,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126334,To,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126335,evaluate,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126336,the,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126337,associations,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126338,of,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126339,changes,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126340,in,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126341,diet,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126342,during,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126343,adult,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126344,life,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126345,with,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126346,adenoma,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126347,risk,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126348,",",O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126349,data,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126350,from,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126351,a,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126352,case,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126353,-,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126354,control,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126355,study,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126356,of,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126357,146,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126358,colorectal,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126359,adenomas,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126360,and,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126361,226,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126362,controls,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126363,were,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126364,analyzed,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126365,.,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126739,Since,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126740,different,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126741,types,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126742,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126743,foods,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126744,contain,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126745,differing,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126746,proportions,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126747,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126748,macronutrients,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126749,",",O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126750,the,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126751,present,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126752,study,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126753,investigated,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126754,the,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126755,associations,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126756,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126757,different,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126758,types,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126759,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126760,foods,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126761,ingested,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126762,at,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126763,various,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126764,times,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126765,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126766,day,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126767,with,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126768,total,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126769,daily,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126770,and,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126771,macronutrient,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126772,intakes,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126773,.,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126913,Dietary,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126914,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126915,density,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126916,appeared,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126917,to,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126918,mediate,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126919,the,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126920,associations,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126921,between,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126922,particular,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126923,foods,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126924,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126925,beverages,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126926,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126927,overall,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126928,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126929,intake,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126930,.,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126993,This,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126994,study,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126995,was,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126996,conducted,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126997,to,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126998,identify,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126999,associations,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127000,between,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127001,total,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127002,sugar,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127003,intake,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127004,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127005,sugar,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127006,intake,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127007,from,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127008,different,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127009,foods,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127010,(,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127011,fruit,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127012,",",O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127013,milk,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127014,",",O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127015,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127016,sugar,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127017,-,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127018,sweetened,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127019,beverages,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127020,(,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127021,SSBs,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127022,),O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127023,),O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127024,",",O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127025,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127026,adiposity,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127027,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127028,continuous,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127029,metabolic,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127030,syndrome,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127031,scores,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127032,(,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127033,cMetS,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127034,),O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127035,among,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127036,Korean,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127037,children,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127038,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127039,adolescents,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127040,using,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127041,cohort,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127042,data,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127043,.,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127075,Dietary,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127076,intake,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127077,data,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127078,were,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127079,collected,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127080,via,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127081,three,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127082,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127083,day,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127084,24,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127085,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127086,h,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127087,food,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127088,records,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127089,",",O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127090,and,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127091,sugar,B,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127092,intake,I,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127093,was,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127094,calculated,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127095,for,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127096,the,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127097,total,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127098,sugar,B,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127099,content,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127100,of,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127101,foods,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127102,using,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127103,our,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127104,database,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127105,compiled,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127106,from,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127107,various,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127108,sources,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127109,.,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127339,Our,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127340,results,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127341,suggest,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127342,that,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127343,strategies,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127344,for,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127345,reducing,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127346,sugar,B,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127347,intake,I,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127348,need,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127349,to,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127350,target,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127351,particular,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127352,food,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127353,groups,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127354,.,O,4429.0,Our results suggest that strategies for reducing sugar intake need to target particular food groups .
127426,Unfortified,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127427,and,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127428,folic,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127429,acid,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127430,fortified,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127431,Baladi,B,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127432,breads,I,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127433,were,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127434,prepared,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127435,.,O,4433.0,Unfortified and folic acid fortified Baladi breads were prepared .
127464,Rats,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127465,were,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127466,divided,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127467,into,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127468,five,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127469,groups,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127470,",",O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127471,four,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127472,of,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127473,them,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127474,were,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127475,injected,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127476,subcutaneously,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127477,with,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127478,dimethylhydrazine,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127479,(,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127480,DMH,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127481,),O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127482,.,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127897,All,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127898,treatments,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127899,were,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127900,administered,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127901,as,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127902,a,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127903,total,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127904,volume,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127905,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127906,1.9,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127907,L.,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127908,Administration,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127909,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127910,PG,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127911,decreased,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127912,concentrations,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127913,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127914,nonesterified,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127915,fatty,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127916,acids,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127917,(,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127918,NEFA,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127919,),O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127920,in,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127921,plasma,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127922,during,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127923,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127924,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127925,7,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127926,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127927,and,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127928,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127929,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127930,21,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127931,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127932,postpartum,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127933,and,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127934,tended,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127935,to,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127936,decrease,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127937,concentrations,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127938,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127939,beta,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127940,-,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127941,hydroxybutyrate,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127942,during,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127943,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127944,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127945,7,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127946,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127947,postpartum,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127948,.,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
128252,These,O,4459.0,These results are based on statistical analyses .
128253,results,O,4459.0,These results are based on statistical analyses .
128254,are,O,4459.0,These results are based on statistical analyses .
128255,based,O,4459.0,These results are based on statistical analyses .
128256,on,O,4459.0,These results are based on statistical analyses .
128257,statistical,O,4459.0,These results are based on statistical analyses .
128258,analyses,O,4459.0,These results are based on statistical analyses .
128259,.,O,4459.0,These results are based on statistical analyses .
128532,Concordance,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128533,between,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128534,skin,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128535,prick,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128536,test,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128537,and,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128538,case,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128539,history,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128540,was,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128541,found,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128542,in,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128543,77,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128544,%,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128545,",",O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128546,52,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128547,%,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128548,",",O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128549,and,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128550,54,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128551,%,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128552,",",O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128553,for,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128554,apple,B,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128555,",",O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128556,peach,B,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128557,",",O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128558,and,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128559,hazelnut,B,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128560,",",O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128561,respectively,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
128562,.,O,4469.0,"Concordance between skin prick test and case history was found in 77 % , 52 % , and 54 % , for apple , peach , and hazelnut , respectively ."
129044,In,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129045,true,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129046,plant,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129047,-,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129048,based,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129049,diets,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129050,",",O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129051,unsaturated,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129052,fatty,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129053,acids,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129054,predominate,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129055,",",O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129056,whereas,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129057,saturated,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129058,fatty,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129059,acids,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129060,come,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129061,largely,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129062,from,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129063,animal,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129064,sources,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129065,such,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129066,as,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129067,dairy,B,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129068,products,I,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129069,and,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129070,eggs,B,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129071,.,O,4489.0,"In true plant - based diets , unsaturated fatty acids predominate , whereas saturated fatty acids come largely from animal sources such as dairy products and eggs ."
129254,About,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129255,50,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129256,%,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129257,of,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129258,those,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129259,studied,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129260,ate,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129261,meat,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129262,products,I,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129263,<,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129264,1,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129265,time,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129266,/,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129267,wk,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129268,or,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129269,not,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129270,at,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129271,all,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129272,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129273,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129274,vegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129275,consumed,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129276,more,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129277,tomatoes,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129278,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129279,legumes,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129280,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129281,nuts,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129282,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129283,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129284,fruit,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129285,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129286,but,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129287,less,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129288,coffee,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129289,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129290,doughnuts,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129291,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129292,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129293,eggs,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129294,than,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129295,did,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129296,nonvegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129297,.,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129571,Although,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129572,acute,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129573,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129574,show,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129575,reductions,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129576,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129577,postprandial,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129578,glycemia,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129579,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129580,healthy,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129581,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129582,ingesting,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129583,60,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129584,to,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129585,90,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129586,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129587,almonds,B,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129588,",",O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129589,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129590,have,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129591,not,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129592,been,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129593,conducted,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129594,using,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129595,a,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129596,single,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129597,serving,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129598,of,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129599,almonds,B,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129600,(,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129601,28,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129602,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129603,),O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129604,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129605,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129606,with,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129607,type,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129608,2,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129609,diabetes,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129610,mellitus,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129611,.,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129697,A,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129698,small,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129699,pilot,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129700,study,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129701,(,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129702,6,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129703,-,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129704,7,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129705,subjects,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129706,per,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129707,group,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129708,),O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129709,was,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129710,also,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129711,conducted,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129712,to,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129713,observe,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129714,whether,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129715,chronic,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129716,almond,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129717,ingestion,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129718,(,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129719,1,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129720,serving,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129721,5,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129722,d,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129723,/,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129724,wk,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129725,for,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129726,12,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129727,weeks,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129728,),O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129729,lowered,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129730,hemoglobin,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129731,A(1c,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129732,),O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129733,in,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129734,individuals,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129735,with,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129736,type,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129737,2,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129738,diabetes,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129739,mellitus,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
129740,.,O,4509.0,A small pilot study ( 6 - 7 subjects per group ) was also conducted to observe whether chronic almond ingestion ( 1 serving 5 d / wk for 12 weeks ) lowered hemoglobin A(1c ) in individuals with type 2 diabetes mellitus .
130269,Scratch,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130270,tests,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130271,with,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130272,common,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130273,spices,B,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130274,were,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130275,performed,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130276,in,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130277,"1,120",O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130278,atopic,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130279,and,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130280,380,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130281,non,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130282,-,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130283,atopic,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130284,patients,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130285,.,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130505,In,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130506,the,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130507,present,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130508,studies,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130509,",",O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130510,dosing,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130511,relied,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130512,on,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130513,injection,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130514,of,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130515,oil,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130516,into,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130517,live,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130518,feeder,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130519,fish,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130520,for,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130521,oral,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130522,dosing,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130523,of,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130524,these,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130525,piscivorous,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130526,birds,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130527,",",O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130528,or,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130529,applying,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130530,oil,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130531,to,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130532,body,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130533,contour,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130534,feathers,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130535,resulting,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130536,in,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130537,transdermal,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130538,oil,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130539,exposure,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130540,and,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130541,oral,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130542,exposure,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130543,through,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130544,preening,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130545,.,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130716,Extensive,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130717,research,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130718,has,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130719,identified,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130720,several,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130721,molecular,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130722,targets,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130723,that,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130724,can,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130725,potentially,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130726,be,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130727,used,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130728,for,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130729,the,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130730,prevention,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130731,and/or,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130732,treatment,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130733,of,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130734,cancer,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130735,.,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130736,In,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130737,this,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130738,review,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130739,",",O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130740,we,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130741,accumulate,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130742,evidences,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130743,of,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130744,modulating,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130745,abilities,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130746,of,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130747,some,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130748,dietary,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130749,plants,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130750,and,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130751,their,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130752,products,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130753,on,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130754,several,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130755,signaling,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130756,pathways,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130757,",",O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130758,including,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130759,the,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130760,inflammatory,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130761,and,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130762,apoptotic,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130763,ones,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130764,",",O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130765,which,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130766,may,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130767,be,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130768,targeted,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130769,for,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130770,cancer,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130771,therapy,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130772,.,O,4549.0,"In this review , we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways , including the inflammatory and apoptotic ones , which may be targeted for cancer therapy ."
130942,Epidemiological,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130943,studies,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130944,have,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130945,observed,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130946,a,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130947,negative,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130948,association,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130949,between,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130950,tomato,B,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130951,intake,I,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130952,and,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130953,the,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130954,incidence,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130955,of,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130956,cardiovascular,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130957,disease,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130958,.,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
131127,Biochemical,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131128,parameters,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131129,and,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131130,cellular,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131131,and,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131132,circulating,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131133,inflammatory,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131134,biomarkers,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131135,were,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131136,assessed,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131137,at,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131138,baseline,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131139,and,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131140,6,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131141,h,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131142,after,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131143,each,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131144,intervention,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131145,.,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131363,The,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131364,Food,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131365,and,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131366,Drug,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131367,Administration,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131368,(,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131369,FDA,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131370,),O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131371,has,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131372,already,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131373,approved,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131374,four,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131375,compounds,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131376,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131377,namely,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131378,vorinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131379,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131380,romidepsin,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131381,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131382,belinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131383,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131384,and,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131385,panobinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131386,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131387,as,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131388,HDACi,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131389,for,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131390,the,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131391,treatment,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131392,of,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131393,cancer,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131394,.,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131455,Several,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131456,HDACi,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131457,of,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131458,natural,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131459,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131460,dietary,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131461,origin,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131462,are,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131463,butein,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131464,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131465,protocatechuic,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131466,aldehyde,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131467,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131468,kaempferol,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131469,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131470,grapes,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131471,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131472,green,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131473,tea,I,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131474,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131475,tomatoes,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131476,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131477,potatoes,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131478,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131479,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131480,onions,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131481,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131482,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131483,resveratrol,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131484,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131485,grapes,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131486,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131487,red,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131488,wine,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131489,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131490,blueberries,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131491,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131492,peanuts,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131493,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131494,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131495,sinapinic,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131496,acid,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131497,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131498,wine,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131499,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131500,vinegar,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131501,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131502,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131503,diallyl,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131504,disulfide,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131505,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131506,garlic,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131507,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131508,",",O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131509,and,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131510,zerumbone,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131511,(,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131512,ginger,B,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131513,),O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131514,.,O,4570.0,"Several HDACi of natural and dietary origin are butein , protocatechuic aldehyde , kaempferol ( grapes , green tea , tomatoes , potatoes , and onions ) , resveratrol ( grapes , red wine , blueberries and peanuts ) , sinapinic acid ( wine and vinegar ) , diallyl disulfide ( garlic ) , and zerumbone ( ginger ) ."
131646,The,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131647,added,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131648,ingredients,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131649,were,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131650,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131651,1,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131652,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131653,hydrocolloids,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131654,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131655,carboxymethylcellulose,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131656,[,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131657,CMC,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131658,],O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131659,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131660,guar,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131661,gum,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131662,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131663,hydroxypropylmethylcellulose,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131664,[,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131665,HPMC,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131666,],O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131667,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131668,and,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131669,xanthan,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131670,gum,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131671,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131672,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131673,and,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131674,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131675,2,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131676,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131677,substitutes,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131678,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131679,buckwheat,B,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131680,flour,I,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131681,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131682,whole,B,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131683,egg,I,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131684,powder,I,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131685,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131686,and,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131687,whey,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131688,proteins,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131689,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131690,.,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131739,Hardness,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131740,decreased,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131741,with,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131742,the,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131743,addition,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131744,of,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131745,hydrocolloids,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131746,",",O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131747,especially,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131748,HPMC,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131749,and,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131750,guar,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
131751,.,O,4579.0,"Hardness decreased with the addition of hydrocolloids , especially HPMC and guar ."
132212,Colorectal,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132213,carcinoma,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132214,(,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132215,CRC,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132216,),O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132217,is,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132218,the,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132219,second,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132220,most,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132221,common,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132222,cancer,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132223,diagnosed,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132224,in,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132225,Algeria,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132226,.,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
